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Tuberculosis is one of the most pernicious diseases in the world. With more than 1.3 million 
death per year, tuberculosis ranks as the second leading cause of death due to a single 
infectious agent. Mycobacterium tuberculosis, the causative agent of tuberculosis is a slow-
growing, G+C-rich Gram-positive bacterium. Mycobacteria in general are characterized by a 
unique and complex cell envelope which forms a permeability barrier conferring natural 
resistance to many chemical compounds and therapeutic agents. Therefore, tuberculosis 
treatment is difficult and lengthy, but especially the increased occurance of antibiotic resistant 
bacteria or bacteria resistant to almost every available drug, exacerbates the fight against the 
disease. To substantially improve this situation, new anti-tuberculosis drugs or potential drug 
targets, new vaccines and a detailed understanding of host-pathogen interactions are needed.  
Lipoproteins are secreted proteins N-terminally modified with fatty acids by the consecutive 
action of preprolipoprotein diacylglyceryl transferase (Lgt), prolipoprotein signal peptidase 
(LspA) and apolipoprotein N-acyltransferase (Lnt). Mycobacterial lipoproteins are 
immunodominant antigens, feature many diverse functions and are involved in several 
biological processes correlated with virulence. Thus, lipoproteins are candidates for novel 
drug targets or subunit vaccines.  
The aim of this study was the molecular characterization of the membrane anchor of 
lipoproteins 1) in the fast-growing Mycobacterium smegmatis, 2) the slow-growing 
Mycobacterium bovis BCG and 3) in the related Streptomyces scabies. The identification of 
enzymes involved in the synthesis of the membrane anchor was an additional aim.  
M. tuberculosis lipoproteins were heterologously expressed in M. smegmatis and M. bovis 
BCG, purified and analysed by MALDI-TOF/TOF analyses. The structure of the lipid 
modification was solved at the molecular level and determined as thioether-linked 
diacylglyceryl residue and an amide-linked third fatty acid. Palmitic, oleic and 
tuberculostearic acid were found as ester-linked moieties in the diacylglyceryl residue, while 
palmitic acid was found as fatty acid for the N-acyl. Aside from that, tuberculostearic acid 
was identified as substrate for N-acylation in M. bovis BCG. Isogenic knockout mutants in the 
gene homologous to Escherichia coli lnt have been generated to investigate N-acylation. ORF 
BCG_2070c was identified as apolipoprotein N-acyltransferase in M. bovis BCG.  
Analysis of lipoproteins expressed in S. scabies showed a similar acylation pattern as in 
mycobacteria and demonstrated Lnt function in a monoderm GC-rich Gram-positive 
bacterium. Therefore, lipoprotein synthesis by Lgt, LspA and Lnt modification seems to be a 
conserved mechanism in bacteria.  
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Tuberkulose gilt als eine der verheerendsten Krankheiten der Welt. Mit mehr als 1.3 
Millionen Todesfällen pro Jahr ist Tuberkulose die zweithäufigste Todesursache unter den 
Infektionskrankheiten. Der Erreger der Tuberkulose, Mycobacterium tuberculosis, ist ein 
langsam wachsendes, Gram-positives Bakterium, dessen Genom einen hohen G+C Anteil 
aufweist. Mykobakterien im Allgemeinen sind durch eine einzigartige und komplexe 
Zellhülle gekennzeichnet, welche eine Permeabilitätsbarriere darstellt und somit natürliche 
Resistenz gegen chemische Substanzen und therapeutische Arzneimittel verleiht. Dies macht 
die Tuberkulosebehandlung schwierig und langwierig, aber besonders die wachsende Anzahl 
antibiotikaresistenter Bakterien und solcher, die gegen annähernd alle vorhandenen 
Medikamente resistent sind, erschwert den Kampf gegen die Krankheit. Um diese Situation 
erheblich zu verbessern werden dringend neue anti-tuberkulöse Medikamente, neue 
Impfstoffe und ein detailliertes Wissen über die Wirt-Pathogen Interaktionen benötigt.  
Lipoproteine sind sekretierte Proteine, welche durch die aufeinanderfolgende Aktion von Pre-
prolipoprotein Diacylglyceryltransferase (Lgt), Prolipoprotein Signalpeptidase (LspA) und 
Apolipoprotein N-acyltransferase (Lnt) N-terminal mit Fettsäuren modifiziert werden. 
Mykobakterielle Lipoproteine sind immunodominante Antigene. Sie weisen viele 
verschiedene Funktionen auf und sind in diverse biologische Prozesse involviert, welche mit 
der Virulenz in Verbindung gebracht werden. Aus diesem Grund stellen Lipoproteine 
Kandidaten als Zielstrukturen für neue Medikamente oder Impfstoffe dar. 
Das Ziel dieser Arbeit war die molekulare Charakterisierung des Membran-Ankers von 
Lipoproteinen 1) im schnell-wachsenden Mycobacterium smegmatis, 2) im langsam-
wachsenden Mycobacterium bovis BCG und 3) im verwandten Streptomyces scabies. Ein 
weiteres Ziel war die Indentifizierung der Enzyme, welche an der Synthese des Membran-
Ankers beteiligt sind. 
M. tuberculosis Lipoproteine wurden heterolog in M. smegmatis und M. bovis BCG 
exprimiert, aufgereinigt und per MALDI-TOF/TOF Analyse analysiert. Die Struktur des 
Lipidankers wurde bis zur molekularen Ebene aufgeklärt und als thioether-gebundener 
Diacylglyceryl Rest und amid-gebundene dritte Fettsäure entschlüsselt. Palmitat, Oleat und 
Tuberculostearat wurden als ester-gebundene Strukturen des Diacylglyceryl Rests und 
Palmitat als Fettsäure für das N-acyl gefunden. Desweiteren wurde Tuberculostearat als 
Substrat für die N-acylierung in M. bovis BCG identifiziert. Zur Untersuchung der 
N-acylierung wurden isogene Deletionsmutanten im homologen Gen zum Escherichia coli lnt 
generiert. Dabei wurde der offene Leserahmen BCG_2070c als Apolipoprotein-
N-acyltranferase in M. bovis BCG identifiziert.  
ZUSAMMENFASSUNG 
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Die Analyse von Lipoproteinen aus S. scabies ergab ein ähnliches Acylierungsmuster wie in 
den Mykobakterien und bestätigte somit eine Lnt Funktion auch in monodermen G+C-reichen 
Gram-positiven Bakterien. Die Lipoprotein-Modifizierung mit drei Fettsäuren durch Lgt, 
LspA und Lnt, kann daher als konservierter Mechanismus in Bakterien angesehen werden. 
INTRODUCTION 
13 
 
 
 
„…erst durch die Entdeckung des Tuberkelbazillus wurde die Ätiologie der 
Tuberkulose auf eine sichere Grundlage gestellt und die Überzeugung 
gewonnen, dass dieselbe eine parasitäre, d. h. eine ansteckende, aber auch 
vermeidbare Krankheit ist. Schon bei den ersten Mitteilungen über die 
Ätiologie der Tuberkulose habe ich auf die Gefahren hingewiesen, welche 
durch die Verbreitung der bazillenhaltigen Absonderungen der 
Schwindsüchtigen entstehen, und habe dazu aufgefordert, prophylaktische 
Massregeln gegen die Seuche zu ergreifen. Aber meine Worte sind 
unbeachtet geblieben. Es war eben noch zu früh, und sie konnten deswegen 
noch keinem vollen Verständnis begegnen. Es ging damit wie bei so vielen 
ähnlichen Gelegenheiten in der Medizin, wo es auch langer Zeit bedurft hat, 
ehe alte Vorurteile überwunden und die neuen Tatsachen von den Ärzten als 
richtig anerkannt wurden. Aber ganz allmählich hat sich dann die 
Erkenntnis von der ansteckenden Natur der Tuberkulose verbreitet und 
immer tiefere Wurzeln gefasst, und je mehr die Überzeugung von der 
Gefährlichkeit der Tuberkulose sich Bahn brach, umso mehr hat sich auch 
die Notwendigkeit aufgedrängt, sich dagegen zu schützen.“ 
 
Dr. Robert Koch „Über den derzeitigen Stand der Tuberkulosebekämpfung“ Nobel-
Vorlesung, gehalten in Stockholm am 12. Dezember 1905. Deutsche Medizinische 
Wochenschrift, 1906, Nr. 3 
Tuberculosis is an ancient scourge. It has plagued mankind worldwide throughout much of 
known human history. Among the early record about tuberculosis, there are 3300 years old 
written texts from India describing the disease. In Egypt, tuberculosis can be dated back to 
even more than 5000 years ago, where typical skeletal abnormalities of tuberculosis have 
been found in mummies. Pulmonary tuberculosis was well known in ancient Greece. 
Hippocrates (460-370 BC) was the first describing it as “phthisis” or consumption and as the 
most considerable of the diseases. During the 18th and 19th centuries tuberculosis reached 
epidemic proportions in Europe and North America so that it was referred to as the “White 
Plague”. Among the thousands of victims it claimed were prominent people such as Friedrich 
Schiller, Frédéric Chopin, Charlotte Brontё, Lord Byron or Franz Kafka. Then the history of 
tuberculosis was changed. The identification of Mycobacterium tuberculosis as the etiologic 
agent by Robert Koch in 1882, the initiation of Mycobacterium bovis BCG by Albert 
Calmette and Camille Guérin as the first tuberculosis vaccine applied to a human in 1921 and
the discovery of antibiotics such as streptomycin in 1944 and isoniazid in 1952 reduced the
INTRODUCTION 
14 
 
death toll from tuberculosis for decades. Nevertheless, tuberculosis remains as deadly as it 
was (Daniel, 2006; Gengenbacher & Kaufmann, 2012). 
 
Tuberculosis 
 
Tuberculosis is still one of the most devastating diseases in the world. With 1.3 million deaths 
occuring in 2012 it is the second leading cause of death from a single infectious agent, after 
the human immunodeficiency virus (HIV) (http://www.who.int/tb/publications/factsheet_
global.pdf?ua=1). The causative agent of tuberculosis, M. tuberculosis is primarily 
transmitted via the respiratory route and establishes its infection usually in the lungs, although 
most organs can be infected. Most people who come in contact with the pathogen remain 
clinically asymptomatic and develop a latent infection. It is estimated that one third of the 
world’s population is latently affected (about 2 billion people). Only 5-10% of the infected 
individuals ever develop an active tuberculosis, however, with the number of 8.6 million new 
active cases in 2012 it is higher than at any other time in history (http://www.who.int/tb/
publications/factsheet_global.pdf?ua=1).  
The risk of resuscitation and transition from latent to active disease is increased by co-
infection with HIV about 30 times compared to that in HIV-negative people 
(http://www.who.int/tb/challenges/hiv/tbhiv_factsheet_2013_web.pdf?ua=1). Other immuno- 
compromising treatments like anti-tumor necrosis factor therapy for chronic inflammatory 
diseases or factors like diabetes, alcoholism or poor nutrition are additional factors favouring 
for reactivation (Gengenbacher & Kaufmann, 2012). 
 
Principally, the enormous success of M. tuberculosis is attributed to several capacities: the 
bacterium evades its elimination by innate and acquired host immune response by persisting 
inside macrophages, it is equipped with a thick and waxy cell wall which protects the 
pathogen against physical or chemical stress, it is naturally resistant to several antibiotics and 
slow-growing which makes antibiotic treatment difficult and longsome (Ducati et al., 2006). 
In addition, the HIV/AIDS pandemic over the past few decades and the occurrence of drug-
resistant strains represent a devastating problem in treatment of tuberculosis and account for 
its worldwide spread.  
 
Co-infection of tuberculosis with HIV is the major risk for the conversion of latent into active 
disease. With one-third, tuberculosis is the most common presenting illness among the 35.3 
INTRODUCTION 
15 
 
million people living with HIV worldwide. In 2012, 320.000 people died from HIV-
associated tuberculosis, which makes it the leading cause of death among HIV-infected 
individuals (http://www.who.int/tb/challenges/hiv/tbhiv_factsheet_2013_web.pdf?ua=1). The 
two infections mainly intersect in the world’s poorest countries and where AIDS is prevalent, 
namely in sub-Saharan Africa and Asia, thereby highly magnifying the death-toll (Dietrich & 
Doherty, 2009). 
 
M. tuberculosis is naturally resistant to several antibiotics. The resistant phenotypes can be 
attributed to the unusual structure and low permeability of the mycobacterial cell wall, the 
presence of drug efflux systems or drug-modifying enzymes (Niederweis et al., 2010). In 
contrast, acquired resistance to anti-tuberculosis drugs primarily arises due to inadequate drug 
prescription, poor drug quality and non-compliance of the patients (Abubakar et al., 2013). 
Over the past two decades acquired drug-resistance mechanisms led to the worldwide 
emergence of multidrug-, then extensively-, and, most recently, totally drug-resistant strains 
of M. tuberculosis (Migliori et al., 2007; Velayati et al., 2009). Tuberculosis caused by these 
resistant strains is much more difficult, cost-intensive and even longer to treat and threatens to 
undermine tuberculosis control (Abubakar et al., 2013).  
 
The standard treatment for drug-susceptible tuberculosis consists of a combination of the four 
first line drugs (isoniazid, rifampicin, pyrazinamide and ethambutol) for an initial phase of 
two months. In this phase, all replicating bacteria are eradicated, the sputum becomes sterile 
and the patient is no longer infectious. In the following four month phase a regimen of two 
first-line drugs, usually isoniazid and rifampicin, is given to eradicate the remaining non-
replicating bacteria. The therapy of multidrug-resistant tuberculosis (MDR-TB), which is 
defined as tuberculosis caused by bacteria that are resistant to at least the two most effective 
first-line drugs, isoniazid and rifampicin (Böttger & Springer, 2008) is considerably longer 
(18-24 months) and based on the use of less effective second-line drugs that are associated 
with toxic effects (Lawn & Zumla, 2011). In 2012, there were more than 450.000 new 
multidrug-resistant cases in the world, with more than one half of these cases occurring in 
China, India and the Russian Federation. In recent years, M. tuberculosis strains additionally 
became resistant to an increasing number of drugs. Extensively drug-resistant (XDR) M. 
tuberculosis shows resistance to isoniazid and rifampicin as well as resistance to any 
fluoroquinolone and any of the injectable second-line drugs (amikacin, kanamycin and 
capreomycin) (http://www.who.int/tb/challenges/mdr/mdr_tb_factsheet.pdf?ua=1). Totally 
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drug-resistant tuberculosis bacteria are resistant to almost all antituberculosis drugs (Migliori 
et al., 2007; Velayati et al., 2009). Due to the resistance of XDR-M. tuberculosis to the most 
effective first- and second-line medications, patients with XDR-tuberculosis are often left 
with less-effective treatment options and it is not uncommon that people die with XDR-TB 
even after starting treatment (Abubakar et al., 2013). 
 
In order to contain the pandemic spread of tuberculosis, there is a strong need for an 
universally effective vaccine. The only licensed current vaccine, Bacille Calmette-Guérin 
(BCG) is an attenuated strain of M. bovis, the agent that causes tuberculosis in cattle. Albert 
Calmette and Camille Guérin developed BCG by 230 continuous in vitro passages in which 
the originally virulent M. bovis had lost its pathogenicity by undefined genetic alterations. The 
first dose was given to an infant in 1921, up to date, the vaccine has been administered to at 
least four billion individuals, making it the most widely used vaccine in the world (Weiner & 
Kaufmann, 2014). However, it has done little to satisfy the control of tuberculosis. Despite 
clear beneficial effects against tuberculosis in childhood, protection induced by BCG can 
wane within a number of years and thus, the protection from adult pulmonary tuberculosis is 
insufficient and varies from 80% to 0% (Gupta et al., 2007). In addition, BCG is a pre-
exposure vaccine and fails to provide protective immunity in people pre-sensitized to 
mycobacteria by M. tuberculosis infection or prior BCG vaccination. This means that BCG 
cannot be used as a booster vaccine to overcome the transient effect of the vaccination 
administered soon after birth (Dietrich & Doherty, 2009). Hence, new tuberculosis vaccines 
are urgently needed. There have been recent advantages in development of new vaccines with 
some candidates already undergoing clinical trials. The majority of these vaccines aim at 
prevention of active tuberculosis. These include pre-exposure prime vaccines, which could 
replace BCG, or pre-exposure booster vaccines given during childhood in addition to BCG 
prime vaccination. Post-exposure booster vaccines are designed for adolescents or adults with 
latent tuberculosis infection who had been vaccinated with BCG in childhood. Some 
therapeutic vaccines are tested for their potential as adjuvants in chemotherapy during active 
tuberculosis in adults (Weiner & Kaufmann, 2014). The ideal vaccine would be counteracting 
M. tuberculosis in all different stages of the infection, thereby being effective against active 
disease and latent infection. However, no such “multistage” vaccine is expected to become 
available until 2020 (Dietrich & Doherty, 2009). 
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Pathogenesis 
 
The infection with the pathogen M. tuberculosis, the causative agent of tuberculosis follows a 
well-defined sequence of events. The infectious bacilli are aerogenically transmitted and after 
inhalation they are phagocytosed by alveolar macrophages in the lung and induce a localized 
inflammatory response (Ducati et al., 2006). Only 1-10 bacilli are necessary to cause an 
infection (Bloom & Murray, 1992). Once the bacterium parasitizes the macrophage, the host 
usually is not able to eliminate, but to contain the pathogen by remodelling the site of 
infection into granuloma. These lesions, also called tubercles, which define the disease, 
contain infected macrophages in the center. This restricts growths and prevents the 
dissemination of the bacteria marking the end of the primary infection. Nevertheless, there are 
also some individuals that progress rapidly into active disease after initial infection, and, also 
some people that are resistant to M. tuberculosis or may have cleared infection through an 
effective innate immune response (O'Garra et al., 2013). 
During the following latent phase of the disease, there are no overt signs of tuberculosis like 
the typical cough and there is no infectious risk for others. The bacteria coexist within the host 
in a dormant form of infection, though still representing a large bacterial reservoir among 
infected individuals. The survival inside the macrophages is an attribute to the ability of 
M. tuberculosis to manipulate the phagosome in which it resides. The bacillus prevents the 
normal maturation of this organelle into an acidic and hydrolytically active compartment, thus 
avoiding a productive host immune response and activation of the macrophage (Russell, 
2001). There is also recent evidence that M. tuberculosis is able to rupture its phagosome, 
thereby it gains access to the host cytosol and induces necrotic cell death of the infected 
macrophage. Like this, the bacterium escapes innate host defences and favors its own spread 
to new cells (Simeone et al., 2012; van der Wel et al., 2007). 
Approximately 5-10 % of the infected individuals develop active tuberculosis during their 
life-time. Reactivation of the latent disease is triggered by factors that compromise the 
immune status of the host, like malnutrition, age, cancer or co-infection with HIV (Ducati et 
al., 2006). Under such circumstances, the cellular immune system is not able to control the 
integrity of the granuloma anymore. The granuloma decays into a structureless mass of cell 
debris and spills viable infectious bacilli into the airways, thus developing a productive 
infectious cough (Russell, 2007). Besides the pulmonary tuberculosis, about 15% of the 
patients with active disease develop extra-pulmonary or miliary tuberculosis. Due to the 
massive growth the bacilli invade into the blood stream and disseminate to various organs of 
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the host. Liver, spleen, lymph nodes, bones and joints can be affected and beside the typical 
cough, this inflammatory process produces symptoms like fever, weakness, chest-pain and 
weight-loss (Ducati et al., 2006).  
 
Mycobacteria 
 
Mycobacteria belong to the family of Mycobacteriaceae in the suborder of 
Corynebacterineae, a distinct group of “Gram-positive GC-rich” bacteria within the order of 
Actinomycetales. The genus Mycobacterium comprises more than 150 species, most of them 
being non-pathogenic, saprophytic soil bacteria. However, there are several exceptions which 
are highly pathogenic to humans, causing tuberculosis (M. tuberculosis, M. bovis, 
M. africanum), leprosy (M. leprae) and Buruli ulcer (M. ulcerans) (Cosma et al., 2003; Ducati 
et al., 2006). Mycobacteria are aerobic-to-facultative anaerobe bacteria with a size of 1-4 µm 
in length. They are nonmotile, not able to form spores (Traag et al., 2010) nor to produce 
toxins, with the exception of M. ulcerans which produces the toxin mycolactone (George et 
al., 1999). Mycobacteria weakly stain Gram-positive and can be visualized by Ziehl-Neelsen 
(acid-fast) staining. The bacilli are rod-shaped and form pale-white, yellow or orange colonies 
with a rough and wrinkled surface. However, some mycobacteria also have a smooth 
appearance which is caused by the glycopeptidolipids in their cell envelope. 
A rough differentiation of mycobacteria can be made with respect to generation time and 
pathogenicity. M. tuberculosis belongs to the group of pathogenic slow-growing bacteria with 
a generation time of 20 to 24 hours. In contrast, M. smegmatis is a non-pathogenic fast-
growing mycobacterium with a generation time of 2 to 3 hours and therefore it is used as 
model organism in mycobacterial research.  
The complete genome sequence of the best characterized and most commonly used laboratory 
strain, M. tuberculosis H37Rv is available. The circular chromosome of 4.4 Mbp consists of 
approximately 4000 genes and features a high G+C content of 65.6% (Cole et al., 1998). The 
genome is rich in repetitive DNA sequences, especially insertion elements which are tolerated 
in intergenic or non-coding regions, but the incidence of natural plasmids has not been 
observed in M. tuberculosis (Ducati et al., 2006). Furthermore, the genome is characterized 
by a high incidence of genes encoding for enzymes involved in lipid metabolism. This unique 
feature distinguishes the M. tuberculosis genome from any other bacteria. About 250 genes 
are either involved in lipogenesis for cell envelope synthesis or lipolysis, required for survival 
inside the host. In E. coli, for example, only 50 genes are involved in fatty acid metabolism. 
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The multitude of genes for lipid metabolism enables mycobacteria to build a complex cell 
wall structure with a high content of different lipid species (Cole et al., 1998). 
 
The Mycobacterial Cell Envelope  
 
Bacteria are phenotypically classified according to their behaviour in the Gram staining 
procedure into Gram-positive or Gram-negative bacteria. The difference in staining is due to 
differences in structure of the cell envelope. The staining dye can be extracted with alcohol 
from Gram-negative but not from Gram-positive bacteria (Madigan, 2000). The cell envelope 
of Gram-negative bacteria is rather complex and consists of different layers, the plasma 
membrane, periplasm, peptidoglycan and the outer membrane. The periplasm is filled with an 
aqueous solution composed of saccharides, amino acids, peptides and biosynthetic precursors 
and is only connected to the surrounding medium by porins. The asymmetric, bilayered outer 
membrane of Gram-negative bacteria resembles the cytoplasmic membrane and consists of 
lipids, lipopolysaccharides and proteins. Based on the existence of two lipid bilayers Gram-
negative bacteria are also termed “diderm” bacteria (Desvaux et al., 2009) (Fig.1). The cell 
envelope of Gram-positive bacteria is composed of the cytoplasmic membrane, a periplasmic 
space and a thick layer of peptidoglycan interspersed with proteins, teichoic- and lipoteichoic-
acids. Due to the fact that the cytoplasmic membrane is the only bilayer in Gram-positive 
bacteria, they are also termed “monoderm” bacteria (Desvaux et al., 2009; Seltmann, 2002) 
(Fig. 1). 
Figure 1: Schematic comparison of the cell wall from Gram-negative diderm, Gram-positive monoderm 
and Gram-positive diderm bacteria (adapted from (Zuber et al., 2008). All three classes of bacteria have an 
inner cytoplasmic membrane (IM) followed by a periplasmic space (PP). The granular-layer (GL) is only present 
in Gram-positive bacteria and mainly composed of penicillin binding proteins (Zuber et al., 2006). The 
peptidoglycan layer (PG) is much thicker in monoderm bacteria than in diderm bacteria. An outer membrane 
(OM) is only present in diderm bacteria. Gram-positive diderm bacteria like M. smegmatis are further mantled 
by a capsule. 
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The mycobacterial cell envelope has a unique and quite complex structure and is highly 
lipidated, with about 40% of the cell dry mass being lipids, compared to only 10% in E. coli 
(Goren, 1979). It consists of the cytoplasmic membrane, a periplasmic space with adjacent 
mycolyl-arabinogalactan-peptidoglycan (MAP) complex and noncovalently linked glycans, 
lipids and proteins which form a capsule-like structure or can be interspersed within the MAP 
complex (Fig 2). The entirety of structures outside the cytoplasmic membrane is referred to as 
cell wall.  
The cytoplasmic membrane mainly consists of phospholipids, as there are 
phosphatidylglycerol, phosphatidylethanolamine, phosphatidylinositol and its mannosides. 
Phosphatidylinositol mannosides (PIMs) are a major component of the cytoplasmic 
membrane and restricted to bacteria within the order Actinomycetales. They also form the 
base of lipoarabinomannan (LAM), a prominent component of the cell wall (Fig 2).  
 
 
Figure 2: Ultrastructure of the mycobacterial cell envelope (derived from (Brennan & Crick, 2007). 
 
The mycolyl-arabinogalactan-peptidoglycan complex shows some distinct characteristics. 
Compared to most other bacteria, the peptidoglycan-layer of mycobacteria contains N-
glycolylmuramic acid instead of N-acetylmuramic acid. As another unique feature, the 
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extensively branched arabinogalactan is phosphodiester-linked to the peptidoglycan and 
covalently linked to the mycolic acids. Mycolic acids are long-chained α-branched, 
β-hydroxylated high molecular weight fatty acids. Compared to mycolic acids from other 
bacteria like corynebacteria, nocardia or rhodococci, mycobacterial mycolic acids are the 
largest (C70 to C90) and contain double bonds or cyclopropane rings (Brennan & Nikaido, 
1995). They are oriented perpendicular to the cytoplasmic membrane forming the outer 
permeability barrier of the periplasmic space, which is defined at its internal border by the 
cytoplasmic membrane (Sutcliffe & Harrington, 2004). Free lipids such as phospholipids, 
trehalose mono- and dimycolates or glycopeptidolipids are intercalating the mycolic acids. 
The capsule-like layer is composed of proteins, polysaccharides, free lipids such as waxes and 
glycolipids noncovalently linked to the mycolyl-arabinogalactan-peptidoglycan complex 
(Brennan & Nikaido, 1995). 
Lipoglycans like the most prevalent PIMs and their multiglycosylated analogues lipomannan 
(LM) and lipoarabinomannan (LAM) are widely interspersed within the mycobacterial cell 
envelope. As a common feature they all share a conserved phosphatidylinositol anchor and 
none of them is covalently attached to the cell envelope. LAM are composed of three major 
structures including the phosphatidylinositol anchor, a D-mannan polymer with D-arabinose 
side chains and capping motifs at the termini of the arabinose residues.  
While PIMs are found in the cytoplasmic membrane among other phospholipids and also in 
the capsule, the localization of LM and LAM remains unclear. LAMs are supposed to span 
the whole cell envelope, with their anchor being attached to the cytoplasmic membrane or the 
mycolic acid layer (Daffe & Draper, 1998). LAM is a heterogenous molecule which differs in 
terms of capping motifs according to mycobacterial species. Three general classes of LAM 
have been described: 1. ManLAM with extensive mannose capping as found in 
M. tuberculosis and other slow-growing, pathogenic mycobacteria, 2. PILAM with 
phosphoinositol capping, found in fast-growing, non-pathogenic mycobacteria like 
M. smegmatis and 3. AraLAM which was found in non-tuberculous M. chelonae and remains 
uncapped (Karakousis et al., 2004). 
 
Although mycobacteria belong to the class of Gram-positive bacteria, it was recently proved 
that they have a pseudo-outer membrane analogous to the outer membrane of Gram-negative 
bacteria. The mycolic acid layer constitutes the inner leaflet and the fatty acyl chains of the 
interspersed lipids intercalating the mycolic acids build up the outer leaflet of this pseudo-
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outer membrane (Hoffmann et al., 2008). Based on this, mycobacteria are also termed 
“diderm” bacteria (Fig. 1).  
The pseudo-outer membrane forms a very hydrophobic barrier which together with the low 
number of pore-forming proteins in the mycobacterial cell wall compared to E. coli contribute 
to the generally low susceptibility to solutes that include many antibiotics and therapeutic 
agents (Zuber et al., 2008). 
 
The bacterial cell envelope is of major importance in terms of interaction between the 
bacterium and its environment, notably the host in the case of bacterial pathogens (Sutcliffe & 
Harrington, 2002). To localize specific proteins to their cell envelopes, almost all bacteria 
perform post-translational lipid modification to produce membrane-anchored lipoproteins 
(Sutcliffe & Harrington, 2004). Lipoproteins have been shown to be key players in the 
interaction of bacterial pathogens with their host.  
Lipoproteins are secreted proteins N-terminally modified with fatty acids by the consecutive 
action of preprolipoprotein diacylglycerol transferase (Lgt), prolipoprotein signal peptidase 
(LspA) and apolipoprotein N-acyltransferase (Lnt). In Gram-negative bacteria, lipoproteins 
are triacylated carrying a S-diacylglyceryl and a N-acyl modification (Rezwan et al., 2007a). 
First direct proof of N-acylation of lipoproteins in Gram-positive bacteria was provided by 
structural analysis of heterologously expressed M. tuberculosis lipoprotein LppX in 
M. smegmatis, a fast-growing mycobacterium and Lnt homologues were identified in 
M. smegmatis and M. tuberculosis (Tschumi et al., 2009).  
In Gram-positive bacteria, cell-associated lipoproteins are anchored in the plasma membrane, 
whereas in Gram-negative bacteria the vast majority of lipoproteins is released from the 
plasma membrane and located in the outer membrane. In mycobacteria, lipoproteins localize 
either in the plasma membrane or in the cell wall (Rezwan et al., 2007b; Sutcliffe & 
Harrington, 2004). Mycobacterial lipoproteins represent about 2.5% of the M. tuberculosis 
predicted proteome, thus representing an important class of cell envelope proteins that 
contribute to the virulence of this pathogen. The virulence-related functions of lipoproteins 
include invasion, signalling, evasion of host defence, and modulation of inflammatory 
processes. In addition, lipoproteins fulfill functions that contribute to the biology of 
mycobacteria, like nutrient uptake or cell wall maintenance (Sutcliffe & Harrington, 2004), 
and thereby indirectly affect host-pathogen interactions. Furthermore, lipoproteins have been 
shown to be key signalling molecules of both the adaptive and innate immune system and 
have been identified as major antigens of M. tuberculosis (Karakousis et al., 2004). 
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Lipoproteins are potent agonists of Toll-like receptor 2 (TLR2). Diacylated lipoproteins are 
recognized by heterodimers of TLR2 and TLR6, while triacylated lipoproteins are recognized 
by heterodimers of TLR1 and TLR2 with the amide bound fatty acid inserting into a 
hydrophobic channel of TLR1. The N-acyl of the lipoprotein is essential for the 
heterodimerization of TLR2 and TLR1 and thus the initiation of TLR1/2 signalling (Jin et al., 
2007; Kang et al., 2009). 
TLR-2 signalling has an important pleiotropic, but seemingly antagonistic role in immune 
responses to M. tuberculosis. TLR-2 signalling enhances both innate and adaptive immune 
responses, but it is also involved in downregulation of some immune functions. 
M. tuberculosis 19 kDa lipoprotein LpqH, Rv3763, for example is identified as an antigen and 
TLR-2 agonist which promotes TLR-2 dependent bactericidal responses and innate immune 
functions in macrophages early in infection. But, during later stages prolonged TLR-2 
signalling inhibits MHC class II expression and antigen processing and presentation, thereby 
decreasing recognition by T cells (Harding & Boom, 2010). In addition, LpqH is as a cell wall 
located adhesin enhancing the phagocytosis of the bacterium by macrophages. The negative-
feedback regulation in macrophages seems to help M. tuberculosis to evade the host immune 
response and persist as long-term infection (Diaz-Silvestre et al., 2005). 
 
 
Aim of the study 
 
Recent studies demonstrated an important role of lipoproteins and their synthesizing enzymes 
in the biology of mycobacteria (Rampini et al., 2008). Due to their involvement in virulence, 
they represent potential drug targets or candidates for novel vaccines. The modification of 
lipoproteins with fatty acids seems to play a crucial role for lipoprotein function, its 
localization and interaction with TLRs. Recently, the molecular structure of M. tuberculosis 
lipoprotein LppX heterologously expressed in M. smegmatis was determined and provided 
first direct proof of N-acylation of a mycobacterial model lipoprotein. However, the exact 
molecular structure of the membrane anchor so far remains poorly defined. 
The goal of this study was, to elucidate if N-acylation represents a general modification for 
mycobacterial lipoproteins and lipoproteins in Streptomyces ssp.. Streptomyces ssp, like 
mycobacteria, are GC-rich Gram-positive bacteria and belong to the order of Actinomycetales. 
But, unlike their relatives from the subfamily of Corynebacterineae they are monoderm 
bacteria, lacking an outer membrane-like structure.  
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Aim of the study: 
 
• Characterize the structure of the membrane anchor of lipoproteins in fast-growing 
M. smegmatis 
• Characterize the structure of the membrane anchor of lipoproteins in slow-growing 
M. bovis BCG 
• Identify genes responsible for N-acylation in slow-growing mycobacteria 
• Characterize the structure of the membrane anchor of lipoproteins and genes 
involved in lipoprotein synthesis in Streptomyces scabies 
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ABSTRACT 
 
The mechanisms underlying the biogenesis and outer membrane sorting of lipoproteins have 
been mostly clarified in Escherichia coli. Three enzymes catalyse the post-translational 
modification of lipoproteins with a membrane anchor comprising a thioether-linked 
diacylglycerol and an amide-linked fatty acid. The Lol system, comprising five Lol proteins, 
mediates the sorting of lipoproteins to the outer membrane. The three enzymes and five 
proteins are essential for E. coli and are widely conserved in Gram-negative diderms having 
cytoplasmic and outer membranes. High G+C content Gram-positive bacteria such as those 
belonging to the genera Mycobacterium and Corynebacterium have an outer membrane-like 
structure. The structure and biogenesis of the cell envelope have been intensively studied in 
mycobacterial species including medically important Mycobacterium tuberculosis. 
Mycobacterial lipoproteins are triacylated, like those of Gram-negative diderms. The enzyme 
catalysing N-acylation was recently identified. The lipoprotein biosynthesis pathway is 
important for virulence of M. tuberculosis. The functions of individual mycobacterial 
lipoproteins are discussed in relation to envelope biogenesis, virulence and influence on 
immune systems. The N-terminal structures of lipoproteins of low G+C content Gram-
positive monoderms are surprisingly diverse. An enzyme catalysing the N-acylation of the 
N-terminal Cys of lipoproteins has not been found in this class of bacteria. However, 
lipoproteins of Staphylococcus species are N-acylated. Moreover, three novel structures of 
lipidated N-terminal Cys were revealed on mass spectrometric analyses. A possible 
biosynthetic pathway generating these structures is discussed. 
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INTRODUCTION 
 
Bacterial lipoproteins constitute a class of membrane proteins functioning outside of the 
cytoplasmic membrane. After lipoprotein precursors have been translocated across the 
cytoplasmic membrane, the conserved N-terminal Cys residue of lipoproteins is modified 
with lipids, which anchor the lipoproteins to membranes. The functions of lipoproteins are 
diverse; they are involved in drug export, substrate import, construction of extracytoplasmic 
structures, molecular chaperone activity in the extracytoplasm, activation of Toll-like receptor 
(TLR) of host cells, etc. 
Gram staining is an empirical method for differentiating bacterial species into two large 
groups, Gram-positive and Gram-negative bacteria. It is almost always the first step in the 
identification of bacterial organisms, particularly in the medical microbiology laboratory. The 
Gram-reactivity of a bacterium is based on the ability of the cell to retain the purple primary 
staining agent crystal violet after undergoing Gram staining. This ability is not based on the 
actual structure of the cell envelope of the bacterium, although there is often a correlation. It 
was therefore proposed that bacteria should be classified whether they have one (monoderm) 
or two (diderm) membranes (Desvaux et al., 2009; Gupta, 1998). Gram-negative bacteria are 
mostly diderms with a cytoplasmic membrane, a thin peptidoglycan layer and an outer 
membrane that acts as a permeability barrier to small hydrophilic molecules (Fig. 1). Typical 
members are Proteobacteria, e.g. Escherichia coli. High GC Gram-positive bacteria are 
generally diderms while low GC ones are monoderms. Low GC Gram positive bacteria are 
covered by multiple peptidoglycan layers (Fig. 1).  
 
 
Fig. 1 Schematic representation of the envelope structures of three bacteria, E. coli (A), M. tuberculosis 
(B), and S. aureus (C), discussed mainly in this chapter. CM, PG and OM represent the cytoplasmic 
membrane, peptidoglycan and outer membrane, respectively. 
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Lipoproteins in monoderm bacteria are only anchored to the outer surface of the cytoplasmic 
membrane. On the other hand, ones in a typical diderm, Escherichia coli, are anchored to the 
periplasmic surface of both the cytoplasmic (inner) and outer membranes. Lipoproteins 
anchored to the outer surface of the outer membrane are also known in Gram-negative 
diderms, although such lipoproteins are few in E. coli. The localization of lipoproteins in 
Gram-positive diderms remains largely unknown.  
The pathways generating mature lipoproteins from their precursors have been extensively 
studied in E. coli. It has been established that lipoproteins in Gram-negative diderms are 
triacylated through three sequential modification reactions (Fig. 2). The first enzyme, Lgt, 
 
 
 
Fig. 2 Lipoprotein processing in bacteria. The lipoprotein maturation pathway found in Gram-negative diderm 
is shown. Essentially the same pathway is present in Gram-positive diderms. A lipoprotein precursor [pre-
prolipoprotein, (a)] is modified by phosphatidylglycerol/ prolipoprotein diacylglyceryl transferase (Lgt), a 
thioether linkage being formed between the N-terminal Cys of the mature region and diacylglycerol. The signal 
sequence of diacylated prolipoprotein (b) is cleaved by prolipoprotein signal peptidase (LspA). The 
apolipoprotein (c) is N-acylated by phospholipid/apolipoprotein transacylase (Lnt), and becomes a triacylated 
mature lipoprotein (d). An Lnt homologue is not found in low GC content Gram-positive bacteria, although 
some of lipoproteins are triacylated. 
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modifies the universally conserved Cys in the so-called ‘lipoprotein box or lipobox’ with a
diacylglycerol moiety derived from phosphatidylglycerol (Sankaran & Wu, 1994) when 
lipoprotein precursors are translocated from the cytoplasm to the periplasmic side of the 
cytoplasmic membrane. The lipobox is a consensus sequence, (LVI)-(ASTVI)-(GAS)-C, 
comprising the C-terminal three residues of the signal peptide and the N-terminal Cys in the
mature region (http://www.mrc-lmb.cam.ac.uk/genomes/dolop/). The second enzyme, LspA 
or signal peptidase II, cleaves the signal peptide of the diacylated lipoprotein precursors, 
rendering the Cys residue a new N-terminus. The last enzyme, Lnt, catalyses the 
aminoacylation of the N-terminal Cys. It has been thought that triacylated lipoproteins are 
limited to Gram-negative bacteria because Lnt homologues have not been found in Gram-
positive bacteria. However, Lnt homologues were recently found in a Gram-positive diderm 
(Tschumi et al., 2009). Moreover, it has been reported that the amino group of Cys are also 
diversely modified even in Gram-positive monoderms (Asanuma et al., 2011; Kurokawa et 
al., 2009; Kurokawa et al., 2012a; Nakayama et al., 2012).  
The aims of this chapter are to discuss, based on recent findings, the mode of N-terminal 
modification, the enzymes involved in lipoprotein processing, the physiological functions of 
lipoproteins, and the sorting of lipoproteins in both monoderms and diderms. The Lyme 
disease spirochaete Borrelia burgdorferi is a Gram-negative diderm that possesses many 
lipoproteins (Fraser et al., 1997), but has no lipopolysaccharides (LPS). Readers interested in 
spirochaete lipoproteins are referred to reports by Haake (Haake, 2000) and Schulze et al. 
(Schulze et al., 2010). 
 
 
LIPOPROTEINS IN GRAM-NEGATIVE DIDERM BACTERIA  
 
The outer membrane is an essential organelle for most Gram-negative diderms, and comprises 
phospholipids, lipopolysaccharides (LPS), membrane spanning β-barrel proteins, and 
lipoproteins. These components are transported from the cytoplasmic to the outer membrane 
through the periplasm. Recent studies revealed that many lipoproteins are involved in the 
transport of and insertion of these components into the outer membrane. Among these four 
components, the sorting of lipoprotein to the outer membrane has been most extensively 
studied and clarified.  
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Lipoprotein-processing enzymes 
 
Three well-conserved enzymes sequentially mediate the maturation reactions (Fig. 2) 
(Sankaran & Wu, 1994):  
 
1 Phosphatidylglycerol/prolipoprotein diacylglyceryl transferase (Lgt) catalyses the 
transfer of the diacylglyceryl moiety from phosphatidylglycerol (PG) in the 
cytoplasmic membrane to the N-terminal Cys residue in the mature region through a 
thioether linkage.  
2 Lipoprotein-specific signal peptidase (LspA or signal peptidase II) then cleaves the 
hydrophobic signal peptide.  
3 The third enzyme, phospholipid/apolipoprotein transacylase (Lnt), attaches an acyl 
chain to the free amino group of the N-terminal Cys residue.  
 
These three enzymes are essential for the growth of E. coli and Salmonella enterica serovar 
Typhimurium (Wu, 1966). The N-acylation of lipoproteins by Lnt has been shown to be 
critically important for their sorting in vitro (Fukuda et al., 2002). An E. coli mutant, in which 
the chromosomal lnt gene was placed under an arabinose promoter, revealed in vivo that 
apolipoproteins were accumulated in the cytoplasmic membrane in the absence of arabinose 
(Robichon et al., 2005). Lnt was found to have at least six transmembrane helices with a 
nitrilase-like periplasmic domain containing the catalytic triad Glu267–Lys335–Cys387 
(Robichon et al., 2005; Vidal-Ingigliardi et al., 2007). It was proposed for the mechanism of 
the third lipid attachment that Lnt attacks the sn-1 acyl chain of a phospholipid and thereby 
forms a thioester acyl-enzyme intermediate, followed by the transfer of the acyl group to the 
α-amino group of the diacylglyceryl Cys (Buddelmeijer & Young, 2010). Recently, the 
N-acyltransferase activity of E. coli Lnt was found to strongly depend on phospholipid head 
group and acyl chain composition (Hillmann et al., 2011). Lnt prefers phospholipids carrying 
a small head group, such as phosphatidylethanolamine (PE) or PG, as an acyl donor, and 
exhibits significant activity only when an unbranched acyl chain is present at position sn-1 
with an unsaturated one at position sn-2 (Hillmann et al., 2011). Finally, the lnt gene was 
found to be dispensable when an ABC transporter, LolCDE complex, is overproduced in 
E. coli cells lacking the major outer membrane lipoprotein Lpp (Narita & Tokuda, 2011). 
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The Lol system 
 
In Gram-negative bacteria such as E. coli, triacylated mature lipoproteins are transported to 
the outer membrane by the Lol (localization of lipoproteins) system or are retained in the 
cytoplasmic membrane, depending on the residue at position 2, which is located adjacent to 
the triacylated N-terminal Cys. The Lol system is composed of five proteins, periplasmic 
carrier protein LolA, outer membrane lipoprotein receptor LolB, and cytoplasmic membrane 
ABC transporter LolCDE (Tokuda & Matsuyama, 2004). These five Lol proteins are 
conserved in Gram-negative bacteria, and are essential for the growth of E. coli and 
S. enterica, as the three processing enzymes are. Membrane subunits LolC and LolE of the 
LolCDE complex are only conserved in diderm bacteria. The conservation of LolB is much 
lower, and seems to be limited to β- and γ-proteobacteria among diderms. It is interesting that 
the proteins involved in the early step of lipoprotein processing or sorting are more strongly 
conserved than those involved in a later step (Okuda & Tokuda, 2011). The diderm bacteria, 
in which LolB is not found, might have some other outer membrane proteins or lipoproteins 
that can compensate for the LolB function. 
 
Periplasmic carrier protein LolA 
 
The finding of a lipoprotein-specific carrier protein, LolA, revealed how hydrophobic 
lipoproteins cross the hydrophilic periplasmic space and how the membrane specificity of 
lipoproteins is determined (Matsuyama et al., 1995). Spheroplasts secrete various periplasmic 
and hydrophobic β-barrel outer membrane proteins into the medium, whereas outer 
membrane-specific lipoproteins, such as Lpp, are retained in the cytoplasmic membrane of 
spheroplasts. However, Lpp is secreted into the spheroplast medium when the periplasmic 
fraction is added externally. The Lpp-releasing activity in the periplasmic fraction has been 
purified, and a water-soluble protein named LolA has been identified. LolA also releases 
other outer membrane-specific lipoproteins such as Pal, BamC, Slp and RlpA, whereas 
cytoplasmic membrane-specific lipoproteins AcrA and NlpA remain in spheroplasts even 
when LolA is added. These observations suggest that the localization of lipoproteins in the 
outer membrane is determined by whether or not they are released from the cytoplasmic 
membrane. Lipoproteins released from spheroplasts were found to form a water-soluble 
complex with LolA in a stoichiometry of 1:1. Moreover, when LolA was genetically depleted, 
outer membrane-specific lipoproteins were accumulated in the cytoplasmic membrane 
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(Tajima et al., 1998). LolA was thus found to play essential roles in the release of lipoproteins 
from the cytoplasmic membrane and their transport through the hydrophilic periplasm. 
 
Outer membrane receptor LolB 
 
The LolA–lipoprotein complex described above has been isolated from a spheroplast 
supernatant, and then incubated with cytoplasmic and outer membranes. It was found that 
lipoproteins were specifically transferred to the outer membrane, but not to the cytoplasmic 
membrane (Matsuyama et al., 1995). This observation suggested that an unidentified factor in 
the outer membrane accepts lipoproteins from LolA and then mediates their outer membrane 
localization. Solubilized outer membrane proteins have been fractionated and then 
reconstituted into proteoliposomes to identify this factor. The outer membrane lipoprotein 
named LolB was thus identified as a lipoprotein receptor anchored to the outer membrane 
(Matsuyama et al., 1997). LolB depletion caused the accumulation of outer membrane-
specific lipoproteins both in the periplasm as a complex with LolA and in the cytoplasmic 
membrane (Tanaka et al., 2001). A LolB derivative, mLolB, lacking an N-terminal acyl chain 
is able to form a complex with lipoproteins as LolA does, indicating that LolA and LolB are 
functionally similar although their amino acid sequences are dissimilar. The modes of 
lipoprotein binding to LolA and LolB, and the importance of the lipid anchor of LolB are 
discussed in a later section.  
 
Cytoplasmic membrane ABC transporter LolCDE  
 
The outer membrane is the final destination of lipoproteins, and they are never released into 
the periplasm even in the presence of LolA. The release of outer membrane-specific 
lipoproteins from right-side-out membrane vesicles occurs in ATP- and LolA-dependent 
manners (Yakushi et al., 1998). These observations indicate that there is an ATPase that 
catalyses the release of lipoproteins exclusively in the cytoplasmic membrane. Cytoplasmic 
membrane proteins have been solubilized, fractionated and reconstituted into liposomes 
together with outer membrane-specific lipoproteins to examine the lipoprotein-releasing 
activity of each fraction in the presence of ATP and LolA. The LolCDE complex, which 
belongs to the ABC (ATP-binding cassette) transporter super family, was thus identified 
(Yakushi et al., 2000). This complex consists of LolC, LolD, and LolE subunits in a 
stoichiometry of 1:2:1. LolC and LolE are membrane subunits, each of which has four 
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membrane-spanning regions and one large periplasmic loop (Yasuda et al., 2009). LolD is a 
nucleotide-binding subunit with conserved ABC signature, Walker A, and Walker B motifs. 
ABC transporters generally mediate the ATP-dependent transport of diverse substrates across 
the lipid bilayers of various organisms. They are composed of four domains; two 
transmembrane domains (TMDs), and two nucleotide-binding domains (NBDs). ABC 
transporters in eukaryotic cells mainly function as drug exporters, of which the TMDs and 
NBDs are expressed in a single polypeptide chain. On the other hand, most bacterial ABC 
transporters are involved in the uptake of nutrients with a specific substrate-binding protein, 
and have four domains frequently in separate polypeptide chains (Davidson & Chen, 2004; 
Dawson et al., 2007). Some bacterial ABC transporters mediate the export of various drugs, 
inhibitors, polysaccharides and proteins.  
LolCDE, having eight membrane-spanning regions in total, is assumed to be a derivative of a 
bacterial exporter, whereas exporters generally have at least twelve membrane-spanning 
regions. MacB, another bacterial ABC transporter, also has eight transmembrane regions in 
total, and exports enterotoxin II from the periplasm to the exterior in collaboration with a 
membrane fusion protein, MacA, and a multifunctional outer membrane channel, TolC 
(Kobayashi et al., 2003; Yamanaka et al., 2008). MacB is predicted to have a large 
periplasmic loop like LolC and LolE have. Both LolCDE and MacB release substrates after 
they have been translocated across the cytoplasmic membrane. Their characteristic structures 
might be related to their unique functions.  
 
Sorting of lipoproteins to the outer membrane of Gram-negative bacteria  
 
The molecular events occurring during the transport of lipoproteins from the cytoplasmic to 
the outer membrane through the periplasm have been extensively studied in E. coli (Fig. 3). 
Outer membrane-specific lipoproteins are recognized by LolCDE in the cytoplasmic 
membrane and then transferred to LolA in an ATP-dependent manner. Lipoproteins cross the 
periplasmic space as a complex with LolA and are transferred to LolB anchored to the outer 
membrane, followed by incorporation of the lipid moiety of the lipoproteins into the outer 
membrane. In this section, the mechanisms underlying the lipoprotein transfer reactions 
through five Lol proteins are discussed.  
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Sorting signals of lipoproteins  
 
Yamaguchi et al. (Yamaguchi et al., 1988) first indicated the importance of Asp at position 2 
for the cytoplasmic membrane localization of lipoproteins in E. coli by demonstrating that the 
substitution of Ser with Asp at position 2 caused the retention of an outer membrane-specific 
lipoprotein in the cytoplasmic membrane. Moreover, substitution of Asp at position 2 of a 
cytoplasmic membrane-specific lipoprotein with another residue was shown to cause the outer 
 
 
Fig. 3 The Lol pathway. An ABC transporter, the LolCDE complex, recognizes an outer membrane-specific 
mature lipoprotein in the cytoplasmic membrane. The Asp residue at position 2 functions as an ‘Lol avoidance 
signal’ and prevents the recognition of lipoproteins by LolCDE. This causes the retention of lipoproteins in the 
cytoplasmic membrane. The released lipoprotein forms a complex with a periplasmic chaperone, LolA, in an 
ATP-dependent manner. The LolA–lipoprotein complex crosses the periplasm and reaches the outer membrane, 
where the lipoprotein is transferred from LolA to LolB. LolB is itself a lipoprotein anchored to the outer 
membrane and mediates the incorporation of lipoproteins into the periplasmic leaflet of the outer membrane. 
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membrane-localization of the lipoprotein. It was reported later that the residue at position 3 
variously affects the Asp-dependent cytoplasmic membrane localization of lipoproteins 
(Gennity & Inouye, 1991). To examine this ‘+2 rule’, the residues at positions 2 and 3 were 
systematically changed and the LolA-dependent release of lipoproteins from the cytoplasmic 
membrane was examined. It was found that only Asp at position 2 caused the retention of a 
lipoprotein in the cytoplasmic membrane when the residue at position 3 was Ser (Terada et 
al., 2001). The residue at position 3 was then found to variously affect the cytoplasmic 
membrane retention of lipoproteins by Asp at position 2. Asp at position 2 was the strongest 
cytoplasmic membrane signal when Asp, Glu or Gln was at position 3 (Terada et al., 2001). 
The combination of Asp and Asn or Asp and Arg at positions 2 and 3, respectively, also 
functioned as a relatively strong cytoplasmic membrane signal. Native cytoplasmic 
membrane-specific lipoproteins of E. coli have Asp at position 2 and Asp, Glu or Gln at 
position 3. Taken together, these results suggested that the negative charge or amide group at 
position 3 increases the potency of Asp at position 2 as a cytoplasmic membrane retention 
signal. Asn at position 2 exceptionally functions as a cytoplasmic membrane retention signal 
only when the residue at position 3 is Asp, as in the case of E. coli native lipoprotein AcrE 
(Klein et al., 1991; Seiffer et al., 1993). It remains to be elucidated why Lys or His with an 
amide group at position 3 decreases the retention of cytoplasmic membrane-specific 
lipoproteins (Terada et al., 2001).  
The bacterial genome carries a number of putative lipoprotein genes (Babu et al., 2006; 
Juncker et al., 2003). In the family Enterobacteriaceae, such as S. enterica serovar 
Typhimurium, Shigella flexneri, Yersinia pseudotuberculosis, Erwinia carotovora, and 
Klebsiella oxytoca, the ‘+2 rule’ seems to be conserved, as judged on the direct visualization 
of fluorescence-labelled lipoproteins in vivo (Lewenza et al., 2006). However, the sorting 
signal may vary in other bacteria even though they possess Lol protein homologues. For 
example, the residue at position 2 of MexA, a cytoplasmic membrane lipoprotein constituting 
the multidrug efflux pump of Pseudomonas aeruginosa, is Gly. Chimeric lipoproteins 
consisting of various regions of MexA and outer membrane-specific lipoprotein OprM 
revealed that Lys and Ser at positions 3 and 4, respectively, but not Gly at position 2, are the 
typical cytoplasmic membrane signals of P. aeruginosa. Although Asp at position 2 also 
caused the cytoplasmic membrane retention of lipoproteins, the residues at positions 3 and 4 
were found to be the innate sorting signals for lipoproteins in P. aeruginosa (Narita & 
Tokuda, 2007). Indeed, the Lys-Ser signal functioned as the cytoplasmic membrane retention 
signal in proteoliposomes reconstituted with a LolCDE homologue purified from 
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P. aeruginosa, while reconstitution of E. coli LolCDE caused the release of this lipoprotein. It 
should be noted that LolA purified from not only E. coli but also P. aeruginosa functions in 
this release from proteoliposomes (Tanaka et al., 2007). Asp at position 2 functions as a 
cytoplasmic membrane retention signal whether LolCDE is derived from E. coli or 
P. aeruginosa. These findings suggest that the mechanisms underlying the Lol-dependent 
localization of lipoproteins are similar in E. coli and P. aeruginosa, although the cytoplasmic 
membrane retention signal of lipoproteins depends on the properties of LolCDE. The 
lipoprotein-sorting signals in Gram-negative bacteria seem to be more diverse than previously 
expected.  
It was once thought to be possible that Asp at position 2 inhibits N-acylation and therefore 
causes retention of lipoproteins in the cytoplasmic membrane. However, this was found not to 
be the case, and cytoplasmic membrane-specific lipoproteins with Asp at position 2 were 
shown to be N-acylated (Fukuda et al., 2002). It was also revealed that non-N-acylated 
lipoproteins (apolipoproteins) are hardly released from the cytoplasmic membrane, indicating 
that LolCDE recognizes triacylated lipoproteins. As mentioned above, the lnt gene can be 
deleted when cells overproduce LolCDE and lack either Lpp or the genes encoding the three 
transpeptidases, which form cross-links between Lpp and peptidoglycan (Narita & Tokuda, 
2011). The diacylated lipoproteins in this ∆lnt mutant were poor substrates for LolCDE, 
therefore overproduction of LolCDE was required for their correct sorting. 
 
The Lol avoidance signal 
 
The reason why Asp at position 2 causes the retention of lipoproteins in the cytoplasmic 
membrane has been studied by means of reconstitution experiments. Pal(S2D), a derivative of 
the outer membrane-specific lipoprotein Pal possessing Asp in place of Ser at position 2, was 
not released from the proteoliposomes reconstituted with LolCDE in the presence of LolA and 
ATP (Yakushi et al., 2000). The ATPase activity of LolCDE was stimulated by Pal, but not 
by Pal(S2D) (Masuda et al., 2002). Moreover, the release of an outer membrane-specific 
lipoprotein from proteoliposomes was completely inhibited by an excess amount of Pal in the 
same proteoliposomes, whereas an excess amount of Pal(S2D) had no effect (Masuda et al., 
2002). These observations suggested that Asp at position 2 functions as a ‘Lol avoidance 
signal’ and thereby prevents the recognition of lipoproteins by LolCDE. Indeed, various 
LolCDE mutants have been isolated that localize cytoplasmic membrane-specific lipoproteins 
to the outer membrane (Narita et al., 2003; Sakamoto et al., 2010). These findings indicate 
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that both LolA and LolB recognize lipoproteins even though they have Asp at position 2 when 
the LolCDE mutants release those lipoproteins. An altered conformation of LolCDE most 
likely accounts for the suppression of the Lol avoidance function of Asp at position 2. 
The mechanism underlying lipoprotein-recognition by LolCDE was further examined with 
proteoliposomes reconstituted with LolCDE and chemically modified lipoproteins (Hara et 
al., 2003). A Pal derivative with Cys in place of Ser at position 2 was released from 
reconstituted proteoliposomes even after the Cys residue had been modified with SH-specific 
reagents. Since N-acylation is essential for recognition by LolCDE, it seemed likely that 
LolCDE recognizes the N-terminal Cys residue modified with three acyl chains, the sole 
common structure of lipoproteins. The oxidation of Cys to cysteic acid resulted in the 
generation of a Lol avoidance signal. The calculated distances between Cα and the negative 
charges of Asp and cysteic acid are very similar. On the other hand, Glu at position 2 does not 
function as a Lol-avoidance signal although it is negatively charged and has similar properties 
to Asp. These results suggest that the distance between the negative charge and Cα at position 
2 is critical for the LolCDE avoidance function. 
E. coli membranes contain 70–75% PE, 20–25% PG, and about 5% cardiolipin (CL). 
Examination of the release of lipoproteins from proteoliposomes reconstituted with various 
phospholipids revealed that Asp at position 2 functioned as the Lol avoidance signal in 
proteoliposomes reconstituted with phosphatidylcholine (PC) possessing a positive charge. In 
contrast, the Lol avoidance function of Asp was abolished if the proteoliposomes were 
reconstituted with E. coli phospholipids pretreated with an amine-specific reagent (Hara et al., 
2003). These observations suggested that the steric and electrostatic complementarity between 
Asp at position 2 and phospholipids such as PE having a positive charge is important for the 
Lol avoidance mechanism. However, an E. coli mutant unable to produce PE can grow on a 
medium supplemented with a high concentration of magnesium (DeChavigny et al., 1991), 
and the sorting of lipoproteins was found to be normal in the mutant cells (Miyamoto & 
Tokuda, 2007), indicating that the positive charge of phospholipids is not essential for the Lol 
avoidance signal. The phospholipids in this mutant were comprised 50% CL and 50% PG. CL 
is thought to exhibit a non-bilayer phospholipid property in the presence of a high 
concentration of magnesium (Rietveld et al., 1995). Both the release of lipoproteins and the 
ATPase activity of LolCDE were stimulated by magnesium when proteoliposomes were 
reconstituted with CL alone (Miyamoto & Tokuda, 2007). However, the lipoproteins with 
Asp at position 2 were also released under these conditions. In contrast, PG added to CL-
liposomes increasingly suppressed the release of lipoproteins with Asp and lowered the 
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ATPase activity of LolCDE. Taken together, these findings indicate that phospholipids have 
diverse effects on lipoprotein sorting in E. coli. It remains unknown how PG negatively 
affects the release of lipoproteins with Asp at position 2.  
 
Isolation of liganded LolCDE  
 
As far as reported, no ABC transporter has been co-purified with its substrate. On the other 
hand, a liganded form of LolCDE could be purified if ATP was absent during its purification. 
Various lipoproteins co-purified with LolCDE were all outer membrane-specific, but not 
cytoplasmic membrane-specific (Ito et al., 2006), indicating that the liganded LolCDE 
represents an intermediate of the lipoprotein release reaction in the cytoplasmic membrane. 
LolCDE liganded exclusively with Pal in a molar ratio of 1:1 was then purified. Taking 
advantage of this novel liganded LolCDE, the molecular events involved in the release of 
lipoproteins by LolCDE was divided into the following steps:  
 
1 Outer membrane-specific lipoproteins are recognized by LolCDE in an ATP-
independent manner unless the lipoprotein has Asp at position 2. The affinity of LolD 
for ATP increases upon lipoprotein binding.  
2 ATP-binding to LolD decreases the strength of the hydrophobic interaction between 
lipoproteins and LolCDE through a conformational change of LolCDE.  
3 Lipoproteins are transferred from LolCDE to LolA upon the hydrolysis of ATP. 
However, when LolA is not present, lipoproteins remain associated with LolCDE even 
if ATP is hydrolysed. This step involves a conformational change of LolA, as 
discussed later.  
 
The crystal structure of the LolCDE complex has not been solved while a methanococcal 
LolD homologue exhibits a very similar tertiary fold to those of the ATPase subunits of other 
ABC transporters (Smith et al., 2002; Yuan et al., 2001). Since LolCDE can be assumed to be 
a variant of ABC exporter, the molecular mechanism of LolCDE might be similar to that 
proposed for crystallized ABC exporter Sav1866 of Staphylococcus aureus (Dawson & 
Locher, 2006; Dawson & Locher, 2007).  
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Structures of LolA and LolB  
 
Both LolA and LolB transiently bind lipoproteins and then transfer the bound lipoproteins to 
LolB and the outer membrane, respectively. Their functions are similar but their amino acid 
sequences exhibit no similarity. In contrast, the crystal structures of E. coli LolA and LolB 
solved at 1.65 and 1.9 Å resolution, respectively, exhibit remarkable similarity to each other 
(Takeda et al., 2003). Both LolA and LolB form an incomplete β-barrel structure composed 
of 11 anti-parallel β-strands with a lid comprising three α-helices (Fig. 4). The incomplete 
β-barrel and the lid form a hydrophobic cavity, which was shown to bind the acyl chains of 
lipoproteins, as discussed later. Their overall structures are similar, but two differences are 
 
 
Fig. 4 Crystal structures of (a) LolA and (b) LolB. The structures of LolA (PDB:1IWL) and LolB (1IWM) are 
strikingly similar, despite their dissimilar sequences. Both structures form a hydrophobic cavity consisting of 11 
anti-parallel β-strand and three α-helices. These hydrophobic cavities bind the acyl chains of lipoproteins. The 
structures on the left were rotated by 90 degrees around the horizontal axis to give the structures on the right. 
 
 
important for their functional differentiation. An extra loop comprising a short helix and a 
twelfth β-strand at the C-terminus of LolA prevents retrograde transfer of lipoproteins to the 
cytoplasmic membrane by inhibiting the interaction between LolA and phospholipids (Okuda 
et al., 2008). The Arg residue at position 43 in the β2-strand of LolA forms hydrogen bonds 
with some residues in the lid, and therefore closes the cavity, whereas the cavity of LolB is 
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open. The LolA(R43L) mutant, in which Arg at position 43 is replaced by Leu, can accept 
lipoproteins from LolCDE, but cannot transfer them to LolB (Miyamoto et al., 2001).  
Therefore, an unusually large amount of the LolA–lipoprotein complex is accumulated in the 
periplasm (Taniguchi et al., 2005). The hydrophobic interaction of LolA(R43L) with 
lipoproteins is as strong as that of LolB (Taniguchi et al., 2005). This is why lipoproteins are 
not transferred from LolA(R43L) to LolB. In contrast, the interaction between wild-type LolA 
and lipoproteins is the weakest, allowing efficient transfer of lipoproteins to LolB. It is also 
noteworthy that the hydrophobic cavity of LolA is formed from aromatic residues, whereas 
that of LolB consists mainly of Leu and Ile, whose hydrophobic side chains are more flexible 
than those of aromatic residues (Takeda et al., 2003). These differences are critical for the 
efficient one-way transfer of lipoproteins in an energy-independent manner.  
It remains unknown how the three acyl chains are localized in LolA and LolB of E. coli, 
because the hydrophobic cavities of LolA and LolB are only large enough to accommodate a 
single acyl chain, i.e. not more. The crystal structure of P. aeruginosa LolA was recently 
shown to be almost the same as that of E. coli (Remans et al., 2010). Additional hydrophobic 
patches were found on the surface of P. aeruginosa LolA. These patches might be the binding 
sites for other acyl chains of lipoproteins. However, LolA(R43L) crystals exhibited two 
structures, open and closed conformations. The hydrophobic cavity of the open conformation 
is larger (~1700 Å3) (Y. Oguchi and H. Tokuda, unpublished) than that of the closed form, 
which is essentially identical to the free form of wild-type LolA (Oguchi et al., 2008). 
However, the hydrophobic cavity of wild-type LolA was found to undergo opening and 
closing upon the binding and release of lipoproteins, respectively (Oguchi et al., 2008; 
Watanabe et al., 2008). LprG, a lipoprotein of Gram-positive diderm M. tuberculosis, has a 
very similar structure to that of LolA. The hydrophobic cavity of LprG is large enough to 
accommodate three acyl chains (Drage et al., 2010). Since its size was reported to be ~1500 
Å3, the open conformation of LolA seems to be able to accommodate all three acyl chains 
inside the hydrophobic cavity.  
In addition to that of LprG, the structures of the N-terminal domains of RseB, LppX and VioE  
are similar to those of LolA and LolB. RseB is a member of the envelope stress response 
system leading to the induction of σE expression. RseB is proposed to bind an unfolded 
lipoprotein in the hydrophobic cavity (Kim et al., 2007). LppX is a lipoprotein of 
M. tuberculosis required for the translocation of complex lipids, the phthiocerol 
dimycocerosates (DIM), to the outer layer of the cell. Its large hydrophobic cavity was 
thought to be sufficient to accommodate a single DIM molecule (Sulzenbacher et al., 2006). 
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These proteins seem to have similar function to LolA and LolB although the transported 
substrates differ. VioE is speculated to play a key role in the biosynthesis of violacein, a 
purple pigment with antibacterial and cytotoxic properties (Hirano et al., 2008; Ryan et al., 
2008).  
A soluble LolB derivative, mLolB, lacking an N-terminal lipid anchor is functional and able 
to replace LolB, although a higher amount of mLolB is required for normal growth 
(Tsukahara et al., 2009). It was then found that mLolB expressed in the periplasm 
incorporates lipoproteins into not only the outer but also the cytoplasmic membrane or 
liposomes, indicating that mLolB has a lipid-targeting function, and does not distinguish the 
cytoplasmic and outer membranes. Therefore, the N-terminal membrane anchor of LolB is 
important for prevention of the mislocalization of lipoproteins to the cytoplasmic membrane. 
The Leu residue at position 68 is expected to play an important role in phospholipid targeting 
(Takeda et al., 2003). Among the three major phospholipids, non-bilayer phospholipid PE is 
important for the LolB-dependent incorporation of lipoproteins (Tsukahara et al., 2009). 
However, it remains largely unknown how mLolB discharges a cargo on the lipid surface.  
 
How Lol proteins interact with each other  
 
In order to elucidate how lipoproteins are transferred through Lol proteins, a photo-cross-
linking technique developed by Schultz and his collaborators was applied to the Lol system 
(Okuda & Tokuda, 2009). This technique enables the introduction of an unnatural photo-
reactive amino acid, p-benzoyl-phenylalanine (pBPA), into an amber (TAG) codon in vivo 
(Chin et al., 2002; Ryu & Schultz, 2006; Wang et al., 2006). A number of LolA or LolB 
mutants having an amber codon at desired positions were constructed. E. coli cells expressing 
such a mutant were irradiated with UV light for in vivo photo-cross-linking. Analyses of the 
cross-linked products revealed that LolA and LolB interact with each other at the entrances of 
their hydrophobic cavities. Moreover, the inside of the LolA cavity was found to interact with 
the outside of the LolB cavity. Lipoproteins were found to interact exclusively with the 
insides of the LolA and LolB cavities. NMR analyses revealed essentially the same mode of 
interaction between LolA and LolB (Nakada et al., 2009). Taking these results together, it 
was proposed that lipoproteins are transferred from the cavity of LolA to that of LolB in a 
mouth-to-mouth fashion. In this model, the hydrophobic cavities of LolA and LolB are very 
close to each other, and therefore the transfer of lipoproteins occur smoothly in the direction 
of higher affinity, namely from LolA to LolB. 
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In vivo photo-cross-linking revealed that LolA interacts with LolC, but not with LolE, at the 
entrance of its cavity (Okuda & Tokuda, 2009). When pBPA was incorporated into 
lipoproteins, cross-linked products were obtained with LolE, but not LolC (unpublished data). 
From these results, it is speculated that LolC functions as a scaffold for LolA whereas LolE 
recognizes outer membrane-specific lipoproteins. LolC and LolE have similar topologies i.e. 
four membrane-spanning regions with a large loop exposed to the periplasm (Narita et al., 
2002; Yasuda et al., 2009). Both proteins are essential for the growth of E. coli. These results 
indicate that LolC and LolE are functionally different, despite their structural and sequence 
similarities (26% identical). The periplasmic loops of LolC and LolE exhibit sequence 
similarity to LolA and/or LolB to some extent (~18% identical). It seems possible that these 
regions also have hydrophobic cavities. The transport of lipoproteins might be performed 
from LolCDE to LolA to LolB through the entrances, or mouths, of their hydrophobic 
cavities. The gene for LolE is only conserved in γ-proteobacteria i.e. not in other subdivisions 
(Narita & Tokuda, 2011). In these bacteria, the ABC transporters responsible for lipoprotein 
release are likely to comprise a LolCD homodimer, in which LolC can bind lipoproteins and 
interact with LolA. 
The LolA–LolC interaction increases upon the binding of lipoproteins to LolCDE (Okuda & 
Tokuda, 2009). Interaction between the LolA–lipoprotein complex and LolB is not inhibited 
by an excess amount of free LolA (Watanabe et al., 2007). The affinity of LolD for ATP 
increases upon lipoprotein binding (Ito et al., 2006). Taking all these results together, the Lol 
system seems to have been designed to achieve the efficient one-way transfer of lipoproteins 
from the cytoplasmic to the outer membrane. 
 
Lipoproteins involved in outer membrane biogenesis 
 
Four major outer membrane components, phospholipids, LPS, β-barrel proteins, and 
lipoproteins, are hydrophobic and must be transported from the cytoplasmic membrane to the 
outer membrane via the hydrophilic periplasm. Then, the transported components must be 
correctly localized to the outer membrane. Since there is no energy source, such as ATP, in 
the periplasm, most of the transport reactions must take place in energy-independent manners. 
In addition to the Lol system described above, the machineries responsible for the transport 
and assembly of LPS and β-barrel proteins have been identified (Bos et al., 2004; Ruiz et al., 
2008; Sklar et al., 2007; Sperandeo et al., 2007; Voulhoux et al., 2003; Wu et al., 2005). 
Various lipoproteins were found to play important roles in these transport-assembly reactions. 
CHAPTER 1 
42 
 
On the other hand, little is known about how phospholipids are transported to the outer 
membrane although a mechanism underlying the transport of phospholipids from the outer to 
the cytoplasmic membrane was reported (Malinverni & Silhavy, 2009). 
LPS is flipped from the cytoplasmic side to the periplasmic side of the inner membrane by an 
ABC transporter, MsbA, and then transported to the outer leaflet of the outer membrane by 
the Lpt (Lipopolysaccharide transport) system. This system is composed of the cytoplasmic 
membrane ABC transporter LptBFG complex, bitopic membrane protein LptC, which forms a 
complex with LptBFG, periplasmic protein LptA, and the complex comprising β-barrel 
protein LptD and lipoprotein LptE (Sperandeo et al., 2009). All factors comprising the Lpt 
system and MsbA are essential for the growth of E. coli. Although LPS is essential for most 
Gram-negative bacteria, Neisseria meningitidis cells grow in the absence of LPS biogenesis, 
and therefore mutants lacking any one of above factors are viable. Moreover, the deletion of 
lptE does not inhibit the transport of LPS to the cell surface, indicating that the function of 
LptE is indirect in this Gram-negative bacterium (Bos & Tommassen, 2011). On the other 
hand, E. coli LptE was reported to bind to LPS strongly (Chng et al., 2010). LptE has a 
chaperone-like function in the LptD–LptE complexes of both E. coli and N. meningitidis. The 
mechanism of the Lpt system might not be the same among Gram-negative diderms.  
The Bam (β-barrel assembly machinery) complex is required for the outer membrane 
assembly of β-barrel proteins in E. coli (Hagan et al., 2011). In addition, the periplasmic 
chaperone DegP, SurA and Skp are also involved in the targeting and assembly of β-barrel 
proteins. The Bam complex consists of one β-barrel protein, BamA, and four outer 
membrane-specific lipoproteins, BamB/C/D/E. A similar complex has been identified in 
N. meningitidis, although an outer membrane protein, RmpM, constitutes the complex instead 
of BamB (Volokhina et al., 2009). Many components of the Bam complex are conserved in 
various bacteria (Anwari et al., 2010; Gatsos et al., 2008). BamA, a central component of the 
complex, is conserved in all Gram-negative bacteria. Among the four lipoproteins, only 
BamD is essential for the growth of E. coli, suggesting that BamD plays an important and 
direct role in the β-barrel protein assembly, while the functions of the respective Bam proteins 
remain to be clarified. The reconstitution of the Bam complex in proteoliposomes will help to 
solve these issues (Hagan et al., 2010; Hagan & Kahne, 2011). The BamA orthologue is 
essential for the assembly of β-barrel proteins in the outer membrane of mitochondria (Gentle 
et al., 2004; Voulhoux & Tommassen, 2004). Although some accessory components of the 
complexes differ between bacteria and mitochondria, which have no lipoproteins, the system 
for β-barrel protein assembly seems to have been evolutionary conserved.  
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As already mentioned, the Lol system mediates the sorting of lipoproteins to the outer 
membrane of E. coli, in which more than 90 species of lipoproteins are expressed (Tokuda, 
2009). Most lipoproteins are predicted to be localized on the periplasmic side of the outer 
membrane. Although many lipoproteins have unknown functions, three essential lipoproteins, 
LolB, LptE and BamD, are involved in outer membrane biogenesis. Therefore, chemicals that 
inhibit the Lol system are expected to block the outer membrane biogenesis. Indeed, LolA has 
been shown to be a promising target of drugs (Pathania et al., 2009).  
 
Structural importance of lipoproteins  
 
Bacterial lipoproteins are involved in a wide variety of cellular functions, such as the 
biogenesis and maintenance of cell surface structures, the transport of substrates, and drug 
efflux (Bernadac et al., 1998; Clavel et al., 1998; Ehrmann et al., 1998; Nikaido, 1998). As 
discussed in later sections, some lipoproteins cause an inflammatory response in human host 
cells, and their lipid moieties account for the bioactivity (Ramesh et al., 2003; Scragg et al., 
2000). Some lipoproteins have been shown to be functional without a lipid anchor (Chng et 
al., 2010; Tsukahara et al., 2009), although the activity of LolB decreases with a lack of the 
lipid anchor because it prevents the mislocalization of lipoproteins. The cytoplasmic 
membrane proteins have hydrophobic α-helical stretches, which cause the retention of the 
proteins in the cytoplasmic membrane. Proteins spanning the outer membrane have 
amphipathic β-strands, which do not cause the retention of the proteins in the cytoplasmic 
membrane. Posttranslational modification of proteins with a lipid anchor might have been 
evolved to generate proteins that can reach and associate with the outer membrane. The 
β-barrel proteins frequently form pores in the outer membrane, while many enzymatic 
functions are most likely due to lipoproteins and peripheral proteins. 
It is known that perturbation of outer membrane biogenesis causes stress to E. coli cells and 
induces stress response systems. A LolA derivative, I93C/F140C, has two Cys residues in 
place of Ile at position 93 and Phe at position 140. Expression of this mutant in the absence of 
a reducing agent is lethal to E. coli because the hydrophobic cavity is closed by a disulfide 
bond, which activates the Cpx two-component system (Tao et al., 2010). The Cpx system 
monitors the biogenesis of cell surface structures and plays an important role in the detection 
of misassembly of β-barrel proteins (Gerken et al., 2010; Raivio & Silhavy, 2001). Since the 
Cpx pathway is generally induced by aberrant disulfide formation in the periplasm, the 
expression of LolA(I93C/F140C) might directly activate the pathway. Alternatively, 
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inhibition of the localization of essential lipoproteins by dominant negative 
LolA(I93C/F140C) causes activation of the Cpx system. The overexpression of YafY, a 
cytoplasmic membrane-specific lipoprotein, whose function is unknown, induces DegP 
expression through activation of the Cpx pathway, as the outer membrane lipoprotein NlpE 
does (Miyadai et al., 2004). Since delipidated NlpE does not induce the expression of DegP, 
overproduction of NlpE may cause its mislocalization to the cytoplasmic membrane, and then 
activation of the Cpx system. Rcs phosphorelay is one of the envelope stress response systems 
in E. coli. The outer membrane-specific lipoprotein RcsF, which transmits the signal from the 
cell surface to the cytoplasmic membrane histidine kinase RcsC, activates the Rcs 
phosphorelay system when overexpressed. The observation that the overexpression of LolA 
activates the Rcs pathway (Chen et al., 2001) also suggests that the Rcs system might monitor 
correct lipoprotein sorting. In any event, involvement in the envelope stress response systems 
is one of the functions of lipoproteins. 
 
 
LIPOPROTEINS IN GRAM-POSITIVE DIDERM BACTERIA 
 
Bacteria that exhibit Gram-positive staining belong to one of two divisions, Actinobacteria 
and Firmicutes. Formerly, these divisions were differentiated according to their G+C 
contents, i.e. high and low G+C Gram-positive bacteria, respectively. Staphylococcus aureus, 
Micrococcus luteus and Bacillus anthracis are typical members of the low G+C order 
Firmicutes. The cell envelope of these bacteria is characterized by a cytoplasmic membrane 
with a thick peptidoglycan layer and secondary glycopolymers, such as wall teichoic acid and 
lipoteichoic acid. Owing to the presence of a single membrane, these bacteria are classified as 
monoderm bacteria (Fig. 1c). 
Within the division Actinobacteria and therein the order Actinomycetales, the genera 
Mycobacterium, Corynebacterium, Rhodococcus and Nocardia are grouped into the suborder 
Corynebacterineae. These genera share a common peptidoglycan structure and, in addition, 
are characterized by the presence of an outer membrane-like impermeable layer. Owing to the 
presence of a second membrane, these bacteria are considered to be diderm bacteria (Fig. 1b). 
Thus, from a general point of view, the cell envelopes of Corynebacterineae and 
Proteobacteria (Gram-negative bacteria) are similar. However, their structures are analogous 
rather than homologous. Major differences exist with respect to the chemical composition 
and, as a result of this with respect to permeability. For example, the lipid content of the cell 
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envelope of mycobacteria may represent up to 40% of the cellular dry mass, compared to only 
10% in Gram-negative bacteria (Goren, 1979). The outer membrane of the Gram-negative 
bacterium Pseudomonas aeruginosa is notably impermeable. However, the mycobacterial 
outer membrane exhibits 10- to 100-fold lower permeability than that of 
P. aeruginosa (Jarlier & Nikaido, 1990).  
 
Mycobacterium tuberculosis – cell envelope composition and drug therapy  
 
Within the subfamily Corynebacterineae, lipoprotein function and biosynthesis have mainly 
been investigated in Mycobacterium tuberculosis and the model organism Mycobacterium 
smegmatis, respectively. M. tuberculosis, the causative agent of human tuberculosis annually 
causes 1.7 million deaths and about one-third of the world’s population is latently infected 
(http://www.who.int/mediacentre/factsheets/fs104/en/index.html). Mycobacterium bovis 
bacille Calmette–Guerin (BCG), an attenuated derivative of Mycobacterium bovis (the 
causative agent of bovine tuberculosis), is applied as a tuberculosis live vaccine in high 
incidence countries. It efficiently protects against disseminated tuberculosis in childhood but 
only shows limited protection against adult lung tuberculosis (Kaufmann et al., 2010). 
M. tuberculosis is an intracellular pathogen that survives and multiplies in macrophages 
(Russell, 2011). The biology of M. tuberculosis is intimately linked to its complex cell 
envelope. The structure, function and synthesis of the mycobacterial cell envelope have been 
extensively discussed recently, and readers interested in further details are referred to two 
excellent books (Cole, 2005; Daffe, 2008). The standard course therapy for tuberculosis is a 
four-drug regimen comprising isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA), and 
ethambutol (EMB) administered for 2 months, followed by INH and RIF alone for an 
additional 4 months. A dramatic increase in drug-resistant tuberculosis has been observed in 
recent years. In the past decade, novel antituberculosis drug candidates have been developed 
intensively (Cole & Riccardi, 2011). However, the tuberculosis drug pipeline is insufficiently 
filled. Therapy for drug-resistant tuberculosis requires the substitution of first line drugs by 
second line drugs and extended medication. Second-line drugs include fluoroquinolones 
[ofloxacin (OFL) and moxifloxacin (MOX)], aminoglycosides [amikacin (AMK) and 
kanamycin (KAN)], peptide antibiotics [viomycin (VIO) and capreomycin (CAP)] and 
thioamides [e.g. ethionamide (ETH)], cycloserine (CYC) and para-aminosalicylic acid 
(PAS)]. Two of the first-line drugs (INH and EMB), several second-line drugs (ETH and 
CYC) as well as drugs under development (Makarov et al., 2009) inhibit the cell envelope 
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biogenesis. INH and ETH are pro-drugs that are activated within bacterial cells by 
catalase/peroxidase KatG and monooxygenase EthA, respectively (Almeida Da Silva & 
Palomino, 2011). Both INH and ETH form an adduct with nicotine adenine dinucleotide 
(NAD) and thereby inhibit the enoyl-acyl carrier protein (ACP) reductase component of a 
dissociable fatty acid synthase (FAS-II), which is involved in the synthesis of mycolic acid 
precursors. PA824 and OPC67683, two nitroimidazoles currently in phase II clinical trials, 
also interfere with mycolic acid biosynthesis (Cole & Riccardi, 2011). EMB interferes with 
arabinan biosynthesis. Most EMB-resistance associated mutations are found in the 
arabinosyltransferase EmbB. Benzothiazinone BTZ043 and dinitrobenzamide DNB are two 
promising antibiotic compounds under pre-clinical development. Both compounds inhibit the 
decaprenylphosphoryl-β-d-ribose 2′ epimerase, encoded by the dprE1 and dprE2 genes 
involved in D-arabinose synthesis. In particular, the enzymes transform 
decaprenylphosphoryl-d-ribose into decaprenylphosphoryl-d-arabinose, a precursor for the 
synthesis of mycobacterial cell-envelope polysaccharides arabinogalactan and lipoara-
binomannan (LAM) (Cole & Riccardi, 2011). The number of antibiotics targeting cell 
envelope biogenesis emphasizes the importance of cell envelope biogenesis for 
M. tuberculosis viability and virulence. 
The cell envelope structure and biogenesis of mycobacteria have been intensively studied by 
means of chemical analyses, microscopic techniques and genetic approaches during the past 
few decades. The structures surrounding the cytoplasm may be subdivided into several 
compartments, the cytoplasmic membrane, outer membrane-like structure (consisting of the 
cell wall core and extractable lipids) and the capsule. 
 
The cytoplasmic membrane and peptidoglycan layer 
 
The cytoplasmic membrane is mainly formed by phospholipids and proteins. The polar lipids 
are composed of hydrophilic head groups and fatty acid chains that usually consist of fatty 
acid residues of less than 20 carbon atoms. Palmitic acid (C16:0), octadecenoic acid (C18:1), 
and 10-methyloctadecanoic acid (tuberculostearic acid) are the major fatty acid constituents. 
The main phospholipids of the cytoplasmic membrane are phosphatidylinositol mannosides 
(PIM), PG, PE and CL (Daffe, 2008). The cytoplasmic membrane contains peripheral and 
integral membrane proteins as well as lipoproteins. It has a thickness of about seven 
nanometres, and it is supposed that it is structurally and functionally very similar to other 
bacterial cytoplasmic membranes (Daffe, 2008). 
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The cell wall core also called mycolyl-arabinogalactan-peptidoglycan (mAGP) complex is 
composed of peptidoglycan and molecules covalently linked to it such as arabinan and 
mycolylesters. This sacculus is an essential structure for mycobacteria and provides the 
bacteria with a formidable protective barrier against xenobiotics. 
The mycobacterial peptidoglycan has some features that distinguish it from E. coli 
peptidoglycan. Its glycan chains are composed of alternating units of (β1→4)-linked 
N-acetylglucosamine (GlcNAc) and N-glycolylmuramic acid (MurNGlyc), whereas most 
other bacteria have N-acetylmuramic acid. A tetrapeptide (l-alanyl-d-isoglutaminyl-meso-
diaminopimelyl-d-alanine) side chain substitutes for the carboxylic acid function of each 
muramic acid residue. The peptide chains are heavily cross-linked (70–80%) as compared to 
in E. coli (degree of cross-linking: 20–25%) (Mahapatra, 2005). Particularly in non-
replicating M. tuberculosis, the non-classical 3→3 linkages between two diaminopimelyl 
residues (rather than the classical 4→3 linkages between the terminal alanyl- and diami-
nopimelyl residues) predominate in the transpeptide network (Gupta et al., 2010). C-6 of 
some muramic acid residues form phosphodiester bonds with C-1 of α-D-GlcNAc, which in 
turn is (1→3) linked to an α-l-rhamno-pyranose (Rhap) residue. Rhap provides the ‘linker 
unit’ between peptidoglycan and the galactan of arabinogalactan (Mahapatra, 2005). The 
galactan consists of a linear chain of about 30 units of alternating 1→5 and 1→6 linked 
β-d-galactofuranose (galf) residues. Two to three of the 1→6 linked galactan residues of the 
galactan chain are glycosylated at their C5 with an α-d-arabinofuranose (araf) chain via an α 
1→5 linkage. A tree-like arabinose structure is formed through the introduction of 1→2 or 
1→3 branch points to the linear 1→5 linked stem. Mycolic acids are esterified to two-thirds 
of the terminal araf (Mahapatra, 2005). Peptidoglycan and arabinogalactan are hydrophilic, 
while mycolic acids are hydrophobic and form part of the mycobacterial outer membrane-like 
structure.  
 
Outer membrane-like structure  
 
Mycolic acids are long chain fatty acids, both α-branched and β-hydroxylated. In 
M. tuberculosis, they contain 70–90 carbon atoms with various modifications of the acyl 
chains. According to a recent model, which is a modification of that originally proposed by 
Minnikin (Minnikin, 1982), mycolic acids form the inner leaflet of an outer membrane-like 
structure, along with phospholipids (Zuber et al., 2008). The acyl chain of mycolic acids is 
not straight but folds back to fit the thickness of the outer membrane-like structure of 7–8 nm, 
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as observed on cryo-electron microscopy of vitreous sections (CEMOVIS) (Hoffmann et al., 
2008; Zuber et al., 2008).  
Besides forming the major part of the cell wall core component, mycolic acids also occur in 
unbound forms as esters of trehalose or glycerol and therefore are extractable with organic 
solvents. A huge variety of other complex lipids, such as phenolic glycolipids (trehalose 
monomycolate and trehalose dimycolate), phthiocerols and sulfolipids, interact with the 
covalently attached mycolic acids to build the outer leaflet of the outer membrane-like 
structure. The M. tuberculosis envelope lipids also contain phosphatidyl-myo-inositol 
mannosides (PIM) and their multiglycosylated counterparts, lipomannans (LM) and 
mannosylated lipoarabinomannans (ManLAM). In other Mycobacteria, LAM is modified 
differently. While PIM are found in the cytoplasmic membrane and also in the outer most 
layer, the capsule, the locations of LM and LAM remain controversial (Gilleron, 2008). 
Recent fractionation experiments on M. smegmatis indicated that LAM and LM are mainly 
co-localized with mycolic acids (Dhiman et al., 2011). More than 400 lipid structures 
representing 15 classes of lipids have been identified in whole lipid extracts of 
M. tuberculosis (Sartain et al., 2011). The extraordinary ability of mycobacteria to degrade 
and synthesize lipids is reflected by the presence of 250 genes in the M. tuberculosis genome 
devoted to lipid metabolism, compared with 50 in E. coli (Cole et al., 1998).  
The presence of a highly impermeable outer layer explains, at least partially, the natural 
resistance of mycobacteria to many hydrophilic antibiotics. However, the existence of such a 
hydrophobic barrier also poses a serious problem with respect to nutrient uptake. Nutrient 
uptake by mycobacteria and Gram-negative bacteria is facilitated by water-filled pore proteins 
(porins) present in the outer membrane (Niederweis et al., 2010). Other proteins of the outer 
membrane include proteins of the PE and PPE families, two highly polymorphic sets of 
proteins characterized by the presence of Pro-Glu (PE) and Pro-Pro-Glu (PPE) motifs near the 
N-terminus (Mukhopadhyay & Balaji, 2011), and lipoproteins (Mawuenyega et al., 2005).  
The capsule mainly contains polysaccharides composed of a glycogen-like saccharides and 
d-arabino-d-mannan heteropolysaccharides, little lipids and proteins also being found in 
culture filtrates (Mahapatra, 2005).  
 
Lipoprotein biosynthesis in mycobacteria  
 
The genome of M. tuberculosis is of medium size (approximately 4 million basepairs) and 
encodes roughly 4000 genes. Approximately 2.5% of the open reading frames encode 
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lipoproteins (Sutcliffe & Harrington, 2004). Lipoprotein biosynthesis in mycobacteria follows 
the general lipoprotein biosynthesis pathway, as described above for E. coli (Rezwan et al., 
2007b; Sutcliffe & Harrington, 2004). Most preprolipoproteins are secreted via the general 
secretory pathway (sec) in a secA1- or secA2-dependent manner (Gibbons et al., 2007); 
however, a significant number of preprolipoproteins are predicted to be translocated across 
the cytoplasmic membrane via the twin arginine transport pathway (tat) (McDonough et al., 
2005). After export, a conserved motif, the lipobox motif [LVI]-[ASTVI]-[GAS]-C (Babu et 
al., 2006), is recognized by the membrane-bound pre-prolipoprotein diacylglycerol 
transferase (Lgt; Rv1614). A thioether linkage between Cys of the lipobox and diacylglycerol 
is formed. Attachment of the diacylglycerol anchor triggers lipoprotein signal peptidase 
(LspA; Rv1539)-dependent cleavage of the immature lipoprotein. This reaction generates a 
free amino group in the Cys carrying the thioether-linked diacylglycerol. It has long been 
assumed that mycobacterial lipoproteins are N-acylated. However, direct evidence of 
N-acylation of mycobacterial lipoproteins was only provided recently (Tschumi et al., 2009). 
 
Mycobacterial Lnt 
A homologue of E. coli apo-lipoprotein N-acyltransferase (Lnt) is present in the genome of 
M. tuberculosis and in a wide variety of other GC-rich Gram-positive bacteria, but is absent 
from the genomes of low GC Gram-positive monoderms (Fig. 5). In M. tuberculosis, open 
reading frame Rv2051c is annotated as ppm1, for a polyprenol monophosphomannose (Ppm) 
synthase, which transfers mannose from GDP-mannose to endogenous polyprenol phosphate. 
Polyprenol phosphate is a metabolic intermediate in the synthesis of mycobacterial cell 
envelope constituents LM and LAM. The Ppm synthase domain is only encoded by the 3′ part 
of open reading frame 2051c. The 5′ part of this open reading frame encodes an amino 
terminal domain that exhibits considerable similarity to that of E. coli Lnt. M. smegmatis, a 
fast growing non-pathogenic Mycobacterium, which is tractable to genetic manipulation, is 
often used as a model organism for elucidating mycobacterial metabolic pathways. 
Heterologous expression of M. tuberculosis lipoprotein LppX in M. smegmatis and 
subsequent mass spectrometry analyses provided direct proof of N-acylation of mycobacterial 
lipoproteins (Tschumi et al., 2009).  
In M. smegmatis, orthologues of the two domains of M. tuberculosis Rv2051c are encoded by 
two distinct open reading frames, Msppm1 and Msppm2. Of these, Msppm2 (Msmeg3863) 
corresponds to Lnt. Targeted gene inactivation of Msppm2 results in a mutant that is unable to 
modify lipoprotein LppX with an N-acyl residue. Complementation of the mutant strain with 
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either M. smegmatis lnt (Msmeg3863) or M. tuberculosis Rv2051c restores the capability of 
N-acylation of LppX (Tschumi et al., 2009). Subsequently, expression and analyses of 
recombinant M. tuberculosis lipoprotein LprF in wild-type M. smegmatis and its ∆lnt strains 
indicated that lnt-dependent N-acylation is not restricted to LppX but represents a general 
modification pathway for mycobacterial lipoproteins (Brülle et al., 2010). 
 
 
Fig. 5 Distribution of Lnt in bacteria. E. coli Lnt was used as a query to identify homologues on the National 
Centre of Biotechnology Information BLASTp server (http://www.ncbi.nlm.nih. gov/sutils/genom_table.cgi). 
The sequence filtering option was switched off, and the expected value was set at 10 and the cut-off value at 10–
4. (Figure adapted from Tschumi et al., J. Biol. Chem., 2009.) 
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The structures of the membrane anchor of the two recombinant lipoproteins, LppX and LprF, 
have been resolved at the molecular level. In both cases, the thioether-linked diacylglycerol 
carries one esterified palmitic acid and one esterified tuberculostearic acid. Whether the 
tuberculostearic acid is at the sn-1 or sn-2 position has not been determined yet. The N-acyl 
residue is mainly derived from palmitic acid. Thus, the distribution of fatty acids in 
mycobacterial lipoproteins reflects the composition of fatty acids in membrane phospholipids. 
In the genome of M. bovis, a second open reading frame, MB2285c, encoding a protein of 502 
amino acids exhibits considerable homology to that of E. coli Lnt. Two of the amino acids of 
the catalytic triad (E267 and K335; E. coli numbering) are conserved, while the third residue 
(C387) is Ser (Vidal-Ingigliardi et al., 2007). Most interestingly, the corresponding open
reading frame in M. tuberculosis is split into two and the putative catalytic triad lies on two 
adjacent open reading frames. Of these, Rv2262c encodes a protein of 360 amino acids and 
Rv2261c encodes a protein of 140 amino acids. It remains to be elucidated whether or not 
proteins MB2285c and Rv2262c in combination with Rv2261c function as apolipoprotein 
N-acyl transferases, and whether or not they have the same specificity as Ppm1 (Rv2051c).  
 
Lipoprotein biosynthesis and virulence  
Lipoproteins have been shown to play a direct role in the interaction of bacterial pathogens 
with their hosts (Kovacs-Simon et al., 2011). The virulence-related functions of lipoproteins 
include colonization, invasion, evasion of host defence, and immunomodulation. 
Additionally, lipoproteins have essential functions in general bacterial physiology, e.g. in 
nutrient acquisition or cell envelope biogenesis, and thereby indirectly affect host–pathogen 
interactions. The lipoprotein biosynthesis pathway is an important virulence factor of 
M. tuberculosis. 
An M. tuberculosis lspA knock-out mutant exhibited a 3–4 log reduced number of colony 
forming units in an animal model of tuberculosis. Mice infected with the lspA mutant strain 
hardly show any lung pathology (Fig. 6) and the bacteria do not spread to secondary organs 
(Rampini et al., 2008; Sander et al., 2004). M. tuberculosis mutants deficient in lgt, the gating 
enzyme of the lipoprotein biosynthesis pathway, have not been described yet and high density 
transposon site hybridization mutagenesis (TRASH) and targeted mutagenesis experiments 
support the view that this gene is essential in M. tuberculosis (Sassetti & Rubin, 2003; 
Tschumi et al., 2012). Although lspA had also been predicted to be essential, such a mutant 
could be generated (Banaiee et al., 2006; Sander et al., 2004). An M. tuberculosis ppm1/lnt 
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mutant was isolated on screening for mutants unable to grow in an acidified medium. Detailed 
characterization of the mutant remains to be reported (Vandal et al., 2008). 
Mycobacteria and Gram-negative bacteria are diderms. Despite their similarities, these 
bacteria differ with respect to the essentiality of lipoprotein synthesis genes; all genes 
involved in lipoprotein synthesis and transport are essential for E. coli (Okuda & Tokuda, 
2011). 
 
 
 
 
Fig. 6 Virulence attenuation of M. tuberculosis lipoprotein biosynthesis mutant lspA. The lung pathology of 
BALB/c mice infected with M. tuberculosis (A) and M. tuberculosis lspA mutant (B) at 42 days after aerosol 
infection is shown, representative haematoxylin/eosin-stained views of lung cross sections (total magnification x 
40) being shown. Note the almost complete absence of inflammatory infiltration in the lungs infected with the 
mutant strain lacking functional LspA. (C) Growth of M. tuberculosis and M. tuberculosis lspA in the lungs of 
CBA/J mice over a 90-day period after intranasal infection (figures from Sander et al., 2004). 
 
 
One reason for the viability of mycobacterial mutants defective in lipoprotein biosynthesis 
(and other monoderm Gram-positive bacteria) could be that some lipoprotein precursors retain 
functionality (Hutchings et al., 2009). Globomycin, a cyclic peptide antibiotic produced by 
Streptomyces, inhibits LspA-dependent processing of lipoproteins in both Gram-negative and  
Gram-positive bacteria (Inukai et al., 1978). A bactericidal effect of globomycin on Gram-
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negative bacteria but not on Gram-positive bacteria is consistent with the essentiality of LspA 
in the former bacteria, and a non-essential role in the latter ones. Globomycin exhibits a 
growth inhibitory effect on M. tuberculosis; however, this effect is not due to LspA inhibition 
since processing of lipoprotein Mpt83 is not affected, and an 
M. tuberculosis lspA mutant is as sensitive to globomycin as the parental strain (Banaiee et 
al., 2007). Antibacterial activity of globomycin derivatives in monoderm Gram-positive 
bacteria, in which lspA is not essential, supports the view that globomycin may have 
additional targets (Kiho et al., 2003; Kiho et al., 2004). 
 
Glycosylation of mycobacterial lipoproteins 
Mycobacterial lipoproteins often contain additional post-translational modifications, besides 
the membrane anchor. Several M. tuberculosis lipoproteins (LpqH, SodC, LppX and LprF) 
have been shown to be modified with one or more glycosyl residues at their N-termini (Brülle 
et al., 2010; Herrmann et al., 1996; Sartain & Belisle, 2009; Tschumi et al., 2009). 
O-glycosylation occurs at Thr and Ser residues, respectively (Sartain & Belisle, 2009). 
Glycosylation increases protease resistance, while the exact molecular nature of the 
glycosylation, as well as its function, remain largely undefined. 
 
Transport and localization of lipoproteins in mycobacteria 
 
Functional and structural investigations have suggested the localization of at least some 
M. tuberculosis lipoproteins in the mycobacterial outer membrane: M. tuberculosis 
lipoproteins have been described as adhesins, immune electron microscopy techniques have 
demonstrated their surface localization, and fractionation experiments have indicated co-
localization with the fraction containing mycolic acids. Analyses of cytoplasmic membrane 
and outer membrane fractions allowed the identification of 21 lipoproteins (Mawuenyega et 
al., 2005). More recently, 24 lipoproteins were identified in the detergent fraction of cell 
extracts (Wolfe et al., 2010). The outer membrane transport of lipoproteins in Gram-negative 
bacteria depends on the localization of the lipoprotein Lol transport system and it has been 
suggested that sorting pathways for lipoproteins are critically important in all diderm bacteria 
(Okuda & Tokuda, 2011). The presence of lipoproteins in the outer membrane of 
mycobacteria suggests the existence of a lipoprotein transport system. However, its 
components remain to be identified. Mycobacteria release membrane vesicles in vitro and 
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during infection. Interestingly, the membrane vesicles of pathogenic mycobacteria are 
enriched in lipoproteins and contribute to virulence (Prados-Rosales et al., 2011).  
 
Mycobacterial lipoproteins in health and disease  
 
Manipulation of the immune system  
Lipoproteins affect both innate and adaptive immunity, and have been identified as major 
antigens of M. tuberculosis. Mycobacterial lipoproteins trigger the activation of humoral and 
cellular immune responses to mycobacteria. Some lipoproteins (LpqH, PstS1) induce a 
protective immune response, while others are deleterious as to protection (LprG) (Hovav et 
al., 2003). Successful immune evasion of M. tuberculosis has partly been attributed to Toll-
like receptor 2 (TLR2)-dependent inhibition of antigen processing and presentation (Drage et 
al., 2009; Harding & Boom, 2010). Lipoproteins (from different bacteria including 
mycobacteria) are potent agonists of TLR2. Although TLR signalling enhances both innate 
and adaptive immune responses, it can also down regulate some immune functions. TLR2, in 
particular, has been implicated in the down regulation or deviation of the immune response 
through the induction of interleukin 10 and T helper 2 cell or regulatory T cell responses. 
Prolonged TLR signalling might constitute homeostatic feedback regulation that limits the 
extent of the induced responses. TLR2 agonist activity has been demonstrated for several 
M. tuberculosis lipoproteins including LpqH, LprA, LprG and PstS1, and also for 
mycobacterial glycolipids such as PIM, LM and LAM. Recognition of these molecules may 
depend on different TLR2-coreceptors and accessory receptors (Drage et al., 2009). De novo 
MHC class II antigen processing and presentation are inhibited by prolonged signalling with 
agonists of TLR2. Down-regulation of antigen presentation is not specific to M. tuberculosis, 
but it could be especially pronounced during infection with M. tuberculosis. M. tuberculosis 
survives and multiplies in an early endosomal compartment by arresting phagosome 
maturation. Thus, M. tuberculosis is persistently co-localized with TLRs. The prolonged 
residence of M. tuberculosis in phagosomes and the abundance of cell envelope ligands for 
TLR2 that are released from viable mycobacteria, and that can transfer out of the phagosomes 
and out of the infected cells into the neighbour cells, provide ample opportunity for TLR2 
signalling in the phagosomes or on the surface of antigen-presenting cells. Thus, TLR2-
dependent suppression of MHC class II expression and processing could be particularly 
relevant in M. tuberculosis (Harding & Boom, 2010). 
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Mycobacterial lipoproteins 
The genome of M. tuberculosis encodes approximately 100 lipoproteins. Some of these 
proteins have annotated functions, which have been reviewed previously (Rezwan et al., 
2007a; Sutcliffe & Harrington, 2004). Despite some progress, many of the open reading 
frames corresponding to lipoproteins still do not have annotated functions. Transposon site 
hybridization mutagenesis of in vitro grown M. tuberculosis mutants has suggested that 
several lipoprotein genes, i.e. lpqW, lprB, lpqF and dppA, are essential (Sassetti et al., 2003). 
Additional lipoprotein genes, i.e. lpqY, lpqZ, lprK, lpqT, lprG, lppX and lprN, were shown to 
be required for virulence on corresponding in vivo screening (Sassetti & Rubin, 2003). 
Besides these genome-wide screenings, a variety of individually generated M. tuberculosis 
mutants deficient in certain lipoprotein genes were attenuated and several lipoproteins were 
characterized in more detail. SodC, LpqH, PstS2, PstS3, LppX, LprG, LpqN, LprC, LppK and 
LpqG were found to be abundantly expressed (Malen et al., 2010). Among a large number of 
M. tuberculosis lipoproteins, some lipoproteins including ones most recently found are 
discussed here. The M. tuberculosis database TubercuList (http://tuberculist.epfl.ch) hosted by 
the Institute of Global Health, École Polytechnique Fédérale de Lausanne, Switzerland, 
provides an excellent update for each M. tuberculosis open reading frame and is linked to 
other mycobacterial databases. 
 
LprG (Rv1411c)  
LprG has been identified in mycobacterial cell envelope fractions by means of various 
techniques. lprG is a non-essential gene of M. tuberculosis, but is required for the survival of 
M. tuberculosis in murine macrophages and for full virulence in mice. The gene is co-
transcribed with Rv1410c, a protein of the major facilitator superfamily of small molecules. 
Inactivation of the homologous gene in M. smegmatis revealed a role of each of these genes in 
ethidium bromide resistance. Moreover, both mutants were deficient in sliding motility and 
exhibited an altered colony morphology. These observations suggest a role of the lprG-operon 
in the cell envelope function (Farrow & Rubin, 2008). M. tuberculosis LprG as well as other 
lipoproteins are potent TLR agonists. Surprisingly, a non-acylated LprG still exhibited TLR2 
stimulation, despite the absence of a membrane anchor. The remaining TLR2-stimulating 
activity of LprG was attributed to glycolipid binding. The crystal structure of LprG revealed a 
binding pocket that could accommodate lipids with three acyl chains. Based on structural 
data, a role of LprG in outer membrane transport of mycobacterial lipoproteins has been 
considered. LAM, LM and PIM were co-purified with recombinant LprG. In contrast, 
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mycobacterial lipoproteins can not be co-purified with LprG. These observations suggest a 
primary role of LprG in lipoglycan transport rather than in lipoprotein transport (Drage et al., 
2010). As mentioned in ‘Lipoproteins in Gram-negative diderm bacteria’ above, the crystal 
structures of LprG and LppX are very similar to those of LolA/LolB.  
 
LppX (Rv2945c)  
M. tuberculosis LppX, similar to LprG, is also involved in the transport of complex lipids. 
This protein has a hydrophobic cavity that binds phthiocerol dimycocerosates (DIM) and 
delivers them to the outer membrane (Sulzenbacher et al., 2006). LppX orthologues are 
restricted to mycobacteria capable of synthesizing DIM, suggesting that their transport 
function is selective. An M. tuberculosis mutant deficient in lppX is attenuated in a mouse 
model of tuberculosis (Camacho et al., 1999).  
 
Rpf B (Rv1009)  
The genome of M. tuberculosis encodes five resuscitation-promoting factor (Rpf) proteins, 
one of them, RpfB, being a lipoprotein. The Rpf proteins have a c-type lysozyme-like fold, 
and are predicted to cleave the glycosidic bond between N-acetyl glucosamine and N-acetyl 
muramic acid in peptidoglycan. Characterization of single and multiple rpf mutants produced 
conflicting results with respect to the importance of individual genes in resuscitation, which 
was due to the use of different resuscitation and virulence models, respectively (Chao & 
Rubin, 2010).  
 
LppA (Rv2543)  
LppA is a lipoprotein confined to mycobacterial pathogens. One copy of its gene is present in 
the genome of M. tuberculosis H37Rv, while two copies (LppA and LprR) are present in the 
genome of M. tuberculosis CDC1551. LppA is highly homologous to its downstream gene, 
LppB (Rv2544), with which it shares 90% amino acid identity. The structure of LppA has 
been solved at 2 Å resolution. However, the lack of sequence and structural homologues of 
LppA hinders any functional assignments (Grana et al., 2010). 
 
LpqB (Rv3224) 
LpqB (Rv3244c) is one of the 233 conserved signature proteins of the Actinobacteria (Gao et 
al., 2006). The lpqB gene is located downstream of the essential signal transduction system, 
MtrAB. LpqB is part of a three-component system that co-ordinates cytokinetic and cell 
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envelope homeostatic processes in mycobacteria, and directly interacts with the extracellular 
domain of MtrB. An M. smegmatis lpqB mutant was isolated during screening for multiple 
antibiotic resistance-defective phenotypes. The mutant exhibited increased cell–cell 
aggregation, and severe defects in surface motility and biofilm growth (Nguyen et al., 2010). 
 
LpqM (Rv0419) 
Screening of M. smegmatis mutants deficient in conjugal DNA transfer revealed lpqM. LpqM 
is a putative lipoprotein with a metalloprotease signature sequence (HExxH). Both 
M. smegmatis and M. tuberculosis lpqM (Rv0419) restore DNA transfer. Secretion and 
lipidation of LpqM are mandatory for complementation of the phenotype. Expression of 
functional LpqM in the donor strain is sufficient for proficient transfer (Nguyen et al., 2009). 
So far, a substrate of LpqM has not been identified. 
 
LpqY(Rv1235)-SugA-SugB-SugC operon 
Five putative carbon uptake permeases are encoded in the genome of M. tuberculosis. Of 
these, LpqY-SugA-SugB-SugC encodes an ABC transporter highly conserved in 
mycobacteria. It comprises periplasmic sugar-binding lipoprotein LpqY, ATP-binding protein 
SugC, and transmembrane proteins SugA and SugB. This ATP-binding cassette transporter is 
highly specific for the uptake of disaccharide trehalose. Disaccharide trehalose is not present 
in mammals. However, trehalose is released as a byproduct of the biosynthesis of the mycolic 
acids by the mycolyltransferase antigen 85 complex. The antigen 85 complex transfers the 
lipid moiety of the glycolipid trehalose monomycolate (TMM) to arabinogalactan or another 
molecule of TMM, yielding trehalose dimycolate. These reactions also lead to the 
concomitant extracellular release of the trehalose moiety of TMM. Disruption of retrograde 
trehalose transport and thus impairment of trehalose recycling attenuates M. tuberculosis 
(Kalscheuer et al., 2010). 
 
SodC (Rv0432) 
SodC encodes a Cu,Zn-dependent superoxide dismutase and is annotated as a putative 
lipoprotein based on the presence of a lipoprotein lipid attachment site and radioactive 
labelling upon heterologous expression in E. coli. It detoxifies reactive oxygen intermediates 
and thereby contributes to the survival of M. tuberculosis, particularly in activated 
macrophages. The crystal structure of SodC has been solved by X-ray crystallography. The 
enzyme is glycosylated at its N-terminus, and is localized to the cytoplasmic and outer 
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membrane fractions. However, its lipidation has recently been questioned due to the results of 
fractionation and mutagenesis experiments combined with 2D gel electrophoresis and mass 
spectrometry (Sartain & Belisle, 2009). 
 
LpqH (Rv3763) 
The 19-kDa antigen (LpqH, Rv3763) of M. tuberculosis has been recognized as an 
immunodominant lipoprotein and often has been used as a mycobacterial model lipoprotein, 
particularly as a TLR2 agonist. LpqH is glycosylated and functions as an adhesin by binding 
to the mannose receptor of monocytic cells (Diaz-Silvestre et al., 2005). An M. tuberculosis 
lpqH knock-out mutant is attenuated in IFN-γ activated monocyte-derived macrophages and 
in mice. The lpqH mutant nearly does not multiply in C57BL/6 mice or even in IFN-γ 
deficient mice. When applied as a live vaccine, the M. tuberculosis lpqH mutant exhibits 
similar protective efficacy to BCG against an aerosol challenge with M. tuberculosis (Henao-
Tamayo et al., 2007).  
 
Lipoprotein biosynthesis in Streptomyces  
 
Streptomyces also has a GC-rich genome, exhibits Gram-positive staining and is a member of 
the order Actinomycetales. Streptomyces species are characterized by a complex secondary 
metabolism. They produce a wide variety of antibiotics, e.g. streptomycin and kanamycin, and 
antifungal and anti-parasitic drugs, and also immunosuppressants. Some of the 550 described 
species are pathogens of humans or plants. Unlike their relatives from the subfamily 
Corynebacterineae, they lack an outer membrane-like structure. Streptomyces export 
lipoproteins via the sec and tat pathways (Shruthi et al., 2010; Thompson et al., 2010). 
Interestingly, Streptomyces coelicolor encodes two functional Lgts (lgt1 and lgt2). Both lgt 
genes could be disrupted separately, but a double deletion mutant was not viable. Likewise an 
lspA knock-out mutant of this species could only survive upon acquisition of suppressor 
mutation (Thompson et al., 2010). In contrast, lgt and lspA deletion mutants of the plant 
pathogen Streptomyces scabies are viable. These mutants are defective in vegetative growth 
and spore development but only moderately attenuated in virulence (Widdick et al., 2011). 
lgt-deficient mutants release some (non-lipidated) lipoproteins into the culture supernatant 
through shedding or shaving, while other lipoproteins are either not expressed or are degraded 
(Widdick et al., 2011). The model lipoprotein SCO3484 was shown to be modified with three 
fatty acids: two ester-bound and one amide-bound fatty acid are attached to the N-terminal 
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Cys. The length of the fatty acids varies between 15 and 18 carbon atoms. All Streptomyces 
species encode two Lnt-homologues. The N-acylation of SCO3484 is completely abolished in 
an S. scabies lnt1 deletion mutant and diminished in an lnt2 mutant. These data indicate that 
Lnt1 is a functional lipoprotein N-acyltransferase, while the role of Lnt2 remains elusive 
(Widdick et al., 2011).  
 
 
LIPOPROTEINS IN GRAM-POSITIVE MONODERM BACTERIA  
 
Low GC-content Gram-positive bacterial species such as Bacillus, Clostridium, Enterococcus, 
Listeria, Staphylococcus, Streptococcus and cell wall-less mycoplasma have a single cellular 
membrane and are classified as monoderm bacteria. An E. coli Lnt homologue was not found 
in their genomes and therefore they had been expected to have only diacylated lipoproteins 
(Hutchings et al., 2009; Kovacs-Simon et al., 2011; Sutcliffe & Russell, 1995). However, 
earlier biochemical studies suggested that the lipoproteins of certain Bacillus and 
Staphylococcus species could be N-acylated (Navarre et al., 1996; Nielsen & Lampen, 1983). 
It is important to determine whether or not the low-GC-content monoderm bacteria have an 
Lnt-like enzyme, and to clarify the exact structures subjected to lipid modification in these 
bacteria (Kovacs-Simon et al., 2011; Schmaler et al., 2010). To address these issues, Lee and 
his collaborators recently provided biochemical evidence that staphylococcal lipoproteins are 
N-acylated triacyl forms (Asanuma et al., 2011; Kurokawa et al., 2009). Serebryakova et al. 
(2011) also reported that lipoproteins of Acholeplasma laidlawii, a mycoplasma strain, are 
triacylated. These studies indicate that staphylococcal and some mycoplasma species must 
have another type of Lnt whose structure is distinct from that in 
E. coli. Furthermore, novel lipopeptide structures have been identified in low GC content 
Gram-positive bacteria (Kurokawa et al., 2012b). Their detailed structures, putative 
biosynthetic pathways, and biological functions are discussed in this section. 
 
N-terminal structures of Staphylococcus aureus lipoproteins 
 
Hantke and Braun (1973) reported the structure of the major outer membrane lipoprotein, 
Lpp, of E. coli in 1973. In this classical study, the Lpp structure was clarified by a 
combination of several methods including chemical degradation, radioisotope incorporation 
and chemical synthesis. However, detailed structural analyses by means of these methods are 
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not always easy because large amounts of purified lipoproteins are required. In contrast, mass 
spectrometric (MS) analysis, which was developed recently (Murphy & Gaskell, 2011), 
enables the direct analysis of the acylated states of bacterial lipoproteins. Furthermore, this 
method quantitatively reveals the lipid compositions of bacterial lipoproteins. Indeed, MS-
based analysis has been used for the determination of lipoprotein/lipopeptide structures and 
their lipid compositions (Hashimoto et al., 2004; Muhlradt et al., 1997). 
The MS-based strategy was applied to determine the molecular lipid moieties attached to the 
N-terminal Cys residue of S. aureus lipoproteins (Kurokawa et al., 2009). S. aureus is a major 
human pathogen causing evasion of the host’s protective immune responses and is known to 
affect human immunity (Foster, 2005). Furthermore, antibiotic-resistant strains such as 
methicillin- and vancomycin-resistant S. aureus ones are emerging worldwide (Lowy, 1998). 
Importantly, S. aureus lipoproteins/lipopeptides are recognized by a host pattern recognition 
receptor, Toll-like receptor 2 (TLR2), and activate the TLR signalling pathway, leading to the 
production of pro-inflammatory cytokines and the establishment of adaptive immunity 
(Iwasaki & Medzhitov, 2010; Takeuchi & Akira, 2010). Therefore, it is important to 
determine the exact structures of lipoproteins as immunostimulatory ligands in order to 
further understand host–pathogen interactions. 
A lipoprotein-enriched fraction was prepared from S. aureus RN4220 cell lysates by means of 
Triton X-114 phase partitioning and then separated by SDS-PAGE (Kurokawa et al., 2009). A 
33-kDa protein band was identified as lipoprotein SitC on LC (liquid chromatography)-
MS/MS analysis. The N-terminal peptides of SitC were prepared by in-gel digestion with 
trypsin and then analysed by matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS). Surprisingly, a series of eight mass peaks exhibiting 14 
mass differences corresponding to the theoretical m/z of N-acyl-S-(diacylglyceryl)-cysteinyl 
peptides were detected (peaks 1–8, Fig. 7a). These peaks consisted of those of three fatty 
acids and increasing numbers of methylene (-CH2-) groups. Consistent with this, Edman 
degradation failed to reveal the N-terminal amino acid sequence. These results indicate that 
S. aureus SitC is a triacylated lipoprotein (Kurokawa et al., 2009). In contrast, Tawaratsumida 
et al. (2009) reported that another lipoprotein, SA2202, of S. aureus SA113 had a diacylated 
(dipalmitoylated) N-terminus, based on the results of MS⁄MS analyses. Thus, the N-acylation 
of S. aureus lipoproteins is controversial. Asanuma et al. (2011) then examined whether the 
α-amino group of the S-diacylglyceryl Cys residue of S. aureus lipoproteins is acylated or not. 
Highly purified lipopeptides generated from SitC were analysed by MALDI-TOF MS and 
revealed to be triacylated (Fig. 7b, left). In this study, the N-terminal SitC lipopeptides were 
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treated with lipoprotein lipase (LPL) and then analysed. LPL specifically hydrolyzes the ester-
linked fatty acids of bacterial lipoproteins. This treatment generated a new series of 14-Da 
interval peaks corresponding to the diacylglyceryl CGTGGK SitC lipopeptide (Fig. 7b, lower 
right). After long-term treatment with LPL, peaks corresponding to monoacylglyceryl 
CGTGGK SitC lipopeptides (Fig. 7b, upper right) were also generated because of the release 
of two O-esterified fatty acids. Taken together, these results indicate that SitC is modified by 
two O-esterified fatty acids and one LPL-resistant fatty acid.  
 
 
 
Fig. 7 N-acylated triacyl structure of S. aureus lipoprotein SitC. (a) MALDI-TOF MS analysis pattern of 
SitC fragments, which were obtained by lysylendopeptidase digestion in an SDS-polyacrylamide gel slice. A 
series of mass peaks exhibiting 14 mass differences are numbered 1–8 in the left panel and listed in the right 
panel. The obtained m/z of peak 1 corresponded to the theoretical m/z of tripalmitic acid (Pam3)-modified 
N-acyl-S-(diacyl-propyl)-cysteinyl-peptide, and those of peaks 2–8 corresponded to those of Pam3-N-terminal 
peptides harbouring increasing numbers of methylene (CH2) groups in their fatty acids. (b) Treatment of 
triacylated SitC with lipoprotein lipase (LPL). LPL specifically hydrolyses ester-bonded fatty acids; triacylated 
N-terminal SitC lipopeptides in the left panel were hydrolysed into diacylated and then monoacylated forms, as 
indicated on the right. The triacylated N-terminal SitC structure was determined by combined MS/MS analysis 
after treatment with lipoprotein lipase. The exact positions and lengths of ester-linked fatty acids could not be 
determined, but were predicted from additional information on the lipoprotein structures of Bacillus species 
(Kurokawa et al., 2012) and the phospholipid structures of S. aureus (Fischer, 1994). 
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To confirm that the α-amino group of the S-diacyl-glyceryl-Cys residue is acylated, a peak 
corresponding to the octadecanoyl-glyceryl lipopeptide of SitC generated after long term 
treatment with LPL was further analysed by MALDI-ion trap MS/MS. The results strongly 
supported that the fatty acid modification site is the N-terminal Cys residue and that the 
octadecanoyl group is linked to the α-amino group of Cys via an amide bond. These results 
indicate that the N-terminal Cys of SitC from S. aureus RN4220 cells is N-acylated with a 
saturated C16 to C20 fatty acid and modified with a diacylglyceryl group containing two 
saturated fatty acids (Fig. 7b, left). Triacylation of SitC was confirmed with S. aureus SA113, 
clinically isolated S. aureus MW2, MSSA476, and S. epidermidis cells (Asanuma et al., 
2011). Furthermore, other S. aureus lipoproteins such as SA0739, SA0771, SA2074 (ModA), 
SA2158 and SA2202 were found to be triacylated. Taken together, these results indicate that 
staphylococcal species, typical monoderm bacteria, synthesize N-acylated S-diacylglyceryl 
lipoproteins even though an E. coli Lnt homologue is absent.  
 
N-terminal lipopeptide structures of other monoderms  
 
The structures of N-terminal lipopeptides generated from the lipoproteins of other low GC 
monoderms were analysed. Novel structures found in these bacteria (Fig. 8a) were N-acyl-S-
monoacyl-glyceryl-Cys (lyso form) in Enterococcus faecalis, N-acetyl-S-diacyl-glyceryl-Cys 
(N-acetyl form) in Bacillus licheniformis and dipeptidyl-S-diacyl-glyceryl-Cys (peptidyl 
form) in Mycoplasma fermentans (Kurokawa et al., 2012b).  
The unexpected lyso-form structure reflects the loss of one of two esterified fatty acids linked 
to the glyceryl group (Fig. 8a). Three lipoproteins of E. faecalis, an intestinal bacterium, were 
found to be of the lyso-form (Kurokawa et al., 2012b) (Table 1). In addition, lyso-form 
lipoproteins were found in Bacillus cereus, a component of the microbiota in the human gut 
and also a food poisoning bacterium, Lactobacillus delbrueckii subsp. bulgaricus, a probiotic 
strain originating from Bulgarian yogurt, and Streptococcus sanguinis, a member of the 
human indigenous oral microflora. These results suggest that lyso-form lipoproteins are one 
of the common structures in low GC content Gram-positive bacteria. It might be possible that 
lyso-form lipoproteins function as immune regulatory molecules in the gut or play a role in 
the host gut mucosal immunity.  
In addition to Bacillus licheniformis, a soil bacterium causing food poisoning, an N-acetyl 
form was found in Bacillus subtilis and strains living in extreme environments such as 
alkalophilic Bacillus halodurans, alkalophilic and extremely halotolerant Oceanobacillus 
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iheyensis, and thermophilic Geobacillus kaustophilus (Kurokawa et al., 2012b). Therefore, 
both N-acetyl-and lyso-forms are found in the Bacillaceae family (Table 1).  
The MBIO_0661 lipoprotein of Mycoplasma fermentans was found to be a dipeptidyl form 
comprising Ala-Gly (Kurokawa et al., 2012b). In contrast, the dipeptide of the MBIO_0319 
lipoprotein was Ala-Ser, while the MBIO_0763 and MBIO_0869 lipoproteins were the 
conventional diacyl form (Table 1). These extension sequences coincided with the C-terminal 
sequences of the respective signal peptides, suggesting that M. fermentans Lsp has unusual 
substrate specificity. Lipoproteins purified from M. genitalium and M. pneumoniae were 
found to be triacylated (Kurokawa et al., 2012b), which was consistent with previous results 
obtained in immunological studies (Shimizu et al., 2007; Shimizu et al., 2008). These results 
indicate that lipoprotein structures are diverse in mycoplasma species and vary depending on 
even lipoprotein species in M. fermentans.  
It should be noted that three lipoproteins of Listeria monocytogenes were found to be of the 
conventional diacyl form (Kurokawa et al., 2012b).  
 
 
Fig. 8 Novel N-terminal structures of lipoproteins and their possible biosynthetic pathways. (a) The 
structures of the lyso-form, N-acetyl form, and peptidyl form are illustrated. (b) Putative lipoprotein biogenesis 
pathways in low GC content monoderms are shown. The dotted lines indicate uncharacterized steps. 
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Putative lipoprotein biogenesis pathways  
 
Based on the results of recent studies (Asanuma et al., 2011; Kurokawa et al., 2009; 
Kurokawa et al., 2012b; Serebryakova et al., 2011), the N-terminal structures of lipoproteins 
in monoderm bacteria and mycoplasma species are classified into three major classes (A to C) 
(Table 1). Possible biosynthetic pathways are shown in Fig. 8b. Class C lipoproteins having 
S-diacylglyceryl-Cys are generated by two enzymes, Lgt and Lsp (steps 1 and 2 or 6). A novel 
type of Lsp (Lsp 2) is postulated, which cleaves inside the signal peptide, probably after a 
serine residue, and leaves a peptide preceding the lipidated Cys (step 6). Class B lipoproteins 
having N-acyl-S-diacyl-glyceryl-Cys can be generated through sequential modification 
reactions by Lgt, Lsp and an unidentified Lnt (steps 1, 2, and 3 or 7). Since an E. coli-type Lnt  
 
Table 1. The biochemical characterization of recently identified bacterial lipoproteins 
   Modified groups to the lipidated cysteine 
 
Bacterial species 
Major 
habitat 
Protein 
name 
Total1 R11 R22 R33 Reference 
Class A. N-acyl-S-monoacylglyceryl-cysteine structures 
A-a. Lyso form 
B. cereus Intestine BC0200 32:0 17:0 H 15:0 Kurokawa et 
al. (2012a) 
 Foods3 OppA 32:0 17:0, 
18:0 
H 14:0, 
15:0 
Kurokawa et 
al. (2012a) 
  PrsA 32:0 17:0 H 15:0 Kurokawa et 
al. (2012a) 
E. faecalis Intestine EF2256 34:1 18:1 H 16:0 Kurokawa et 
al. (2012a) 
  EF3256 34:1 18:1 H 16:0  Kurokawa et 
al. (2012a) 
  PnrA 34:1 18:0, 
18:1 
H 16:0, 
16:1 
Kurokawa et 
al. (2012a) 
L. bulgaricus Intestine Ldb0202  18:1 H 18:1 Kurokawa et 
al. (2012a) 
  Ldb2183  18:1 H 18:1 Kurokawa et 
al. (2012a) 
S. sanguinis Oral 
cavity 
SSA_0375  18:1 H 16:0 Kurokawa et 
al. (2012a) 
  SSA_1038  18:0, 
18:1 
H 16:0, 
16:1 
Kurokawa et 
al. (2012a) 
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Class B. N-acyl-S-diacylglyceryl-cysteine structures 
B-a. N-acetyl form 
B. halodurans Soil BH3460 32:0 15:0 15:0 2:0 Kurokawa et 
al. (2012b) 
  MalE 32:0 15:0 15:0 2:0 Kurokawa et 
al. (2012b) 
B. licheniformis Soil MntA 34:0 17:0 15:0 2:0 Kurokawa et 
al. (2012b) 
  OppA 34:0 17:0 15:0 2:0 Kurokawa et 
al. (2012b) 
B. subtilis Soil BSU01630 34:0 17:0 15:0 2:0 Kurokawa et 
al. (2012b) 
  PrsA 34:0 17:0 15:0 2:0 Kurokawa et 
al. (2012b) 
G. kaustophilus Deep sea GK1283 34:0 32:04  2:0 Kurokawa et 
al. (2012b) 
   34:0 17:0 15:0 2:0 Kurokawa et 
al. (2012b) 
O. iheyensis Deep sea CtaC 32:0 15:0 15:0 2:0 Kurokawa et 
al. (2012b) 
B-b. Conventional triacyl form 
A. laidlawii Waste 
water 
ACL_1223 48:0, 
50:05 
16:0 16:0 16:0, 
18:0 
Serebryakova 
et al. (2011) 
   50:0 (18:0)6 (16:0)6 (16:0)6 Nakayama et 
al. (2012) 
  ACL_1410 48:0, 
50:05 
16:0 16:0 16:0, 
18:0 
Serebryakova 
et al. (2011) 
   50:0 (18:0)6 (16:0)6 (16:0)6 Nakayama et 
al. (2012) 
M .genitalium Genital MG_040 50:1 18:1 16:0 16:0 Kurokawa et 
al. (2012b) 
M. pneumonia Respira- 
tory 
tracts 
 
 
MPN052 50:1 18:1 16:0 16:0 Kurokawa et 
al. (2012b) 
 MPN415 50:1 18:1 16:0 16:0 Kurokawa et 
al. (2012b) 
S. aureus Nares, 
skin 
SA0739 52:0 32:0–  
37:04 
 15:0–  
20:0 
Asanuma et 
al. (2011) 
  SA0771 52:0 32:0–  
36:04 
 16:0–  
20:0 
Asanuma et 
al. (2011) 
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  SA2074 51:0 31:0–  
36:04 
 15:0–  
20:0 
Asanuma et 
al. (2011) 
  SA2202 52:0 32:0–  
36:04 
 16:0–  
20:0 
Asanuma et 
al. (2011) 
  SitC 53:0 33:0–  
37:04 
 16:0–  
20:0 
Asanuma et 
al. (2011) 
S. epidermidis Skin SitC 53:0 32:0–  
35:04 
 17:0–  
20:0 
Kurokawa et 
al. (2012b) 
        Class C. S-diacylglyceryl-cysteine structures 
C-a. Conventional diacyl form 
L. monocytogenes Foods3 Lmo0135 32:0 17:0 15:0 H Kurokawa et 
al. (2012b) 
  Lmo2196 32:0 17:0 15:0 H Kurokawa et 
al. (2012b) 
  Lmo2219 32:0 17:0 15:0 H Kurokawa et 
al. (2012b) 
M. fermentans Throat MBIO_076
3 
34:0 34:04  H Kurokawa et 
al. (2012b) 
  MBIO_086
9 
34:0 34:04  H Kurokawa et 
al. (2012b) 
S. aureus Nares, 
skin 
SA1659 33:0 18:0 15:0 H Kurokawa et 
al. (2012a) 
  SitC 32:0–  
35:0 
17:0–  
20:0 
15:0 H Kurokawa et 
al. (2012a) 
C-b. Peptidyl form 
M. fermentans Throat MBIO_031
9 
34:0 18:0 16:0 Ala- 
Ser- 
Kurokawa et 
al. (2012b) 
  MBIO_066
1 
34:0 18:0 16:0 Ala- 
Gly- 
Kurokawa et 
al. (2012b) 
 
1 The total carbon number of modified acyl groups on the lipidated cysteine is calculated from the MS/MS- 
analyzed lipopeptide peak. The most abundant N-terminal lipopeptide ion in MALDI-TOF MS was usually 
analyzed by MS/MS. 
2 R1 and R2 denote a hydrogen or an acyl group attached to the sn-1 and sn-2 positions of the S-glyceryl group of 
the lipidated cysteine, respectively. R3 denotes a hydrogen, an acyl group, or a dipeptide attached to the α-amino 
group of the lipidated cysteine. 
3 Foods probably contained human, animal, and/or soil contaminants. 
4 The total carbon number of modified acyl groups on R1 and R2 is shown. 
5 Descending order in abundance. 
6 Our interpretation is shown in parenthesis. 
 
homologue is not found in monoderm bacteria, not only the structure but also the properties of 
this putative Lnt seem to be significantly different from those of E. coli-type Lnt. Class A 
lipoproteins having N-acyl-S-monoacyl-glyceryl-Cys can be generated by either a putative 
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lipoprotein O-deacylase from the triacyl form (step 4) or a putative lipoprotein transacylase 
from diacyl form (step 5). In E. coli, N-acylation is essential for correct outer membrane 
localization of lipoproteins by the Lol system (Fukuda et al., 2002; Robichon et al., 2005). To 
understand the biological significance of lipoproteins in low GC content monoderms, it is 
important to characterize the enzymes involved in lipoprotein modification.  
It seems interesting to consider the fatty acid preference of the putative Lnt enzymes involved 
in the formation of the triacyl form in monoderms (Kurokawa et al., 2012a). In S. aureus, 
48% of fatty acids bound to the α-amino group of Cys (R3 position) are 18:0 (18 carbons with 
no double bond), whereas 18:0 fatty acid constitutes only 3.2% of total membrane lipids and 
13.4% of PG. In contrast, 15:0 and 20:0 fatty acids occupy 40% and 22% of total membrane 
fatty acids, respectively. These results suggest that Lnt of S. aureus seems to prefer 18:0 fatty 
acid although the source of the fatty acid remains to be determined. On the other hand, the R3 
position of the M. pneumoniae MPN052 lipoprotein carried only 16:0 fatty acid, while 
M. pneumoniae total membrane contained 18:0 and 18:1 fatty acids, each at about 20%, in 
addition to 16:0. Thus, the putative Lnt of M. pneumonia is specific to 16:0 fatty acid. 
Moreover, lyso form lipoproteins such as PrsA of B. cereus, PnrA of E. faecalis, and Ldb2183 
of L. bulgaricus also exhibit strong fatty acid specificity at the R3 position (Kurokawa et al., 
2012b). Lnt of E. coli was recently found to exhibit specificities for both fatty acid species 
and lipid head groups (Hillmann et al., 2011). Kurokawa et al. (2012a) discovered conditions 
that alter between triacyl and diacyl forms of lipoproteins in S. aureus. Under the combination 
of low pH and post-log growth phase, S. aureus cells accumulated N-terminal free diacyl 
forms of lipoproteins. High temperatures and/or high salt concentrations additively increased 
the accumulation of diacyl forms. Interestingly, pH shift assays revealed that protein synthesis 
is required to the structural alterations, suggesting that the expression level or activity of 
unidentified Lnt should be regulated via protein synthesis. 
 
Biological functions of monoderm-derived lipoproteins 
 
Mammalian TLRs play an important role in recognizing microorganisms to activate host 
innate immune responses (Takeuchi & Akira, 2010). Eleven human TLRs and 13 mouse 
TLRs have been identified, and each TLR appears to recognize a pathogen-associated 
molecular pattern molecule derived from various microorganisms, including bacteria, viruses, 
protozoa, and fungi (Takeuchi & Akira, 2010). Among them, TLR4, TLR5 and TLR9 
recognize a single class of pattern molecule, such as lipopolysaccharides (LPS), bacterial 
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flagellin, and bacterial DNA, respectively (Ewald & Barton, 2011; Ramos et al., 2004). Outer 
membrane LPS play a critical role in the activation of TLR4 in diderm Gram-negative 
bacteria (Hoshino et al., 1999). TLR2 plays a major role in recognition of Gram-positive 
bacteria (Takeuchi et al., 1999). TLR2 had been reported to recognize several molecules, 
including lipoproteins, synthetic lipopeptides, peptidoglycan, lipoteichoic acids (LTAs), 
lipomannans and lipoarabinomannans (Zahringer et al., 2008). Since these molecules are 
structurally diverse, it appeared unlikely that TLR2 has the ability to react with all agonists to 
the same degree. To address this issue, two mutant strains of S. aureus, ∆ltaS (Grundling & 
Schneewind, 2007; Oku et al., 2009) and ∆lgt (Stoll et al., 2005), were used. It was found that 
bacterial lipoproteins, but neither LTA nor peptidoglycan, act as native TLR2 ligands 
(Kurokawa et al., 2009). The lgt-deficient mutants of S. aureus, L. monocytogenes, and Group 
B Streptococcus also indicated that bacterial lipoproteins function as major ligands for TLR2 
(Bubeck Wardenburg et al., 2006; Hashimoto et al., 2006; Henneke et al., 2008; Machata et 
al., 2008). Some lipoproteins tightly associate with peptidoglycan. When peptidoglycan-
associated lipoproteins were enzymatically removed, TLR2 activation by peptidoglycan was 
completely abolished, while lipoproteins extracted from peptidoglycan remained active as to 
TLR2 activation (Kurokawa et al., 2009). Taken together, these results indicate that true 
TLR2 ligands are lipoproteins. 
Because S. aureus lipoproteins anchored to the cytoplasmic membrane are covered by a thick 
layer of peptidoglycan (Fig. 1), bacterial cells must be engulfed and delivered to acidic 
phagosomes for the efficient activation of TLR2. Enzymes in phagosomes digest the 
internalized bacteria, causing the release of bacterial lipoproteins. Thus, phagocytosis of 
S. aureus cells and following degradation of the cell wall are critical for an efficient 
lipoprotein–TLR2 interaction (Ip et al., 2010; Kang et al., 2011; Shimada et al., 2010). 
TLR2 was thought to function as a heterodimer with TLR1 or TLR6. It was then examined as 
to which heterodimer is involved in the cytokine production by triacylated SitC. Synthetic 
lipoprotein analogues, such as N-palmitoyl-S-dipalmitoylglyceryl (Pam3)-Cys-Ser-Lys-Lys-
Lys-Lys (Pam3CSK4) and S-dipalmitoylated macrophage-activating lipopeptide-2 kDa 
(MALP-2) (Muhlradt et al., 1997), were used to examine the pro-inflammatory cytokine 
release. These examinations suggested that the TLR2⁄TLR1 heterodimer generally recognizes 
triacylated lipopeptides whereas the TLR2⁄TLR6 heterodimer responds to diacylated 
lipopeptides (Buwitt-Beckmann et al., 2005; Omueti et al., 2005; Takeuchi et al., 2001; 
Takeuchi et al., 2002). The crystal structures of the two TLR2 heterodimers complexed with 
synthetic lipopeptide support this model (Jin et al., 2007; Kang et al., 2009).  
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Induction of pro-inflammatory cytokines by purified triacylated SitC was examined using 
mouse thioglycolate-elicited peritoneal macrophages. The native SitC protein induced the 
production of both tumour necrosis factor-α (TNF-α) and interleukin 6 (IL-6) in wild-type 
mouse macrophages (Fig. 9) (Kurokawa et al., 2009). In contrast, TLR2–/– mouse 
macrophages released neither TNF-α nor IL-6 upon the addition of SitC. Since both cytokines 
were induced in macrophages from TLR1–/– and TLR6–/– mice, the two TLRs are not 
essential for SitC-mediated cytokine production while TLR2 is essential, suggesting that 
triacylated SitC stimulates immune cells through both the TLR2/TLR1 and TLR2/ TLR6 
heterodimers.  
Lyso form lipoprotein OppA of B. cereus induced both TNF-α and IL-6 in a TLR2- dependent 
manner (Fig. 9) (Kurokawa et al., 2012b). Neither TLR1 nor TLR6 is required for this. In 
contrast, cytokine secretion induced by lyso form lipoprotein PnrA of E. faecalis is dependent 
on both TLR2 and TLR6 but independent of TLR1 (Fig. 9). N-acetyl lipoprotein/lipopeptide 
induced the release of TNF-α and IL-6 in TLR2- and TLR6-dependent and TLR1-independent 
manners (Fig. 9). Taken together, these results indicate that the lyso and N-acetyl form 
lipoproteins in monoderms activate TLR2 by forming a heterodimer with either TLR1 or 
TLR6. The choice of co-receptor seems to depend on the species of bacterial lipoproteins.  
 
 
PROBLEMS TO BE ANSWERED  
 
As discussed in this chapter, much new information has been obtained in relation to the 
N-terminal structures of lipoproteins, the enzymes involved in lipoprotein maturation, the 
physiological functions of lipoproteins, and the sorting of lipoproteins. However, there are 
many unanswered questions, as listed below.  
 
Gram-negative diderms  
1 The Lol avoidance mechanism is probably general for the cytoplasmic membrane 
retention of lipoproteins. However, how do different residues function as Lol 
avoidance signals when the origin of LolCDE is different?  
2 How are lipoproteins transported to the cell surface of some bacteria? Does the Lol 
system contribute to this transport?  
Gram-positive diderms  
1 How are lipoproteins transported to the mycobacterial outer membrane?  
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2 Which lipoprotein motifs direct retention in the cytoplasmic membrane or transport to 
the mycobacterial outer membrane?  
3 What is the function of lipoprotein glycosylation in mycobacteria?  
4 Is the glycosylation of lipoproteins dependent on lipidation?  
Low GC monoderms  
1 Why is the lipid modification of N-terminal Cys so diverse in low-GC monoderms?  
2 Are modification enzymes also diverse?  
3 Is there any physiological advantage of synthesizing N-acylated triacyl lipoproteins 
even though bacteria do not possess an outer membrane?  
4 Is structural alteration between lipid modifications unique in S. aureus, or common in 
other bacteria? 
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ABSTRACT 
 
Lipoproteins are well known virulence factors of bacterial pathogens in general and of 
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, in particular. 
Lipoprotein lipidation between Gram-positive and Gram-negative bacteria differs 
significantly as these are di- and triacylated, respectively. Little is known about the lipid 
anchor of mycobacterial lipoproteins. We reported recently that mycobacterial LppX, a 
lipoprotein involved in synthesis of cell wall components is triacylated, although 
mycobacteria are classified as GC-rich Gram-positive bacteria. We here exploited the model 
organism Mycobacterium smegmatis for the expression of Mtb LprF and characterized 
N-terminal modifications at the molecular level. LprF is a putative lipoprotein of Mtb 
involved in signaling of potassium-dependent osmotic stress. LprF is extensively modified in 
a mycobacterium-specific manner by a thioether-linked diacylglyceryl residue with one ester-
bound tuberculostearic- and one C16:0 fatty acid and additionally by a third N-linked C16:0 
fatty acid, and a hexose. 
 
 
 
 
 
* These authors contributed equally to this work 
 
CHAPTER 2 
73 
 
INTRODUCTION 
 
Tuberculosis is a major cause of death around the world, with 9.3 million new cases and 1.8 
million deaths occurring in 2007, which is the highest rate claimed by a single bacterial 
pathogen (WHO TB-factsheet, 2009). The causative agent of the disease is Mycobacterium 
tuberculosis (Mtb), an acid-fast bacillus that is primarily transmitted via the respiratory route. 
The reasons for the pathogens extraordinary success are diverse: it is slow-growing which 
makes antibiotic treatment complicated and lengthy, it has a thick waxy cell wall and 
therefore is resistant to different kinds of mechanical and chemical stress and it evades the 
immune system by parasitizing the macrophages of its host. 
The high immunogenic potential of Mtb is based on its unusual cell envelope which is 
exceptionally rich in lipids, glycolipids and polysaccharides (Daffe & Draper, 1998). Among 
others, uncommon cell wall components like mycolic acids, mycocerosic acid, 
phenolthiocerol, lipoarabinomannan (LAM) and arabinogalactan trigger inflammatory host 
reactions (Daffe & Draper, 1998). On the other hand, Mtb is able to subvert the immune 
response of the host by inhibiting its innate defense by several mechanisms. It prevents 
inflammasome activation (Master et al., 2008), delays phagosome maturation in macrophages 
(Russell, 2001) and suppresses MHC class II antigen presentation (Baena & Porcelli, 2009). 
Suppression of MHC II antigen expression is conferred by several lipoproteins, e.g., the 19 
kDa lipoprotein (LpqH) (Noss et al., 2001). 
Lipoproteins are a subclass of proteins found in the cell envelope of all bacteria. Lipoproteins 
are either di- (in case of Gram-positive bacteria) or triacylated (in case of Gram-negative 
bacteria) on a highly conserved cysteine located at the N-terminus, which is part of the 
lipobox [LVI][ASTVI][GAS][C] (Rezwan et al., 2007a). By the consecutive action of the 
three enzymes pre-prolipoprotein diacyl glyceryl transferase (Lgt), prolipoprotein signal 
peptidase (LspA) and apolipoprotein N-acyltransferase (Lnt), lipoproteins are post-
translationally modified after translocation over the cytoplasmic membrane. Lgt attaches a 
diacylglyceryl residue to the universally conserved cysteine in the lipobox by thioether-
linkage. Then LspA removes the lipoprotein signal peptide and Lnt attaches a third acyl chain 
to the amino group of the modified cysteine. Despite the fact that N-acylation in Bacillus 
subtilis and Staphylococcus aureus was reported (Hayashi et al., 1985; Kurokawa et al., 2009; 
Tawaratsumida et al., 2009), Lnt was found exclusively in Gram-negative bacteria. Even 
though Mtb is deemed to be a Gram-positive bacterium because of its staining properties, it 
has been shown recently that mycobacteria have a periplasmic-like structure (Zuber et al., 
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2008). Furthermore, it has been shown that mycobacteria express a functional Lnt as at least 
one lipoprotein, LppX was found to be triacylated (Tschumi et al., 2009). 
The functions of lipoproteins are manifold; they may be involved in protein export and 
folding, in antibiotic resistance, in ABC transporter systems, act as substrate-binding proteins 
and are involved in cell signaling. Examples of mycobacterial lipoproteins which have been 
explored are Mpt83, LppX, LpqW and the 19 kDa lipoprotein. Mpt83 is assumed to be an 
adhesin and it has been shown that RNA encoding Mpt83 induces protective immune 
responses against Mtb infection (Xue et al., 2004). LpqW and LppX have been shown to be 
key players in synthesis and transport of unique components of the mycobacterial cell 
envelope. While LppX is involved in translocation of phthiocerol dimycocerosates (DIM) to 
the outer membrane (Sulzenbacher et al., 2006), LpqW has been shown to be essential in the 
synthesis of the cell wall components phosphatidyl-myo-inositol mannoside (PIM) and LAM 
(Kovacevic et al., 2006; Marland et al., 2006). The 19 kDa lipoprotein has been described as 
an adhesin (Diaz-Silvestre et al., 2005). It induces IL-1, IL-2 and TNF-α through TLR2-
signaling in macrophages. Overall, lipoproteins are important in host–pathogen interactions 
and they have a high pathogenic potential which has been proven by disruption of lspA, the 
lipoprotein signal peptidase. An lspA-deficient strain of Mtb exhibited reduced multiplication 
in mouse macrophages and reduced number of colony forming units in a mouse model by 3–4 
logs (Sander et al., 2004). 
The putative lipoproteins LprF and LprJ of Mtb recently have been described to interact with 
the histidine kinase KdpD in a yeast two-hybrid screen (Steyn et al., 2003). Both lipoproteins 
have been suggested to form ternary complexes with the histidine kinase domain of KdpD 
which in turn seems to be activated after potassium-dependent sensing of environmental 
osmotic stress and activates a signal transduction pathway. 
Even though advances in the past few years contributed to the knowledge of the function of 
lipoproteins, there is scarcely known anything about the chemical composition of the lipid 
modifications. Modern tools like mass spectrometry instead of incorporation of radioactive 
precursors provide support to understand post-translational modifications by lipidation and 
glycosylation of lipoproteins. Mycobacterial lipoprotein LppX is the first and only lipoprotein 
characterized at the molecular level (Tschumi et al., 2009). Investigations in other bacteria 
indicate that lipids of lipoproteins may differ significantly within one species (Kurokawa et 
al., 2009; Tawaratsumida et al., 2009). Therefore, we extended our studies on mycobacterial 
lipoproteins. 
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In this study, we cloned, expressed and purified LprF of Mtb in Mycobacterium smegmatis, a 
non-pathogenic but phylogenetically close relative of Mtb. We show for the first time that a 
putatively membrane-localized lipoprotein of Mtb is N-acylated and determine the 
predominant fatty acids by matrix-assisted laser desorption ionization time-of-flight tandem 
mass spectrometry (MALDI-TOF/TOF MS). 
 
 
EXPERIMENTAL PROCEDURES 
 
Bacterial strains and growth conditions. Mycobacterium smegmatis strains were cultivated in 
LB medium or on LB agar. If necessary, gentamicin was added at a final concentration of 
5 µg/ml. Strains used in this study were M. smegmatis SmR5 (Sander et al., 1995), a strain 
carrying a non-restrictive rpsL mutation conferring streptomycin resistance, and 
M. smegmatis lnt::aph mutant (Tschumi et al., 2009). 
Expression of recombinant lipoprotein LprF. LprF of Mtb was expressed under control of the 
19 kDa antigen (lpqH) promoter. The recombinant protein was generated by fusion PCR; 
fragment 1 contains the sequence of the 19 kDa promoter, fragment 2 contains the functional 
domain of the LprF lipoprotein including the leader peptide and the sequence of a C-terminal 
thrombin cleavage site and a HA-epitope tag (hemagglutinin protein), followed by a 6× His-
epitope tag. Fragment 1 was amplified with primers 1a (5′-GGGTTAACGAATTC 
TACATTG-3′, bold letters indicate sites of restriction enzymes HpaI and EcoRI) and 1b (5′-
CTTGTGAGATCAAGCCATTCATCCTGTGCTCCT-3′, italic letters indicate the linker for 
lprF) from plasmid pMV261-Gm-FusLppX (Tschumi et al., 2009). Fragment 2 was amplified 
with primers 2a (5′-AGGAGCACAGGATGAATGGCTTGATCTCACAAG-3′, italic letters 
indicate the linker for lprF) and 2b (5′-CCGTTAACGAATTCTAGTGGTGGTG 
GTGGTGGTGAGTGGCGTAGTCGGGGACGTCGTAGGGGTAACTACCACGTGGAAC
TAGTCCCGCCGGGTTCGG-3′, bold letters indicate sites of restriction enzymes HpaI and 
EcoRI, underlined letters indicate thrombin cleavage site, HA- and His-tag) from Mtb 
genomic DNA. Fusion PCR was performed with primers 1a and 2b. The recombinant lprF 
gene was cloned into pMV261-Gm (a shuttle vector replicating in Escherichia coli as well as 
in mycobacteria, derived from pMV261) using the EcoRI-restriction sites. The resulting 
plasmid pMV261-Gm-lprF was transformed into M. smegmatis SmR5 and M. smegmatis 
lnt::aph. 
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Preparation of cell extracts and Western blot analysis. Bacteria transformed with pMV261-
Gm-lprF were cultured in 2 L LB medium for 3 days at 37 C°. The cultures were harvested 
(4400 rpm, 1 h) and resuspended in PBS containing Complete EDTA-free tablets (Roche). 
Cells were lysed by three French press cycles (American Instrument Company) at 1.1 × 106 
Pa. Extracts were treated with 2% sodium N-lauroylsarcosine (SLS) for 1 h at room 
temperature, and for 16 h at 4 C° thereafter. Soluble and insoluble fractions were separated by 
centrifugation at 30,000g for 1 h at 4 C°. Extracts corresponding to 1–5 µg of total protein 
were separated by a 12.5% SDS–PAGE and subsequently analyzed by Western blot using 
anti-HA-antibodies (1:300, Roche). 
Protein fingerprinting. Proteins were digested with trypsin and dissolved in 25 µl 0.1% formic 
acid. Samples were desalted by using a Ziptip C18 column, mixed 1:1 with matrix solution 
(5 mg/ml α-cyano-4-hydroxy-cinnamic acid (Bruker Daltonics) in 0.1% trifluoroacetic acid, 
50% acetonitrile) and spotted onto the target. 
 
FPLC protein purification. The soluble fraction of cell extracts expressing epitope-tagged 
proteins was mixed with dilution buffer (20 mM NaH2PO4, 0.5 M NaCl, pH 7.4) and loaded 
on a HisTrap™ HP column (GE Healthcare) previously equilibrated with equilibration buffer 
(20 mM NaH2PO4, 0.5 M NaCl, 0.2% SLS, 20 mM imidazole, pH 7.4). Proteins were eluted 
applying an imidazole gradient (0.125–0.5 M). 
As a further purification step, the column flow through from His-tag purification was dialyzed 
against equilibration buffer (20 mM Tris-hydroxymethyl-aminomethane, 0.1 M NaCl, 0.1 
mM EDTA, pH 7.5), loaded onto an anti-HA-affinity matrix (Roche), washed with a buffer 
containing 20 mM Tris-hydroxymethyl-aminomethane, 0.1 M NaCl, 0.1 mM EDTA, 0.05% 
(v/v) Tween 20, pH 7.5 and eluted with column regeneration buffer (0.1 M glycine, pH 2.0). 
MALDI-TOF/TOF. 100–200 pmol of purified lipoprotein were prepared and analyzed 
according to Ujihara et al. (Ujihara et al., 2008). Lipoproteins were digested with AspN. 
Extracted peptides were dried and dissolved in 5 µl 0.1% trifluoroacetic acid, 50% 
acetonitrile. Samples were mixed 1:1 with matrix solution (5 mg/ml α-cyano-4-hydroxy-
cinnamic acid (Bruker Daltonics) in 0.1% trifluoroacetic acid, 50% acetonitrile) and spotted 
onto the target. The MALDI-TOF/TOF mass spectra were recorded on an Ultraflex II 
MALDI-TOF/TOF instrument with smartbeam laser upgrade (Bruker Daltonics). The laser 
was set to a repetition rate of 100 Hz and the ion acceleration voltage was 29.5 kV. The mass 
measurements were performed in the positive ion reflector mode. 
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Edman degradation. For N-terminal sequencing, proteins were separated by 12.5% SDS–
PAGE, blotted onto a PVDF membrane and stained with Coomassie Brilliant Blue (0.03% 
(w/v) Coomassie Brilliant Blue R-250, 25% (v/v) isopropanol, 10% (v/v) acetic acid) for 5 
min. The membrane was destained (10% acetic acid, 35% methanol) and washed once with 
Aqua B. Braun (Ecotainer®). Visible bands were cut out and analyzed by Edman degradation 
(Procise 492 cLC protein sequencer, Applied Biosystems), according to the manufacturer’s 
instructions. 
 
 
RESULTS AND DISCUSSION 
 
To analyze the putative lipoprotein LprF from Mtb concerning the lipoprotein specific 
modifications with fatty acids we generated the expression vector pMV261-Gm-lprF. Plasmid 
pMV261-Gm-lprF was transformed into M. smegmatis SmR5 wildtype and an isogenic 
lnt::aph mutant strain, lacking a functional apolipoprotein-N-acyl-transferase (Lnt). 
Recombinant LprF from whole cell extracts was purified using the His-epitope and 
subsequently analyzed by Western blot using anti-HA-antibodies. Depending on the kinetics 
of the enzymes of the lipoprotein biosynthesis pathway (Rezwan et al., 2007a), the cell extract 
may contain different forms of the lipoprotein, the pre-prolipoprotein, prolipoprotein, 
apolipoprotein and the mature lipoprotein. The theoretically calculated molecular masses for 
LprF are in the range of 26–30 kDa. However, the apparent molecular masses estimated from 
an SDS–PAGE may differ significantly. Analysis of the elution fractions from wildtype and 
lnt::aph mutant by Western blot and Coomassie stained SDS–PAGE showed bands with an 
apparent size of 30 and 35 kDa in both strains (data not shown). 
 
Protein analysis 
 
Fingerprint analysis of the 30 and 35 kDa proteins from wildtype and lnt::aph mutant 
confirmed these proteins as LprF from Mtb. For characterization and identification of the 
N-terminal modifications of LprF only the mature lipoprotein is needed. To characterize the 
30 and 35 kDa forms of LprF which have been detected after His-tag purification we applied 
several methods. Edman degradation provides a suitable method to identify the pre-
prolipoprotein, prolipoprotein and apolipoprotein. N-acylation blocks Edman degradation. 
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Therefore, MALDI-TOF/TOF MS was used to confirm N-acylated LprF forms and to identify 
modifications at the molecular level. 
 
Edman degradation 
 
The proteins with an apparent size of 35 kDa (Fig. 1A) revealed the sequence MNGLI, which 
is an LprF sequence starting with the initial methionine of the signal peptide (Fig. 1C) thereby 
confirming these forms as pre-pro-LprF or pro-LprF in both strains. The proteins with a size 
of 30 kDa (Fig. 1A) revealed the sequence KKPTT in wildtype and TVVAG in the lnt::aph 
mutant. These determined sequences start at position +3 and at position −5, respectively, in 
relation to the cysteine (+1) of the lipobox (Fig. 1C).  
 
 
Fig. 1. Copper chloride stained SDS–PAGE and amino acid sequence of purified LprF. (A) HisTrap™-
column purified LprF from M. smegmatis wildtype and lnt::aph mutant. (B) HA-affinity matrix purified LprF 
from M. smegmatis wildtype and lnt::aph mutant. Proteins at 25 kDa were identified as histone-like protein 
HupB from M. smegmatis. (C) Amino acid sequence of recombinant LprF. Italic letters indicate the signal 
peptide cleaved by LspA. Bold letters indicate the lipobox including the conserved cysteine at position +1 
modified by Lgt and Lnt. Inverted commas indicate AspN cleavage sites. The modified N-terminal peptide after 
AspN digestion found in M. smegmatis wt and lnt::aph mutant is underlined. 
 
 
These results indicate that the 30 kDa forms of LprF are not the desired LspA-cleaved LprF 
but LprF forms cleaved by other proteases. The 30 kDa protein form isolated from the 
lnt::aph mutant and starting with the sequence TVVAG contains potentially diacylglycerol 
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modified cysteine and therefore was subjected to MALDI-TOF/TOF MS analysis. The 30 
kDa band isolated from the wildtype strain may be a mixture of triacylated LprF and truncated 
LprF with the N-terminal residues KKPTT. As triacylated lipoprotein is not accessible to 
Edman degradation due to the blocked N-terminus, the 30 kDa band from wildtype was also 
subjected to MALDI-TOF/TOF MS. 
 
MALDI-TOF/TOF MS analysis 
 
The copper chloride stained SDS–PAGE of His-tag-purified LprF showed the same bands 
detected before on Western blot and Coomassie stained SDS–PAGE (Fig. 1A). AspN-
digested peptides from the 30 kDa recombinant LprF of both strains were analyzed with 
MALDI-TOF/TOF MS to confirm the N-terminal sequence of mature LprF and to 
characterize the predominant modifications occurring in M. smegmatis lipoprotein LprF at the 
molecular level. The calculated monoisotopic m/z value for the AspN digested unmodified 
N-terminal peptide of the LspA-cleaved LprF is m/z = 2496.2 (Fig. 1C). The fatty acids found 
in mycobacterial phospholipids are palmitic (C16:0), palmitoleic (C16:1), oleic (C18:1) and 
tuberculostearic acid (10-methyloctadecanoic acid) (C19:0) (Goren, 1979). Since fatty acids 
of membrane phospholipids are used for N-acylation of lipoproteins in E. coli (Jackowski & 
Rock, 1986; Lai & Wu, 1980), we calculated the theoretical mass of the N-terminal peptide of 
LprF with all possible combinations of the above mentioned four fatty acids. Lipoproteins 
sometimes are glycosylated (Sartain & Belisle, 2009) and putative sites for O-glycosylation 
are also present in the N-terminal AspN-fragment of LprF. Therefore, we also calculated the 
mass with several hexose modifications. However, no signals corresponding to the free or 
acylated N-terminal peptides (with or without glycosylations) were found in the mass 
spectrum (data not shown). So, the analyzed 30 kDa proteins of LprF are most likely the non-
modified but truncated proteins, as indicated by the results of the Edman degradation. 
 
Analysis of HA-tag purified LprF 
 
Since the 35 kDa LprF clearly was identified as the (pre-) pro-LprF and the 30 kDa forms 
were not the LspA-processed LprF we assumed that the expected mature forms were not yet 
isolated. Concentrating again on the Western blots and Coomassie stained SDS–PAGE from 
His-tag purification, we found another distinct band on the Western blots from the column 
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flow throughs. This band had an apparent size of 28 kDa possibly corresponding to the LspA-
cleaved LprF (data not shown). 
Due to the fact that this protein form did not bind to the HisTrap™ HP column, we used the 
HA-epitope in the recombinant LprF to purify this protein from the flow through fractions. 
After purification with the HA-affinity matrix, the proteins with the size of 28 kDa in 
wildtype and lnt::aph mutant were observed on Western blot, Coomassie and copper chloride 
stained SDS–PAGE as well (Fig. 1B). 
 
Edman degradation of HA-tag purified LprF 
 
To determine whether these 28 kDa forms from wildtype and lnt::aph mutant are the LspA-
cleaved LprF or LprF at all, Edman degradation was performed although for the mature 
lipoprotein from wildtype N-terminal sequencing is expected to be blocked by the modified 
N-terminus. The analyses revealed the unique sequence xxKKP in LprF indicating that these 
proteins start with the cysteine at position +1 (Fig. 1C) thereby confirming these proteins as 
the LspA-cleaved LprF in the wildtype and the mutant. As the resolution of the SDS–PAGE is 
not sufficient to separate triacylated and diacylated lipoproteins, the 28 kDa band from 
wildtype may be a mixture of both forms. 
 
MALDI-TOF/TOF MS analysis of HA-tag purified LprF 
 
For the identification of the lipoprotein specific modifications at the conserved cysteine the 
AspN digested peptides from the 28 kDa LprF from wildtype and lnt::aph mutant were 
investigated by MALDI-TOF MS. Instead of the [M+H]+ signal at m/z = 2496.2 as calculated 
for the AspN digested, unmodified N-terminal peptide we found a signal at m/z = 3488.9 for 
the modified N-terminal peptide of LprF from wildtype (Fig. 2A). In the lnt::aph mutant we 
found a signal at m/z = 3250.5 (Fig. 2B), indicating a smaller size of the N-terminal peptide 
and thus suggesting an Lnt dependent modification in the wildtype. The difference in 
molecular mass between the unmodified N-terminal peptide (m/z = 2496.2) and the peptide 
found in the lnt::aph mutant (m/z = 3250.5) is 754.3 Da indicating a diacylglyceryl 
modification with ester-linked tuberculostearic acid and C16:0 fatty acid (592.5 Da) and a 
glycosylation with one hexose (162.2 Da, Σ = 754.7). The difference in molecular mass of 
238.4 Da between wildtype (m/z = 3488.9) and mutant indicates an additional modification of 
the N-terminal peptide with a C16:0 fatty acid in the wildtype. 
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Fig. 2. MALDI-TOF MS analysis of AspN digested purified LprF (28 kDa). MS data of AspN digested LprF 
peptides from (A) M. smegmatis wildtype and (B) M. smegmatislnt::aph mutant. Black arrow indicates 
triacylated monoglycosylated N-terminal peptide. Open arrow indicates diacylated monoglycosylated N-terminal 
peptide. The mass at m/z = 3368.5 corresponds to an internal AspN peptide of LprF (residue 201–232 of the 
mature lipoprotein). 
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In order to confirm the modifications of the AspN digested N-terminal peptide of LprF from 
wildtype (m/z = 3488.9) and lnt::aph mutant (m/z = 3250.5), the structure of the N-terminal 
peptide was analyzed with MALDI-TOF/TOF MS. In wildtype (Fig. 3A) the ion at m/z = 
3326.7 corresponds to the cleavage of a hexose (∆ = 161.2 Da). The ion at m/z = 2698.7 is the 
most intense ion and corresponds to the release of the diacylthioglyceryl carrying both, an 
O-linked tuberculostearic and a C16:0 fatty acid (∆ = 628.0 Da). The release of 257.1 Da from 
the ion at m/z = 3326.7 corresponds to the elimination of a C16:0 fatty acid and the release of 
370.9 Da from the ion at m/z = 3069.6 corresponds to the elimination of a tuberculostearic 
acid α-thioglyceryl ester. The difference in molecular mass between the MS signal for the 
N-terminal peptide from wildtype and lnt::aph mutant is 238.4 Da which indicates a third 
acylation with a C16:0 fatty acid in the wildtype peptide in an Lnt dependent manner. 
In the lnt::aph mutant (Fig. 3B) the ions at m/z = 3088.8 and 2461.9 correspond to the release 
of a hexose (∆ = 161.8) and a diacylthioglyceryl carrying both O-linked tuberculostearic and 
C16:0 fatty acid (∆ = 626.9), respectively. Of note – a loss of the His-epitope in this 28 kDa 
LprF forms was assumed to be responsible for the failure to extract this proteins by the His-
tag purification. But, the presence of the tag was confirmed by MALDI-TOF/TOF MS 
analysis (data not shown). 
 
 
CONCLUSIONS 
 
This study shows for the first time the modifications of a putative membrane located 
lipoprotein of Mtb on the molecular level. The LprF of Mtb wildtype is a triacylated and 
glycosylated lipoprotein carrying a thioether-linked diacylglyceryl residue with an ester-
bound tuberculostearic- and C16:0 fatty acid and a third C16:0 fatty acid most likely at the 
amino terminal cysteine residue. These results together with the recent analysis of LppX 
(Marland et al., 2006) indicate that N-acylation seems to be a common motif in mycobacterial 
lipoproteins. As expected for the lnt::aph mutant the cysteine in LprF is modified with the 
diacylglyceryl residue, but is missing the third acylation (only glycosylated and modified with 
the diacylglyceryl residue), thereby confirming lipoprotein acylation by MSMEG_3860 in 
mycobacteria. Due to the close phylogenetic relation between M. smegmatis and Mtb the same 
acylation pattern of LprF in Mtb is assumed. Although glycosylation of the N-terminal AspN 
peptide of LprF was identified, the exact glycosylation site of seven possible sites within the 
peptide could not be determined.  
CHAPTER 2 
83 
 
 
Fig. 3. MALDI-TOF/TOF MS analysis of N-terminal peptides of LprF. MS/MS data of the N-terminal 
peptides of LprF from (A) M. smegmatis wildtype and (B) M. smegmatis lnt::aph mutant. Schematic drawings of 
the structure of the modified N-terminal peptide of LprF are shown in the upper part of each MS/MS spectrum. 
Dotted frames indicate the modified conserved cysteine at molecular level. Cleavage sites of each identified m/z 
signal are indicated. Eliminated fragments of LprF modifications are depicted in the spectra. 
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Fingerprinting and Edman degradation identified several proteins isolated either by His- or 
HA-affinity purification as LprF. However, the N-terminal lipidated LprF could not be 
purified by His-tag purification suggesting that the lipidation interferes with His-purification 
despite the presence of the His-tag which was proved by analysis of the C-terminus (data not 
shown) or somehow reduces the binding affinity of the protein. Beside the pre-pro-
lipoprotein, apolipoprotein and the mature LprF a protein with an apparent size of 32 kDa 
found only in the wildtype was confirmed by fingerprint as LprF as well, but was not 
subjected to further analysis in this study. This LprF may result from cleavage by proteases 
other than LspA. 
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ABSTRACT 
 
Background   Lipoproteins are virulence factors of Mycobacterium tuberculosis. Bacterial 
lipoproteins are modified by the consecutive action of preprolipoprotein diacylglyceryl 
transferase (Lgt), prolipoprotein signal peptidase (LspA) and apolipoprotein 
N-acyltransferase (Lnt) leading to the formation of mature triacylated lipoproteins. Lnt 
homologues are found in Gram-negative and high GC-rich Gram-positive, but not in low GC-
rich Gram-positive bacteria, although N-acylation is observed. In fast-growing 
Mycobacterium smegmatis, the molecular structure of the lipid modification of lipoproteins 
was resolved recently as a diacylglyceryl residue carrying ester-bound palmitic acid and ester-
bound tuberculostearic acid and an additional amide-bound palmitic acid.  
Results   We exploit the vaccine strain Mycobacterium bovis BCG as model organism to 
investigate lipoprotein modifications in slow-growing mycobacteria. Using Escherichia coli 
Lnt as a query in BLASTp search, we identified BCG_2070c and BCG_2279c as putative lnt 
genes in M. bovis BCG. Lipoproteins LprF, LpqH, LpqL and LppX were expressed in 
M. bovis BCG and BCG_2070c lnt knock-out mutant and lipid modifications were analyzed 
at molecular level by matrix-assisted laser desorption ionization time-of-flight/time-of-flight 
analysis. Lipoprotein N-acylation was observed in wildtype but not in BCG_2070c mutants. 
Lipoprotein N- acylation with palmitoyl and tuberculostearyl residues was observed.  
Conclusions  Lipoproteins are triacylated in slow-growing mycobacteria. BCG_2070c 
encodes a functional Lnt in M. bovis BCG. We identified mycobacteria-specific 
tuberculostearic acid as further substrate for N-acylation in slow-growing mycobacteria.  
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INTRODUCTION 
 
Proteins posttranslationally modified by covalent lipid attachment are present in eukaryal and 
bacterial organisms. In bacteria, 1-3 % of the genome encode for lipoproteins. Bacterial 
lipoproteins are anchored in the membrane surface where they fulfill various cellular 
functions, ranging from cell wall integrity, secretion, nutrient uptake, environmental signaling 
to virulence (Babu et al., 2006; Kovacs-Simon et al., 2011; Sutcliffe & Harrington, 2004). 
Lipoproteins from Gram-positive and Gram-negative bacteria are synthesized in the cytosol as 
preprolipoproteins and are translocated across the cytoplasmic membrane via the Sec- or 
Twin arginine translocation (Tat) system (McDonough et al., 2005). Lipoprotein signal 
sequences terminate in a highly conserved lipobox motif consisting of four amino acids 
(LVI/ASTVI/GAS/C) (Babu et al., 2006). Processing of lipoprotein precursors into mature 
forms takes place at the outer leaflet of the cytoplasmic membrane and is accomplished by the 
sequential action of three enzymes attacking the conserved cysteine in the lipobox: 1) the 
phosphatidylglycerol:pre-prolipoprotein diacylglyceryl transferase (Lgt) attaches a 
diacylglyceryl residue to the cysteine via thioether linkage (Sankaran & Wu, 1994), 2) the 
prolipoprotein signal peptidase (LspA) cleaves off the signal peptide and 3) apolipoprotein 
N-acyltransferase (Lnt) acylates the N-terminal cysteine residue at its free amino group 
(Okuda & Tokuda, 2011; Rezwan et al., 2007a; Sutcliffe & Harrington, 2004). In 
proteobacteria, N-acylation of lipoproteins is a prerequisite for the transport to the outer 
membrane by the Lol system (Narita & Tokuda, 2011; Yakushi et al., 2000).  
Lgt and LspA are universally present in Gram-positive and Gram-negative bacteria (Wu, 
1996). The gene encoding Lnt was originally identified in the Gram-negative bacterium 
Salmonella enterica sv. Typhimurium and is conserved in proteobacteria. The Lnt structure 
and function are well studied in Escherichia coli (Vidal-Ingigliardi et al., 2007). Contrary to 
the long held assumption that lnt is restricted to Gram-negative bacteria (Wu, 1996) lnt 
homologues are also present in high GC-rich Gram-positive bacteria. In the fast-growing, 
saprophytic mycobacterial model organism Mycobacterium smegmatis, Lnt-dependent 
N-acylation was demonstrated and the lipid moiety of lipoproteins has been resolved at 
molecular level. M. smegmatis lipoproteins are modified with a thioether-linked 
diacylglyceryl residue composed of ester-linked palmitic acid and ester-linked 
tuberculostearic acid and an additional palmitic acid amide-linked to the α-amino group of the 
conserved cysteine. Diacylglycerol modification and signal peptide cleavage are prerequisites 
for N-acylation (Brülle et al., 2010; Tschumi et al., 2009). Secreted proteins, among them 
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lipoproteins often are modified by glycosylation. O-glycosylation in mycobacteria occurs 
through a stepwise process depending on at least a protein mannosyl tranferase (PMT) 
performing the initial mannosylation step and a α1-2 mannosyl tranferase realizing the 
subsequent elongation of the mannosyl chains. Recently, PMT enzyme responsible for the 
initial attachment of mannose residue to the protein was identified (Liu et al., 2013).  
In addition to M. smegmatis, N-acyltransferase activity by Lnt homologues was shown in two 
other high GC-rich Gram-positive bacteria, namely Streptomyces scabies (Widdick et al., 
2011) and Corynebacterium glutamicum (Mohiman et al., 2012). Recent mass spectrometry 
analyses of lipoproteins in low GC-rich Gram-positive bacteria (firmicutes and mollicutes) 
provided evidence that N-acylation also occurs in these bacterial species, however, no obvious 
lnt-like gene has been identified to date (Hayashi et al., 1985; Kurokawa et al., 2009; 
Nakayama et al., 2012; Serebryakova et al., 2011; Tawaratsumida et al., 2009). Instead, 
biochemical analysis identified two new lipoprotein structures, the “N-acetyl” and the 
“peptidyl” lipoprotein structure. These novel structures strongly suggest the presence of yet to 
be identified key enzymes involved in bacterial lipoprotein biosynthesis (Kurokawa et al., 
2012b). 
Most pathogenic mycobacteria belong to the group of slow-growing mycobacteria, including 
Mycobacterium leprae, the causative agent of leprosy and the members of the Mycobacterium 
tuberculosis complex (e.g. M. tuberculosis, Mycobacterium africanum, Mycobacterium 
cannetti, Mycobacterium bovis). Mycobacterium tuberculosis is the causative agent of human 
tuberculosis, a major cause of death around the world (http://www.who.int/tb/
publications/factsheets/en/index.html). Elimination of tuberculosis requires an improved 
understanding of the host, the pathogen and their interaction for the development of better, 
more effective drugs and vaccines. Lipoprotein biogenesis is a major virulence factor of 
M. tuberculosis (Rampini et al., 2008; Sander et al., 2004). Moreover, lipoproteins evidently 
meet pathogen-associated molecular patterns (PAMPs) criteria and are well detected by innate 
immune recognition mechanisms (Ray et al., 2013). M. tuberculosis lipoproteins are major 
antigens and trigger the activation of cellular and humoral immune responses to mycobacteria. 
Lipoproteins are potent agonists of toll-like receptor 2 (TLR2) which upon long term 
stimulation has been associated with the down regulation or deviation of the immune 
response. TLR2 agonist activity has been demonstrated for several M. tuberculosis 
lipoproteins including LpqH, LprA, LprG and PstSI (Drage et al., 2009; Harding & Boom, 
2010). Recently, it was reported that mycobacteria generate and release membrane vesicles 
(MVs) (Prados-Rosales et al., 2013). Strikingly, MVs from pathogenic mycobacteria as 
CHAPTER 3 
89 
 
compared to non-pathogenic mycobacteria are enriched in lipoproteins, some of them well 
known TLR2 agonists. MVs produced a severe TLR2 dependent inflammatory response in 
vitro and in vivo (Prados-Rosales et al., 2013). Investigations regarding the vaccine potential 
of MVs from pathogenic mycobacteria elicited a mixed cellular and humoral immune 
response. This suggests a vaccine potential of MVs and their lipoproteins against 
M. tuberculosis.  
Even though research on lipoproteins in fast-growing mycobacteria contributed to the 
knowledge of lipoprotein biosynthesis and modification, there is scarcely known anything 
about lipoprotein modifications and their chemical structures in slow-growing mycobacteria. 
Mycobacterium bovis bacille Calmette Guerin (BCG) is derived from virulent M. bovis, the 
causative agent of bovine tuberculosis. The genome of M. bovis BCG is highly similar to the 
M. tuberculosis genome (>99.5% sequence identity) (Brosch et al., 2007). M. bovis BCG was 
first used in 1921 as a live vaccine against tuberculosis. Since then four billion doses have 
been applied to humans. Still today it is the only licensed tuberculosis vaccine, despite its 
incomplete protective efficacy, particular against adult lung tuberculosis (Kaufmann & 
Gengenbacher, 2012). 
Concerning the presence of open reading frames (ORFs) encoding lipoprotein modifying 
enzymes, both genomes of M. tuberculosis and M. bovis BCG Pasteur reveal a single ORF 
encoding Lgt (Rv1614, BCG_1652) and a single ORF encoding LspA (Rv1539, BCG_1591). 
Two ORFs encoding Lnt are found in M. bovis BCG (BCG_2070c, BCG_2279c). 
BCG_2070c (which is identical to M. tuberculosis Rv2051c = ppm1) is a two domain protein 
with a conserved apolipoprotein-N-acyltransferase and a Ppm-like domain. BCG_2279c 
shows conserved apolipoprotein-N-acyltransferase domain and exhibits considerable 
homology to E. coli Lnt. In M. tuberculosis, the corresponding open reading frame is split into 
two, Rv2262c and Rv2261c. In our previous analysis (Tschumi et al., 2009), these may have 
escaped our attention, since split. Only upon completion of the M. bovis BCG sequence the 
homology to Lnt became apparent. Due to this polymorphism in the second M. tuberculosis 
putative Lnt ORF, we focussed our studies on lipoproteins and lipoprotein synthesis in slow-
growing mycobacteria on the vaccine strain M. bovis BCG. Prediction of lipoproteins in 
M. tuberculosis complex using DOLOP database suggests the presence of 50 potential 
lipoproteins of the approximately 4000 ORFs (Babu et al., 2006). However, the existence of 
twice as many lipoproteins has been discussed (Sutcliffe & Harrington, 2004).  
In this study, we show that lipoproteins are triacylated in slow-growing M. bovis BCG. We 
demonstrate apolipoprotein N-acyltransferase acitivity and by targeted gene deletion identify 
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BCG_2070c as a functional Lnt. We give structural information about the lipid modification 
of four mycobacterial lipoproteins, LprF, LpqH, LpqL and LppX. Hereby mycobacteria-
specific tuberculostearic acid is identified as a further substrate for N-acylation. 
 
 
EXPERIMENTAL PROCEDURES 
 
Bacterial strains and growth conditions. Mycobacterium bovis BCG Pasteur strains were 
cultivated in Middlebrook 7H9 medium or on Middlebrook 7H10 agar enriched with oleic 
acid albumin dextrose (OADC, Difco). Liquid broth was supplemented with 0.05 % of Tween 
80 to avoid clumping. If necessary, the appropriate antibiotic was added at the following 
concentration: 5 µg ml-1 gentamicin, 100 µg ml-1 streptomycin, 25 µg ml-1 hygromycin. Strains 
used in this study were M. bovis BCG SmR (further referred to as M. bovis BCG or parental 
strain) (Sander et al., 2001), a streptomycin resistant derivative of M. bovis BCG Pasteur 
1173P2, ∆lnt = M. bovis BCG SmR lnt knock out mutant in BCG_2070c and ∆lnt-
lntBCG_2070c = M. bovis BCG SmR lnt knock out mutant in BCG_2070c transformed with 
complementing vector pMV361-hyg-lntBCG_2070c. 
 
Disruption of lnt in M. bovis BCG. A 1.9 kbp MluI/NsiI fragment of M. bovis BCG from 
position 2296156 to 2294306 comprising the 5’lnt flanking sequence and a 2.8 kbp 
SnaBI/MluI fragment from position 2292652 to 2289856 comprising the 3’lnt flanking 
sequence of the lnt domain of BCG_2070c were PCR amplified using genomic DNA from 
M. bovis BCG Pasteur and cloned into vector pMCS5-rpsL-hyg with the respective enzymes 
resulting in knock-out vector pMCS5-rpsL-hyg-∆lntBCG. This way, we deleted a 1.6 kbp of 
the Lnt domain without introducing a frameshift or any other deletion to the Ppm synthase 
domain. The lntBCG allele was deleted in the M. bovis BCG SmR chromosome as described 
previously (Sander et al., 1995; Sander et al., 2001) and confirmed by Southern blot analysis 
with 0.2 kbp SalI lnt downstream probe. For complementation with M. bovis BCG 
BCG_2070c a 6.3 kbp fragment from M. bovis BCG from position 2289839 to 2296178 
spanning the entire lnt gene was cloned into pGEM-T Easy (Promega) to result in pGEM-T 
Easy-lntBCG_2070c and subsequently subcloned as a 6.3 kbp EcoRI fragment into the HpaI 
site of plasmid pMV361-hyg (Sander et al., 1997) to result in pMV361-hyg- lntBCG_2070c. 
Complementation was confirmed by Southern blot analyses with 0.2 kbp KpnI/HindIII 
lntBCG_2070c upstream probe.  
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Expression of Lipoproteins LprF, LpqH, LpqL and LppX. Plasmid pMV261-Gm, a derivative 
of pMV261 shuttle vector, is able to replicate in E. coli as well as in mycobacteria (Stover et 
al., 1991). LprF (Brülle et al., 2010), lpqH, lpqL and lppX (Tschumi et al., 2009) were 
amplified by PCR from M. tuberculosis genomic DNA and fused to the M. tuberculosis 19 
kDa promoter. The target proteins and 19 kDa promoter are identical between M. tuberculosis 
and M. bovis BCG. Sequences encoding a hemagglutinin and a hexa- histidine epitope were 
fused to the 3’ part of each gene to facilitate subsequent purification and detection on Western 
blot. The insert was cloned into the EcoRI site of pMV261-Gm to result in pMV261-Gm-
LprF, pMV261-Gm-LpqH, pMV261-Gm-LpqL and pMV261-Gm-LppX. Subsequently 
plasmids were transformed into BCG parental strain, ∆lnt and ∆lnt-lntBCG_2070c. 
 
Preparation of cell extracts and Western blot analysis. Bacteria from 1-liter cultures were 
harvested and resuspended in phosphate-buffered saline containing Complete EDTA-free 
tablets (Roche) to inhibit protein degradation. Cells were lysed by three French Press cycles 
(American Instrument Co.) at 1.1 x 106 Pa. Extracts were treated with 2% sodium 
N-lauroylsarcosine (SLS) for 1 h at room temperature, and incubated for 16 h at 4 °C 
thereafter. Extracts corresponding to 1-5 µg of total protein were separated by a 12.5% SDS-
PAGE gel and subsequently analyzed by Western blot using anti-HA-antibody (1:300, Roche) 
and corresponding secondary antibody conjugated with horseradish peroxidase. 
 
Fast Protein Liquid Chromatography Protein Purification. Soluble fractions of cell extracts 
from recombinant strains expressing epitope-tagged proteins were diluted with buffer 
containing 20 mM NaH2PO4, 0.5 M NaCl, pH 7.4 to 1% sodium N-lauroylsarcosine and 
loaded on a HisTrapTM HP column (GE Healthcare) previously equilibrated with buffer 
containing 20 mM NaH2PO4, 0.5 M NaCl, 0.2% sodium N-lauroylsarcosine and 20 mM 
imidazole, pH 7.4. Proteins were eluted applying an imidazole gradient (0.125-0.5 M). As a 
further purification step, if necessary, HisTrapTM HP column flow through was dialyzed 
against buffer containing 20 mM Tris-hydroxymethyl-aminomethane, 0.1 M NaCl, 0.1 mM 
EDTA, pH 7.5 and loaded onto anti-HA-affinity matrix (Roche). Proteins were eluted with 
buffer containing 0.1 M glycine, pH 2.0.  
 
MALDI-TOF/TOF analysis. 100-200 pmol of purified lipoprotein were prepared and analyzed 
according to Ujihara et al. (Ujihara et al., 2008). Briefly, lipoproteins in elution fractions from 
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FPLC or HA chromatography were precipitated and SDS-PAGE gel was performed. Proteins 
separated by electrophoresis were visualized with copper staining. Protein bands with the 
apparent molecular weight of apolipoprotein/mature lipoprotein were cut from the stained gel. 
Lipoproteins were in-gel digested with Trypsin or AspN and extracted peptides were dried 
and dissolved in 5 µl 0.1% trifluoroacetic acid, 50% acetonitrile. Samples were loaded onto 
the target and covered with 1 µl matrix solution (5 mg ml-1 α-cyano-4-hydroxy-cinnamic acid 
(Bruker Daltonics) in 0.1% trifluoroacetic acid, 50% acetonitrile). The MALDI-TOF/TOF 
mass spectra were recorded on an Ultraflex II MALDI-TOF/TOF instrument with smartbeam 
laser upgrade (Bruker Daltonics). The laser was set to a repetition rate of 100 Hz and the ion 
acceleration voltage was 29.5 kV. The mass measurements were performed in the positive ion 
reflector mode. 
 
 
RESULTS 
 
Lipoproteins are expressed in M. bovis BCG  
 
As model substrates for lipoprotein modification in slow-growing mycobacteria we chose four 
different lipoproteins being identical in M. tuberculosis and in M. bovis BCG Pasteur. The 
well characterized LppX (Sulzenbacher et al., 2006; Tschumi et al., 2009) and LprF (Brülle et 
al., 2010) in addition to LpqH and LpqL. LppX (Rv2945c) has been shown to be involved in 
translocation of phthiocerol dimycocerosates (DIM) to the outer membrane (Sulzenbacher et 
al., 2006). LprF (Rv1368) is involved in signaling and has been suggested to interact with the 
histidine kinase KdpD in response to environmental osmotic stress (Steyn et al., 2003). LpqH 
(19 kDa antigen, Rv3763) functions as an adhesin and has been recognized as an 
immunodominant lipoprotein (Diaz-Silvestre et al., 2005). LpqL (Rv0418) is predicted to be a 
lipoprotein aminopeptidase. Hence, our choice of lipoproteins is representing different classes 
of lipoproteins. The four expression vectors pMV261-Gm for hexa-histidine/hemagglutinine 
tagged LprF, LpqH, LpqL or LppX were transformed into M. bovis BCG. Whole cell extracts 
from the four strains expressing the recombinant lipoproteins were analyzed by Western blot. 
The apparent molecular masses of the detected proteins correspond to the predicted mass of 
the recombinant apolipoproteins/mature lipoproteins (LprF 29.4 kDa, LpqH 17.3 kDa, LpqL 
54.2 kDa, LppX 26.3 kDa). Eventually the prepro-/pro-lipoprotein forms whose sizes are 
increased by 2-3 kDa due to the presence of the signal peptide, are also detected. 
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Identification of the lipoprotein lipid anchor in M. bovis BCG  
 
To characterize the modifications of lipoproteins at the molecular level, the four recombinant 
lipoproteins LprF, LpqH, LpqL and LppX were expressed in M. bovis BCG parental strain. 
Proteins were purified by FPLC or HA affinity chromatography. Eluted fractions were 
analyzed by Western blot (see additional file 2) and lipoprotein containing fractions were 
precipitated for SDS-PAGE gel. Bands of purified lipoproteins were visualized with copper 
staining, cut from the gel and the proteins were in-gel digested with Trypsin or AspN (in case 
of LprF). Resulting peptides were prepared and analyzed by MALDI-TOF/TOF mass 
spectrometry (Ujihara et al., 2008). For the identification of the modification we determined 
the structure and calculated the expected monoisotopic molecular masses of the unmodified 
N-terminal tryptic or AspN-digested peptides of LprF, LpqH, LpqL and LppX (without signal 
peptide). Phospholipids found in mycobacteria mainly consist of palmitic (C16:0), palmitoleic 
(C16:1), oleic (C18:1) and tuberculostearic acid (10-methyloctadecanoic acid) (C19:0) 
(Goren, 1979). In E. coli, fatty acids of membrane phospholipids, i.e. myristic (C14:0), 
palmitic, palmitoleic, oleic (C18:1 ω9) or vaccenic (18:1 ω7) acid are used for the 
modification of lipoproteins (Gupta et al., 1991; Hillmann et al., 2011; Jackowski & Rock, 
1986; Lai & Wu, 1980; Lin et al., 1980). Therefore we calculated the theoretical mass of the 
N-terminal peptides of the four lipoproteins with all possible combinations of the above 
mentioned fatty acids observed in mycobacterial phospholipids to identify putative 
modifications. Glycosylations are also commonly found in lipoproteins (Garbe et al., 1993; 
Sartain & Belisle, 2009). Some of the analyzed N-terminal peptides carry putative 
O-glycosylation sites, therefore we also calculated the masses with hexose modifications. 
[M+H]+ signals at m/z values which we calculated for the unmodified N-terminal peptides 
were not found. Instead, we found MS signals at m/z values which indicate that the N-terminal 
peptides are modified in a lipoprotein-specific manner with different combinations of 
saturated and unsaturated C16, C18 and C19 fatty acids. The calculated m/z values are 
summarized and compared with the experimentally determined m/z values in Table 1.  
The modifications we estimated from the [M+H]+ signals in the MS spectrum were confirmed 
by MS/MS fragmentation and thereby information about the linkage of the modification was 
obtained. The structures of the di- or triacylated N-terminal tryptic or AspN-digested peptides 
from LprF, LpqH, LpqL and LppX were investigated by MS/MS. All eliminations found in 
MS/MS of lipoproteins isolated from the parental strain are summarized in Table 2.  
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TABLE 1. Comparison of m/z values of N-terminal AspN-digested/tryptic peptides of 
LprF, LpqH, LpqL and LppX found in BCG parental and ∆lnt mutant strain. 
 
 
Peptide Calculated 
m/z 
Parental strain 
m/z 
∆lnt 
m/z 
LprF 
CGK…ILQ 2496.24 - - 
CGK…ILQ  
   + Diacylglycerol (C16/C16) 
3047.11 
(+550.87) - 
3046.70 
(+550.46) 
CGK…ILQ  
   + Diacylglycerol (C16/C18) 
3073.15 
(+576.91) - 
3072.71 
(+576.47) 
CGK…ILQ  
   + Diacylglycerol (C16/C19) 
3089.20 
(+592.96) - 
3088.74 
(+592.50) 
CGK…ILQ 
   + Diacylglycerol (C16/C19) 
   + Hexose 
3251.44 
(+755.20) - 
3251.65 
(+755.41) 
CGK…ILQ 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
3327.60 
(+831.36) 
3326.83 
(+830.59) - 
CGK…ILQ 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C19) 
   + Hexose 
3531.93 
(+1035.69) 
3530.56 
(+1034.32) - 
LpqH 
CSSNK 538.23 - - 
CSSNK 
   + Diacylglycerol (C16/C16) 
1089.10 
(+550.87) - 
1088.60 
(+550.37) 
CSSNK 
   + Diacylglycerol (C16/C18) 
1115.14 
(+576.91) - 
1114.68 
(+576.45) 
CSSNK 
   + Diacylglycerol (C16/C19) 
1131.19 
(+592.96) 
1130.79 
(+592.56) 
1130.71 
(+592.48) 
CSSNK 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
1369.59 
(+831.36) 
1369.04 
(+830.81) - 
LpqL 
CIR 391.21 - - 
CIR 
   + Diacylglycerol (C16/C19) 
984.17 
(+592.96) 
984.50 
(+593.29) 
983.77 
(+592.56) 
CIR 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
1222.57 
(+831.36) 
1221.98 
(+830.77) - 
 
 
 
 
LppX 
 
 
 
 
 
CSS…EIR 2964.46 - - 
CSS…EIR 
   + Diacylglycerol (C16/C16) 
3515.33 
(+550.87) 
3514.94 
(+550.48) 
3514.94 
(+550.48) 
CSS…EIR   
   + Diacylglycerol (C16/C19) 
3557.42 
(+592.96) - 
3556.96 
(+592.50) 
CSS…EIR   
   + Diacylglycerol (C16/C19) 
   + Hexose 
3719.66 
(+755.20) - 
3719.00 
(+754.54) 
CSS…EIR 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
3795.82 
(+831.36) 
3795.21 
(+830.75) - 
CSS…EIR   
   + Diacylglycerol (C16/C19) 
   + 2 Hexoses 
3881.90 
(+917.44) - 
3881.06 
(+916.60) 
CSS…EIR 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
   + Hexose 
3958.06 
(+993.60) 
3957.28 
(+992.82) - 
CSS…EIR 
   + Diacylglycerol (C16/C19) 
   + N-acyl (C16) 
   + 2 Hexoses 
4120.30 
(+1155.84) 
4119.45 
(+1154.99) - 
Peptides correspond to the N-terminal AspN-digested/tryptic peptides of LprF, LpqH, LpqL and LppX upon 
cleavage of the signal peptide by LspA. Mass differences to the corresponding unmodified peptide (bold 
number) due to modifications are given in parentheses. Observed modifications are: diacylglycerol with C16 
fatty acid and C16 fatty acid (+550.87 Da). Diacylglycerol with C16 fatty acid and tuberculostearic acid (C19:0) 
(+592.96 Da), plus one hexose (+162.24 Da, Σ = 755.20 Da) or two hexoses (+324.48 Da, Σ = 917.44). 
Diacylglycerol with C16 fatty acid and C19:0 fatty acid (+592.96 Da) plus N-acyl with C16 fatty acid (+238.40 
Da, Σ = 831.36), N-acyl with C16 fatty acid plus one hexose (+162.24 Da, Σ = 993.6 Da) or two hexoses 
(+324.48 Da, Σ = 1155.84 Da). Or diacylglycerol with C16 fatty acid and C19:0 fatty acid (+592.96 Da) plus N-
acyl with C19:0 fatty acid and hexose (+280.49 Da +162.24 Σ = 1035.69). 
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Lipoproteins in slow-growing Mycobacteria are N-acylated with C16 or C19 fatty acids  
 
Since N-acylation was shown to be a common motif in lipoproteins of high GC-rich Gram-
positive M. smegmatis (Brülle et al., 2010; Tschumi et al., 2009), we proposed Lnt 
modification also taking place in slow-growing mycobacteria. This proposal was based on the 
observation that M. tuberculosis apolipoprotein N-acyltransferase Ppm1 could complement a 
M. smegmatis lnt mutant (Tschumi et al., 2009).  
In M. bovis BCG, differences in molecular mass of about 831.36 Da for LprF, LpqH, LpqL 
and LppX, 993.60 Da for LppX, 1035.69 Da for LprF and 1155.84 Da for LppX between the 
experimentally determined peptide and unmodified N-terminal peptide were found (Table 1).  
These differences indicated posttranslational modifications of lipoproteins by Lgt, LspA and 
Lnt. The difference in molecular mass of 831.36 Da points to a modification with 
diacylglyceryl residue with ester-linked C16 and C19 fatty acid and amide-linked C16 fatty 
acid. The difference of 993.60 Da indicates a modification with diacylglyceryl residue with 
ester-linked C16 and C19 fatty acid, amide-linked C16 fatty acid and a glycosylation with one 
hexose on an O-glycosylation site in the N-terminal peptide of LppX. The difference of 
1155.84 Da points to a modification with diacylglyceryl residue carrying ester-linked C16 and 
C19 fatty acid, amide-linked C16 fatty acid and a glycosylation with two hexoses. The 
difference in molecular mass of 1034.32 Da suggests a modification of LprF with 
diacylglyceryl residue carrying ester-linked C16 and C19 fatty acid, amide-linked C19 fatty 
acid and a glycosylation with one hexose (Table 1). Moreover, differences in molecular mass 
of about 550.87 Da for LppX and 592.96 Da for LpqH, LpqL and LppX were found, both 
indicating (Lgt and LspA, but not Lnt modified peptides carrying) a diacylglycerol 
modification with ester-linked C16 and C16 or ester-linked C16 and C19 fatty acid, 
respectively.  
All modifications we estimated from MS data were confirmed by MS/MS (Table 2). 
Modifications with diacylglyceryl residue were confirmed by eliminations of fragments with 
the mass of 626.53 Da (C16/C19), corresponding to the elimination of a diacylthioglyceryl 
carrying C16 and C19 fatty acid. The O-linked C16 or C19 fatty acids were confirmed by 
neutral losses of 256.24 Da and 298.29 Da, corresponding to the elimination of palmitic acid 
or tuberculostearic acid. Further, neutral losses of 328.24 Da and 370.29 Da correspond to the 
elimination of C16 or C19 fatty acid α-thioglyceryl ester, respectively. Proposed modification 
with N-linked C16 fatty acid was identified by the neutral loss of 307.26 Da which is
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consistent with the elimination of palmitamide plus didehydroalanine. Glycosylations in the 
tryptic or AspN-digested N-terminal peptides at other amino acids than the conserved cysteine 
were confirmed by the eliminations of fragments of 162.24 Da for each hexose. (Note, since 
MS data of LppX from this study are comparable with data from our recent study in 
M. smegmatis (Tschumi et al., 2009), MS/MS data for LppX were not further determined). 
Previous structure analyses of lipoprotein modifications in M. smegmatis recovered C16 and 
C19 moieties as ester-linked acyl residues of the diacylglycerol and C16 fatty acid exclusively 
as substrate for N-acylation (Brülle et al., 2010; Tschumi et al., 2009). However, beside the 
signal at m/z=3326.828, an additional signal at m/z = 3530.562 was found in the MS of LprF 
(Fig. 1A). The signal at m/z = 3326.828 corresponds to LprF modified with a diacylglyceryl 
residue carrying ester-linked C16 and C19 fatty acid and N-linked C16 fatty acid. Eliminated 
fragments in MS/MS analysis of the signal m/z = 3530.562 (Fig. 1B) confirmed a 
modification with diacylglyceryl residue carrying ester-linked C16 and C19 fatty acid, 
N-linked C19 fatty acid and a hexose. The neutral loss of 625.89 Da from the ion at m/z = 
3368.508 corresponds to the elimination of diacylthioglyceryl carrying both O-linked C16
and C19 fatty acids. In addition, the neutral loss of 349.82 Da from m/z = 2742.615 
corresponds to the elimination of tuberculostearinamide plus didehydroalanine. This 
fragmentation pattern shows that the +1 cysteine is modified at the sulfhydryl group by a 
diacylglyceryl residue carrying ester-bound C16 fatty acid and C19 fatty acid and an amide-
bound C19 fatty acid at the cysteine (Fig. 1C).  
 
Generation of an lnt deletion mutant in M. bovis BCG  
 
Using E. coli Lnt as a query in a BLASTp search on a subset of mycobacteria, we identified 
three open reading frames annotated as polyprenol-monophosphomannose synthase Ppm1, i.e. 
Rv2051c in M. tuberculosis, BCG_2070c in M. bovis BCG Pasteur and MSMEG_3860 in M. 
smegmatis, respectively. In M. tuberculosis two additional putative homologous open reading 
frames, Rv2262c and Rv2261c annotated as hypothetical proteins were found (Fig. 2). Both, 
MSMEG_3860 as well as the N-terminal part of the two-domain protein encoded by Rv2051c 
are already identified as functional N-acyltransferases in mycobacteria (Tschumi et al., 2009). 
A further search with M. tuberculosis Rv2262c/2261c as a query in a BLASTp search 
identified BCG_2279c as homologue in M. bovis BCG Pasteur, whereas no homologue was 
found in M. smegmatis. We used sequence alignment with the Needleman-Wunsch algorithm 
(http://www.ebi.ac.uk/Tools/psa/emboss_needle) with default settings to compare both
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M. bovis ORFs to E. coli lnt, M. tuberculosis lnt Rv2051c, as well as M. tuberculosis 
Rv2262c/2261c sequences. Pairwise sequence alignment revealed the highest sequence 
identity (100%) between BCG_2070c and Rv2051c from M. tuberculosis. Interestingly, 
pairwise sequence alignment of BCG_2279c and Rv2262c/2261c reveals that both sequences 
differ by a 2bp insertion in Rv2262c (see additional file 3). This leads to a stop codon and 
initiation of Rv2261c with codon ttg. BCG_2279c does not have this insertion and therefore 
encodes only one protein. We confirmed this polymorphism by sequencing corresponding 
regions of M. tuberculosis and M. bovis BCG genomes. We also used protein sequence 
alignment with the Needleman-Wunsch algorithm (http://www.ebi.ac.uk/ 
Tools/psa/emboss_needle) and ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) with 
default settings to analyze the conservation of essential residues (see additional file 4). 
 
 
Fig. 2: A comparison of the genomic region of Lnt homologues in mycobacteria. Black bars/arrows indicate 
Lnt homologues. A second domain is fused to the lnt domain in M. tuberculosis Rv2051c, and M. bovis BCG 
BCG_2070c (grey arrows) and is homologous to M. smegmatis MSMEG_3859 (grey arrow). White arrows 
indicate orientation of surrounding genes.  
 
 
BCG_2070c and Rv2051c showed conservation of 14 among 23 residues required for optimal 
activity of E. coli Lnt and conservation of the three essential residues of the catalytic triad of 
E. coli Lnt i.e. E267, K335, C387 (see additional file 1) (Vidal-Ingigliardi et al., 2007). For 
comparison, the alignment of BCG_2279c and Rv2262c/2261c with E. coli Lnt also showed 
conservation of 13 or 12 (in Rv2262c/2261c E. coli P346 is altered from proline to leucine) 
among the 23 residues of E. coli Lnt. However, different residues among the 23 were 
conserved (see additional file 1). In BCG_2279c and Rv2262c/2261c it revealed that essential 
residue C387 of the catalytic triad is altered from cysteine to serine. C387 is essential for Lnt-
activity and transfer of the acyl residue to the apo-lipoprotein in E. coli. However, it has been 
shown that a Lnt (C387S) mutant also formed an acyl-enzyme intermediate as the wildtype 
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Lnt C387, but did not have any detectable Lnt activity (Buddelmeijer & Young, 2009; Vidal-
Ingigliardi et al., 2007). Moreover, it is noteworthy that the residues of the catalytic triad are 
separated on two different ORFs encoded by Rv2262c/2261c in M. tuberculosis. Beside the 
three essential residues of the catalytic triad, four other essential residues W237, E343, Y388 
and E389 are absolutely required for Lnt function. Among these seven essential residues, five 
residues are conserved in M. tuberculosis Rv2051c, Rv2262c/2261c and M. bovis BCG 
BCG_2070c, BCG_2279c Lnt homologues.  
In summary, homology searches and comparison of essential residues in the putative Lnts 
revealed only small differences and it may be hypothesized that both BCG_2070c and 
BCG_2279c are functional N-acyltransferases. BCG_2070c is identical to an ORF with 
proven N-acyltransferase activity since M. tuberculosis Lnt complemented the M. smegmatis 
lnt deletion mutant and all three residues of the catalytic triad essential for Lnt function in 
E. coli are conserved. Lnt activity of BCG_2279c may be buried by the Lnt activity of 
BCG_2070c. Therefore we generated a BCG_2070c lnt deletion mutant and characterized 
lipoprotein modifications in the mutant. The lnt deletion mutant was constructed by 
transformation of M. bovis BCG with the suicide plasmid pMCS5-rpsL-hyg-∆lntBCG 
applying rpsL counter-selection strategy, a powerful tool to generate deletion mutants in 
mycobacteria (Sander et al., 1995; Sander et al., 2001). The mutant strain resulting from 
allelic exchange is referred to as M. bovis BCG ∆lnt. Deletion of lnt was verified by Southern 
blot analysis using a 5’lnt DNA probe (see additional file 5). The probe hybridized to an 8.1-
kbp fragment of the parental strain and to a 3.1-kbp fragment of the ∆lnt mutant. Moreover, a 
complemented mutant strain was constructed by transformation of M. bovis BCG ∆lnt mutant 
with complementation vector pMV361-hyg-lntBCG_2070c expressing M. bovis BCG 
BCG_2070c. The complemented strain is referred to as M. bovis BCG ∆lnt-lntBCG_2070c. 
 
BCG_2070c is a functional N-acyltransferase in M. bovis BCG  
 
The four expression vectors pMV261-Gm for hexa-histidine/hemagglutinine tagged LprF, 
LpqH, LpqL or LppX were transformed into M. bovis BCG ∆lnt mutant. Recombinant 
lipoproteins expressed in the four strains were analyzed by Western blot. The apparent 
molecular masses of the detected proteins correspond to the predicted mass of the 
recombinant apolipoproteins/mature lipoproteins. Eventually the prepro-/pro-lipoprotein 
forms, whose sizes are increased by 2-3 kDa due to the presence of the signal peptide, are also 
detected. 
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In order to characterize BCG_2070c and eventually residual N-aclytransferase activity in 
M. bovis BCG, lipoprotein modifications of LprF, LpqH, LpqL and LppX from ∆lnt mutant 
were analyzed at the molecular level. In ∆lnt, signals with molecular masses indicating Lgt- 
and LspA- modified and glycosylated peptides were found. The differences in molecular mass 
of 550.87 Da for LprF, LpqH and LppX and 576.91 Da for LprF and LpqH between the 
experimentally found peptide and the unmodified N-terminal peptide (Table 1) indicate (Lgt 
and LspA, but not Lnt modified peptides carrying) a diacylglycerol modification carrying 
ester-linked C16 and C16 or ester-linked C16 and C18 fatty acid, respectively. The 
differences in molecular mass of 592.96 Da for LprF, LpqH, LpqL and LppX refer to a 
diacylglycerol modification with ester-linked C16 and C19 fatty acid. The differences in 
molecular mass of 755.20 Da for LprF and LppX refer to a diacylglycerol modification with 
ester-linked C16 and C19 fatty acid plus glycosylation with one hexose (592.96 Da + 162.24 
Da). The difference in molecular mass of 917.90 Da for LppX refers to a diacylglycerol 
modification with ester-linked C16 and C19 fatty acid plus modification with two hexoses 
(592.96 Da + 162.24 Da + 162.24 Da). 
In contrast to the MS from parental strain, no molecular masses which we calculated for 
modifications with three fatty acids were found in the ∆lnt mutant strain. In particular, the 
differences in molecular mass of 238.4 Da (831.36 Da - 592.96 Da) or 280.49 Da (1035.69 Da 
- 162.24 Da - 592.96 Da) between the C16/C19/C16 or C16/C19/C19 triacylated modification 
found in the parental strain and the corresponding estimated C16/C19 modification in the ∆lnt 
mutant indicate a lack of N-acylation with a C16 or C19 fatty acid in the ∆lnt mutant. In 
MS/MS analysis, this indication of missing N-acylation in the mutant was confirmed by 
identification of the estimated modifications and information about its linkage (Table 2). 
Modifications with C16/C19 diacylglyceryl residue were confirmed by eliminations of 
fragments with the molecular mass of 626.53 Da, corresponding to the elimination of a 
diacylthioglyceryl carrying C16 and C19 fatty acid. The O-linked C16 or C19 fatty acids were 
confirmed by neutral losses of 256.24 Da or 298.29 Da, corresponding to the elimination of 
palmitic acid or tuberculostearic acid, respectively. Further, the neutral loss of 370.29 Da 
corresponds to the elimination of C19 fatty acid α-thioglyceryl ester. A glycosylation at other 
amino acids than the conserved cysteine was confirmed by the release of a fragment of 162.24 
Da for a hexose. These findings indicate that N-acylation is not a prerequisite for 
glycosylation. As mentioned before, only diacylglyceryl residues composed of a C16 and a 
C19 fatty acid were identified in mycobacterial lipid anchors so far (Brülle et al., 2010; 
Tschumi et al., 2009). However, the eliminations of fragments with the molecular mass of 
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584.44 Da or 256.24 Da, corresponding to the elimination of diacylthioglyceryl and palmitic 
acid, give evidence for modifications with diacylglyceryl residue carrying C16 and C16 fatty 
acids. Moreover, estimated diacylglycerol modifications carrying C16 and C18 fatty acids 
were confirmed by neutral losses of fragments with the molecular mass of 256.24 Da and 
282.44 Da, corresponding to the elimination of palmitic and oleic acid. In complemented 
mutant ∆lnt-lntBCG_2070c, lipoproteins LprF and LppX were triacylated and glycosylated 
(see additional file 6 and additional file 7). This confirmed that BCG_2070c restored the 
BCG_2070c mutant. 
The absence of N-acylation of the four analyzed lipoproteins in the ∆lnt mutant and the 
complementation of the mutant provide strong evidence that BCG_2070c is the only 
functional apolipoprotein N-acyltransferase that modifies these lipoproteins with an amide-
linked fatty acid in M. bovis BCG. In addition, it demonstrates that BCG_2279c is not able to 
adopt or substitute N-acylation of the four lipoproteins in the ∆lnt mutant.  
 
 
DISCUSSION 
 
Lipoproteins are present in all bacterial species, but their biogenesis and lipid moieties differ, 
especially between Gram-negative and Gram-positive bacteria. The three enzymes involved in 
lipoprotein biosynthesis, namely Lgt, LspA and Lnt first were identified in E. coli. Therefore, 
the lipoprotein biosynthesis pathway in E. coli is intensively studied and well described 
(Okuda & Tokuda, 2011). Mycobacteria are classified as Gram-positive bacteria, but their 
lipoprotein biosynthesis pathway resembles that of Gram-negative bacteria. The discovery of 
Lnt in mycobacteria and the identification of lipoprotein N-acylation in M. smegmatis 
renewed interest within the field of mycobacterial lipoprotein research. The evidence of 
triacylated lipoproteins in mycobacteria refuted the long held assumption, that N-acylation is 
restricted to Gram-negative bacteria. Thus, the acylation with three fatty acids is a common 
feature of mycobacterial and E. coli lipoproteins. But, mycobacterial lipoproteins differ from 
E. coli lipoproteins with respect to the fatty acids used for the triacylation. Mycobacteria-
specific fatty acid 10-methyl octadecanoic acid (tuberculostearic acid) is uniquely found in 
lipoproteins of M. smegmatis (Brülle et al., 2010; Tschumi et al., 2009).  
All three enzymes of the lipoprotein biosynthesis pathway, Lgt, LspA and Lnt are essential in 
Gram-negative, but not in Gram-positive bacteria. However, in M. tuberculosis, lgt, the first 
enzyme of the lipoprotein biosynthesis pathway is essential. A targeted deletion of lgt was not 
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possible (Tschumi et al., 2012). In contrast, an lspA deletion mutant was viable, but the 
mutant strain showed a reduced number of CFU in an animal model and induced hardly any 
lung pathology. This confirmed a role of the lipoprotein biosynthesis pathway in pathogenesis 
of M. tuberculosis (Rampini et al., 2008; Sander et al., 2004).  
Lipoproteins itself are well known virulence factors in pathogenic bacteria. M. tuberculosis 
lipoproteins in particular have been shown to suppress innate immune responses by TLR2 
agonist activity (Drage et al., 2009). Newest data also show that lipoproteins constitute the 
main proteinaceous content of membrane vesicles released by pathogenic mycobacteria and 
that they are highly immunogenic (Ziegenbalg et al., 2013). Several M. tuberculosis mutants 
deficient in individual lipoproteins are attenuated in virulence as shown for LppX (Camacho 
et al., 1999), LprG (Bigi et al., 2004) and LpqH (Henao-Tamayo et al., 2007). Recently, a 
M. tuberculosis deletion mutant, defective in lipoprotein LpqS showed attenuation in 
macrophages (Sakthi & Narayanan, 2013). Despite the important role of M. tuberculosis 
lipoproteins in immunogenicity and pathogenicity and all the achievements in knowledge 
about the lipoprotein modification in apathogenic M. smegmatis, still little is known about the 
molecular structure of lipoproteins in pathogenic mycobacteria. The elucidation of lipoprotein 
structure can build the fundamental knowledge for future development of lipoprotein based 
subunit vaccines and antitubercular drugs targeting enzymes of the lipoprotein synthesis 
pathway (Gowthaman et al., 2012). Therefore we extended our research in lipoprotein 
modifications to slow-growing mycobacteria. Most of the pathogenic mycobacteria and the 
tuberculosis vaccine strain M. bovis BCG belong to this sub-group.  
In the present study, we investigated the lipid moieties of four mycobacterial lipoproteins 
representing lipoproteins with different functions. By MALDI-TOF/TOF analyses of a 
Trypsin digest of purified LpqH, LpqL and LppX and an AspN digest of purified LprF, we 
unambiguously identified modifications at the universally conserved cysteine in the parental 
strain. All four proteins were found to be triacylated carrying a thioether-linked diacylglyceryl 
residue with C16 and C19 fatty acid (C16/C19) to the sulfhydryl group of the lipobox cysteine 
and an amide-linked C16 fatty acid. Whether the fatty acids of the diacylglyceryl residue are 
in the Sn1 or Sn2 position could not be determined by mass spectrometry and therefore 
currently remains elusive. In LprF, a novel triacylation with C16/C19 diacylglycerol and C19 
N-acyl was identified. This differs from previous lipoprotein analyses in M. smegmatis, where 
C16 fatty acid was the single substrate for Lnt (Brülle et al., 2010; Tschumi et al., 2009). 
Likewise, it shows that mycobacteria not only use mycobacteria-specific fatty acids for 
diacylglycerol modification, but also for N-acylation. Lipoprotein modifications with acyl 
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residues of different length, stiffness and bulkiness may influence membrane fluidity and 
localization of lipoproteins. In Francisella novicida, an environmentally regulated membrane 
remodelling directed by multiple alleles of the lipid A-modifying N-acyltransferase enzyme is 
reported. By incorporation of shorter or longer N-acyl fatty acid chains to the outer membrane 
lipid A, the bacterium regulates the maintenance of membrane fluidity and integrity (Li et al., 
2012). Therefore, it is obvious to speculate a similar important role of the C19 N-acyl 
lipoprotein modification for mycobacteria in terms of adaptations to environmental alterations 
or specific bacterial conditions. Adaptation of lipoprotein modification to environmental 
conditions has been shown for S. aureus. A combination of conditions including acidic pH 
and post-logarithmic growth phase induced the accumulation of diacylated lipoproteins 
(Kurokawa et al., 2012a).  
By the usage of C19 fatty acid, mycobacterial Lnt strongly differs in substrate specificity from 
E. coli Lnt. E. coli Lnt utilizes all three major phospholipids of E. coli 
phosphatidylethanolamine, phosphatidylglycerol and cardiolipin as its fatty acid source in 
vivo (Gupta et al., 1991). Subsequent analysis revealed that both the phospholipid head group 
and its acyl chain composition affect N-acyltransferase activity in vitro (Hillmann et al., 
2011). E. coli Lnt incorporates palmitic (C16) fatty acids from the Sn1 position of 
phospholipids to diacylated lipoproteins (Jackowski & Rock, 1986). In mycobacterial 
phospholipids the Sn1 position is esterified principally with octadecanoic or tuberculostearic 
acid (C18 related fatty acids), whereas palmitic acid (C16) is mainly located at the Sn2 
position (Okuyama et al., 1967). Based on this and the fact, that palmitic acids were used for 
N-acylation of lipoproteins in M. smegmatis (Brülle et al., 2010; Tschumi et al., 2009), 
Nakayama et al. proposed that M. smegmatis Lnt uses fatty acids from the Sn2 position as 
substrates and therefore has a different specificity than E. coli Lnt (Nakayama et al., 2012). 
This specificity obviously is different in M. bovis BCG. Our results provide strong evidence, 
that not only palmitic acid from the Sn2 position, but also tuberculostearic acid (C19), a fatty 
acid from the Sn1 position of phospholipids is transferred by Lnt (Okuyama et al., 1967).  
Lipoproteins are recognized by TLR2 in association with TLR1 or TLR6. While diacylated 
lipoproteins carrying the S-diacylglyceryl residue are recognized by TLR2/6 heterodimers, 
triacylated lipoproteins carrying the additional N-acyl are recognized by TLR1/2 
heterodimers. The two ester-bound fatty acids are inserted into a pocket in TLR2 while the 
amide-bound fatty acid is inserted into a hydrophobic channel in TLR1. Therefore the N-acyl 
of the lipoprotein is indispensable for the heterodimerization of TLR2 and TLR1 and thus the 
initiation of TLR2/1 signaling (Jin et al., 2007; Kang et al., 2009). Recent investigations 
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indicate that TLR1 polymorphisms are associated with resistance towards bacterial pathogens, 
including M. tuberculosis (Azad et al., 2012; Mayerle et al., 2013). It may be hypothesized 
that the modification of lipoproteins with particular fatty acids plays a crucial role for 
lipoprotein function, its retention in a membrane, and interaction with TLRs. However, 
whether the N-acylation with C19 fatty acid is only characteristic for LprF or also for other 
lipoproteins and whether it is a feature of M. bovis BCG Lnt remains to be investigated. 
Beside the triacylated forms, also diacylated forms of the N-terminal peptide were found in 
proteins from the parental BCG strain. A modification with C16/C19 diacylglycerol was 
found in LpqL and a C16/C16 diacylglycerol was found in LppX. These molecules probably 
indicate N-terminal peptides from unmature proteins which have not converted to mature 
lipoproteins by Lnt yet.  
Lipoproteins from M. bovis BCG were identified to be triacylated at their N-terminus which 
suggests that N-acylation by an Lnt enzyme also exists in slow-growing mycobacteria. We 
identified the open reading frame, encoding the Lnt enzyme responsible for the N-acylation. 
M. bovis BCG Pasteur genome analysis revealed two open reading frames BCG_2070c and 
BCG_2279c homologous to E. coli Lnt. Our biochemical analyses of four lipoproteins 
expressed in a BCG_2070c ∆lnt mutant demonstrated that BCG_2070c is the major if not the 
only functional mycobacterial Lnt in M. bovis BCG. When we subjected lipoproteins LprF, 
LpqH, LpqL and LppX expressed in the ∆lnt mutant to MALDI-TOF/TOF analyses, none of 
the proteins was found to be N-acylated. All four proteins were found to be only diacylated in 
contrast to the triacylated proteins in the parental strain. Diacylglyceryl residues composed of 
C16/C19 fatty acid, C16/C16 fatty acid or C16/C18 were found. Hereby the usage of oleic 
acid as a substrate for lipoprotein modification in mycobacteria, to our knowledge is shown 
for the first time.  
We showed that the lack of BCG_2070c results in a failure of lipoprotein N-acylation and that 
BCG_2279c is not able to compensate Lnt function. BCG_2279c has a C to S amino acid 
substitution in C387, a residue essential for Lnt function in E. coli. In E. coli, a C387 
alteration absolutely abolishes Lnt function, because this residue is part of the catalytic triad 
of Lnt (Vidal-Ingigliardi et al., 2007). Alterations in BCG_2279c therefore could account for 
its inactivity as Lnt. But we cannot exclude that BCG_2279c is a second Lnt particularly 
active under specific growth conditions. Alternatively, BCG_2279c may act only on a small 
subset of dozens of putative mycobacterial lipoproteins not yet characterized by MALDI-
TOF/TOF.  
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Streptomyces spp., bacteria closely related to mycobacteria, also encode two Lnt homologues. 
Deleting Streptomyces scabies lnt1 and lnt2 genes individually or in combination revealed 
that Lnt1 is a functional Lnt sufficient and required for N-acylation. Lnt2 could not 
compensate for the Lnt1 deletion. However, both Lnts seem to be required for efficient 
lipoprotein N-acylation as the lack of Lnt2 alone resulted in a marginal N-acylation activity. 
This implies a subsidiary but inessential role for Lnt2, not directly involved in N-acylation of 
lipoproteins (Widdick et al., 2011). Likewise, an interplay can count for the two Lnt 
homologues in M. bovis BCG. But, in contrast to the Lnts in S. scabies, BCG_2279c is 
missing one of the three essential residues required for Lnt activity in E. coli. This, in our 
opinion diminishes the possibility for BCG_2279c to be an Lnt with N-acylation activity and 
favours a contributive role for it. In vitro biochemical assays (Hillmann et al., 2011) with 
purified BCG_2279c or analyses of a BCG_2279c mutant alone or in combination with 
BCG_2070c would be required to elucidate this. 
Beside the fatty acid modifications, we also identified hexose glycosylations in LprF and 
LppX. Modifications with one or more glycosyl residues have been shown for several 
mycobacterial lipoproteins (Brülle et al., 2010; Herrmann et al., 1996; Sartain & Belisle, 
2009). O-glycosylation occurs at Ser and Thr residues respectively. Although glycosylations 
of the tryptic or AspN-digested N-terminal peptides of LprF and LppX were identified, the 
exact glycosylation site within the peptide could not be determined. No glycosylations were 
found for N-terminal fragments of LpqH and LpqL. This possibly is due to the use of 
proteases which have cleavage sites close to the N-terminus and therefore the peptide 
fragment may be too short to include O-glycosylation sites. The information about the exact 
molecular nature and function of the glycosylation is scarce, but its influence on subcellular 
lipoprotein localization and its protection from proteolytic degradation are proposed 
(Herrmann et al., 1996; Sartain & Belisle, 2009). In B. subtilis lipoprotein glycosylation is 
discussed to control a lipoprotein “shaving” mechanism and thus their release into the culture 
medium (Tjalsma & van Dijl, 2005). In our study, glycosylations were found also in 
lipoproteins from the ∆lnt mutant, demonstrating that N-acylation is not a prerequisite for 
glycosylation. Lnt independent glycosylation was also demonstrated in C. glutamicum 
(Mohiman et al., 2012). In C. glutamicum Cg-Ppm1 is responsible for glycosylation. Cg-
ppm1 (Ppm synthase) and Cg-ppm2 (Lnt) are similar organized as MSMEG_3859 (Ppm 
synthase) and MSMEG_3860 (Lnt) in M. smegmatis (Fig. 2). Deletion of the Lnt domain of 
BCG_2070c obviously did not abolish Ppm activity encoded in the same ORF. Of note, Lnt is 
dispensable while Ppm is essential in M. tuberculosis (Zhang et al., 2012). 
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In Gram-negative bacteria, the efficient lipoprotein transport to the outer membrane depends 
on the localization of lipoproteins (Lol) transport system and there is good evidence that 
N-acylation by Lnt facilitates lipoprotein translocation in E. coli (Okuda & Tokuda, 2011; 
Robichon et al., 2005). Lnt is essential in E. coli, however deletion of lnt was possible upon 
overexpression of proteins from the Lol system, indicating an important role of N-acylation in 
targeting lipoproteins to the outer membrane (Narita & Tokuda, 2011). Mycobacteria have an 
outer membrane mycolic acid bilayer (Niederweis et al., 2010; Sutcliffe, 2010; Zuber et al., 
2008) and are known to localize lipoproteins to the cell surface (Niederweis et al., 2010). 
Nevertheless, no mechanisms for translocation or transport systems are identified and whether 
N-acylation and glycosylation, alone or in combination are involved in the translocation of 
specific lipoproteins to the mycolate layer is not known so far.  
In the present study we show that lipoproteins from M. bovis BCG, the live vaccine for 
tuberculosis are triacylated and we identified the lipid modifications at the molecular level. 
BCG_2070c is a functional homologue of E. coli Lnt, but differs in substrate specificity. The 
identification of N-linked tuberculostearic acid shows for the first time, to our knowledge, that 
mycobacteria-specific fatty acids are used by mycobacterial Lnts.  
The antituberculosis drug pipeline is not sufficiently filled and the vaccines used at present do 
not provide effective protection against tuberculosis in adults. For lipoproteins and their 
biosynthesis pathway potential implications in M. tuberculosis pathogenesis and 
immunogenicity have been shown. Our results about lipoprotein structure therefore may 
contribute to provide the knowledge which is required to develop novel vaccines and 
antituberculosis drugs to eliminate this worldwide epidemic.  
 
 
CONCLUSIONS 
 
Lipoproteins are triacylated in slow-growing mycobacteria. By MALDI-TOF/TOF analyses 
lipoprotein modifications in M. bovis BCG wildtype and BCG_2070c lnt deletion mutant 
were analyzed at the molecular level. N-acylation of lipoproteins was only found in the 
wildtype strain, but not in the mutant strain, which confirmed BCG_2070c as functional lnt in 
M. bovis BCG. Moreover, we identified mycobacteria-specific tuberculostearic acid as further 
substrate for N-acylation in slow-growing mycobacteria.  
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SUPPLEMENTAL MATERIAL 
 
Supplemental Table S1 
 
TABLE S1. Conservation of essential residues in Lnt homologues.  
Escherichia coli 
Lnt 
essential residue* 
Mycobacterium 
tuberculosis 
Rv2051c 
Mycobacterium 
bovis BCG 
BCG_2070c 
Mycobacterium 
tuberculosis 
Rv2262c/2261c** 
Mycobacterium 
bovis BCG 
BCG_2279c 
W74 F F F F 
F146 G G G G 
W148 + + + + 
Q228 + + + + 
Q233 + + G G 
W237 V V D D 
Y249 A A T T 
P266 + + G G 
E267 + + + + 
N314 T T K K 
Y333 H H + + 
K335 + + + + 
E343 + + + + 
P346 + + L + 
Q372 T T  A  P 
C387 + + S S 
Y388 W W + + 
E389 + + + + 
Q424 + + + + 
R432 + + + + 
A433 + + + + 
E435 + + + + 
L436 H H A A 
Essential residues of the catalytic triad are written in bold letters. Other essential residues absolutely required for 
function are written in italic letters. 
*Vidal-Ingigliardi et al. 2007 
**Residues above the bar are encoded by Rv2262c, residues below the bar are encoded by Rv2261c. 
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Supplemental Figure S1 
 
Fig. S1. Western blot analysis of purified lipoproteins of M. bovis BCG wildtype and ∆lnt mutant strain. 
Elution fractions from FPLC or HA affinity chromatography were analyzed by Western blot using anti-HA 
antibody and corresponding secondary antibody conjugated with horseradish peroxidase. A. LprF B. LpqH C. 
LpqL D. LppX. Bands with a higher molecular weight (labeled with an asterisk) correspond to pre-pro-
lipoprotein or pro-lipoprotein, lower bands correspond to apolipoprotein and/or mature lipoprotein, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
112 
 
Supplemental Figure S2 
 
Fig. S2. Sequence alignment of M. tuberculosis Rv2262c/Rv2261c and M. bovis BCG_2070c using 
EMBOSS Needle. 2bp difference in sequence is marked with a box. Resulting stop codon TAG of Rv2262c is 
marked with a box (dotted line) and start of Rv2261c is indicated with an arrow. 
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Supplemental Figure S3 
 
Fig. S3. Multiple sequence alignment of Lnt homologues using Clustal W2. Essential residues required for 
E. coli Lnt function and corresponding residues in the Lnt homologues are marked with a box. Start of Rv2261c 
sequence is indicated with an arrow.  
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Supplemental Figure S4 
 
Fig. S4. Disruption of Mycobacterium bovis BCG lnt (BCG_2070c). Genomic DNAs from M. bovis BCG 
(lane 1), lnt single-crossover (3‘ sco) mutant (lane 2) and ∆lnt mutant (lane 3) were digested with MluI and 
probed with a 222 bps SalI lnt gene fragment. The presence of the 3.1 kbp fragment in the ∆lnt knockout 
compared to the 8.1 kbp fragment in the parental strain demonstrates inactivation of lnt.  
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DISSECTING THE COMPLETE LIPOPROTEIN BIOGENESIS PATHWAY IN  
STREPTOMYCES SCABIES 
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Chandra, Iain C Sutcliffe, Juliane K. Brülle, Peter Sander, Tracy Palmer and Matthew I. 
Hutchings 
 
Molecular Microbiology (2011) 80 (5), 1395-1412 
 
 
ABSTRACT 
 
Following translocation, bacterial lipoproteins are lipidated by lipoprotein diacylglycerol 
transferase (Lgt) and cleaved of their signal peptides by lipoprotein signal peptidase (Lsp). In 
Gram-negative bacteria and mycobacteria, lipoproteins are further lipidated by lipoprotein 
N-acyl transferase (Lnt), to give triacylated lipoproteins. Streptomyces are unusual amongst 
Gram-positive bacteria because they export large numbers of lipoproteins via the twin 
arginine protein transport (Tat) pathway. Furthermore, some Streptomyces species encode two 
Lgt homologues and all Streptomyces species encode two homologues of Lnt. Here we 
characterise lipoprotein biogenesis in the plant pathogen Streptomyces scabies and report that 
lgt and lsp mutants are defective in growth and development while only moderately affected 
in virulence. Lipoproteins are lost from the membrane in an S. scabies lgt mutant but restored 
by expression of S. coelicolor lgt1 or lgt2 confirming that both encode functional Lgt 
enzymes. Furthermore, lipoproteins are N-acylated in Streptomyces with efficient N-acylation 
dependent on Lnt1 and Lnt2. However, deletion of lnt1 and lnt2 has no effect on growth, 
development or virulence. We thus present a detailed study of lipoprotein biogenesis in 
Streptomyces, the first study of Lnt function in a monoderm bacterium and the first study of 
bacterial lipoproteins as virulence factors in a plant pathogen. 
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INTRODUCTION 
 
Bacterial lipoproteins are a specialised class of membrane proteins that play important roles in 
nutrient scavenging, cell envelope assembly, protein folding, environmental signalling, host 
cell adhesion and virulence (Hutchings et al., 2009; Paradis-Bleau et al., 2010; Typas et al., 
2010). Precursor lipoproteins are translocated across the cytoplasmic membrane by either the 
Sec (general secretory) or Tat (twin arginine translocation) pathways (Thompson et al., 2010) 
and then lipid modified by the enzyme lipoprotein diacylglycerol transferase (Lgt) on the 
sulphydryl group of a conserved cysteine. This cysteine is located in a lipobox motif, typically 
L
-3 – (A/S)-2 – (G/A)-1 – C+1, at the end of the signal peptide and becomes the N-terminal 
residue of the mature lipoprotein following cleavage of the signal peptide by lipoprotein 
signal peptidase (Lsp) (Hutchings et al., 2009). In Gram-negative bacteria and Gram-positive 
mycobacteria a third enzyme, lipoprotein N-acyl transferase (Lnt), adds another fatty acid to 
the amino group of the conserved cysteine (Tschumi et al., 2009; Vidal-Ingigliardi et al., 
2007). There is good evidence that N-acylation is involved in targeting lipoproteins to the 
outer membrane in E. coli and other Gram-negative bacteria (Robichon et al., 2005). 
However, although mycobacteria have an outer membrane mycolic acid bilayer (Niederweis 
et al., 2010; Sutcliffe, 2010; Zuber et al., 2008) and are known to localise lipoproteins to the 
cell surface (Mawuenyega et al., 2005; Niederweis et al., 2010; Wu et al., 1998), no 
mechanisms for the translocation of specific lipoproteins to the mycolate layer are known. 
We recently characterised lipoprotein biogenesis in the model Gram-positive actinomycete 
bacterium Streptomyces coelicolor and found evidence that the pathway is essential in this 
organism. S. coelicolor is unusual in encoding two Lgt homologues and we were unable to 
construct a double lgt mutant. Furthermore, deletion of lsp seemingly resulted in the 
generation of secondary mutations that likely suppress the lethal phenotype of this mutation 
(Thompson et al., 2010). To further investigate lipoprotein biogenesis in Streptomyces and in 
particular the role of Lgt and Lnt, we turned to the plant pathogenic species Streptomyces 
scabies which encodes single Lgt and Lsp enzymes. S. scabies 87-22 and other genome 
sequenced Streptomyces species also encode two Lnt homologues despite only containing a 
single lipid bilayer. S. scabies is a soil dwelling saprophytic bacterium with a complex 
developmental life cycle that has acquired a set of genes which enables it to colonise a variety 
of plants. Although best known as the causative agent of potato scab disease, S. scabies 
appears to be neither host, nor tissue, specific and will infect seedlings of monocotyledonous 
or dicotyledonous plants (Bignell et al., 2010a). The main phenotype of an infected potato 
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plant is the presence of lesions or scabs on the surface of the potato, which can overlap to 
cover a significant proportion of its surface. These lesions are usually identified at the time of 
harvesting and they reduce the market value of the potato, making potato scab disease of great 
economic importance to farmers worldwide.  
The role of lipoproteins in host cell attachment and virulence have been well studied in Gram-
positive human and animal pathogens (Hutchings et al., 2009; Sander et al., 2004) but have 
only been studied from a bioinformatic perspective in plant pathogenic bacteria (Kovacs-
Simon et al., 2011; Sutcliffe & Hutchings, 2007). Streptomyces species export large numbers 
of lipoproteins via the Tat pathway (Shruthi et al., 2010; Thompson et al., 2010) and the Tat 
machinery is known to be essential for virulence in S. scabies (Joshi et al., 2010). To 
understand the role of lipoproteins in the virulence of S. scabies and to further characterise 
lipoprotein biogenesis and the role of Lgt and Lnt in the genus Streptomyces, we identified 
putative Sec- and Tat-dependent lipoproteins in S. scabies and disrupted the lipoprotein 
biogenesis pathway by deleting the single lgt and lsp genes and the lnt1 and lnt2 genes 
individually and in combination. Here we report the effects of these mutations on growth and 
development, lipoprotein biogenesis and virulence in S. scabies. This in depth analysis of 
lipoprotein biogenesis is the first characterisation of Lgt and Lnt function in Streptomyces 
and, to our knowledge, the first study of lipoprotein biogenesis as a potential virulence 
determinant in a plant pathogen.  
 
 
EXPERIMENTAL PROCEDURES 
 
Bioinformatic identification of lipoproteins. All S. scabies proteins in StrepDB 
[http://strepdb.streptomyces.org.uk] were analysed for Sec- or Tat-dependent lipoprotein 
signal peptides as described previously (Thompson et al., 2010). Functional predictions were 
based on the sequence annotation of these proteins, combined with BlastP analysis and 
conserved domain analyses. 
 
Strains, plasmids, cosmids, primers and growth conditions. The strains, plasmids, cosmids 
and primers used in this study are listed in Table 1. E. coli was routinely grown in LB, or 
modified LB lacking NaCl to select for hygromycin resistance. S. scabies strains were grown 
on instant potato mash (IPM) agar (20g ‘Smash’ brand instant potato, 20g agar in 1 litre of tap 
water), Difco nutrient broth (DNB) or DNB agar (BD Diagnostics) and a 50:50 mix of 
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Tryptone Soya Broth (TSB; Oxoid) / Yeast extract malt extract (YEME) agar. Liquid cultures 
were grown in DNB or a 50:50 mix of TSB/YEME (Kieser, 2000). 
 
Mutagenesis. Genes were replaced with apramycin resistance cassettes by PCR targeting the 
relevant cosmids from an ordered S. scabies cosmid library (Table 1) in E. coli using the 
Redirect method (Gust et al., 2003). The primers used to construct and confirm the knockout 
cosmids and strains are listed in Table 1. All mutant and wild-type cosmids were checked by 
restriction digest and PCR with the relevant test primers before being introduced into E. coli 
strain ET12567/pUZ8002 and conjugated into S. scabies 87-22 as described previously (Joshi 
et al., 2010). Mutant colonies were selected using the appropriate antibiotic and the mutation 
was checked by PCR using isolated genomic DNA from the mutant compared to the wild-
type strain. Strains were complemented in trans in single copy by introduction of the genes 
and their native promoters on the integrative vector pSET152 in which the apramycin 
resistance cassette is replaced with a hygromycin resistance cassette. The gene encoding 
SCO3484-His was introduced on the same pSET152 vector (Table 1).  
 
Microscopy. Brightfield images were acquired using a Zeiss M2 Bio Quad SV11 
stereomicroscope. The samples were illuminated with a halogen lamp and reflected-light 
images captured with an AxioCam HRc CCD camera and AxioVision software (Carl Zeiss, 
Welwyn Garden City, UK). Preparation and imaging of samples using the scanning electron 
microscope was performed exactly as described (Thompson et al., 2010). Images were saved 
as digital TIFF files and manipulated using Adobe Photoshop CS4.  
 
Sample preparation for 2D gels. Cellophane discs were placed on YEME agar plates and 
inoculated with 105 spores or 106 spores of the ∆lsp and ∆lgt strains to give confluent growth 
after 48 hours. The mycelium was harvested and the lipoprotein fraction was extracted using 
Triton X-114 and prepared for 2D gel analysis as described previously. Extracellular protein 
samples were prepared as described previously (Thompson et al., 2010). 
 
2D PAGE. Analytical 2D page was carried out as described previously (Widdick et al., 2006). 
For phenotypic analysis smaller 2D PAGE was used. Briefly, proteins were loaded onto 7cm 
pH4-7 IEF strips (GE Healthcare #17-6001-10) by rehydration at 20oC for 12-14 hours then 
run using the following program: hold at 300V for 30 minutes, gradient to 1000V for 30
minutes, gradient to 5000V for 90 minutes then hold at 5000V for 5 hours. The 2nd dimension
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Table 1. Strains, plasmids and primers 
 
Strain  Reference 
   S. scabies   
87-22 Wild-type S. scabies  
BJT1040 S. scabies ∆lgt::apr This work 
BJT1041 S. scabies ∆lgt::apr + lgt in trans This work 
BJT1044 S. scabies ∆lsp::apr This work 
BJT1045 S. scabies ∆lsp::apr + lsp in trans This work 
BJT1047 S. scabies ∆lnt1::apr This work 
BJT1048 S. scabies ∆lnt2::apr This work 
BJT1049 S. scabies ∆lnt2::hyg This work 
BJT1050 S. scabies ∆lnt1::apr ∆lnt2::hyg This work 
BW25113 (pIJ790) BW25113 containing λ RED recombination (Gust et al., 2003) 
ET12567 (pUZ8002) dam dcm strain containing helper plasmid pUZ8002 (Gust et al., 2003) 
Plasmids   
   pMS82 Integrative Streptomyces vector (Gregory et al., 
2003) 
pIJ10706 pSET152 with hygromycin resistance marker (Kieser, 2000) 
pBT110 pIJ10706 + full length Streptomyces coelicolor lsp This work 
pBT119 pMS82 + full length Streptomyces coelicolor lgt1 (Thompson et al., 
2010) 
pBT120 pMS82 + truncated Streptomyces coelicolor lgt1 This work 
pBT121 pMS82 + full length Streptomyces coelicolor lgt2 (Thompson et al., 
2010) 
pBT123 pMS82 carrying the S. scabies lsp gene and its native promoter This work 
pBT124 pMS82 carrying the S. scabies lgt gene and its native promoter This work 
pAU3-45 pSET152 with thiostrepton resistance marker (Bignell et al., 2005; 
Thompson et al., 
2010) 
pDWU59 pAU3-45 + SCO3484 6xHis This work 
Cosmids   
   Scab 139 Cosmid with full length S. scabies lgt  
Scab 139 lgt::apr Cosmid 139 with the lgt gene replaced with the apr cassette  
Scab 45 Cosmid + full length Scabies lsp This work 
Scab 45 lsp::apr Cosmid 45 with the lsp gene replaced with the apr cassette This work 
Scab 351 Cosmid + full length Scabies lnt1 This work 
Scab 351 lnt1::apr Cosmid 351 with the lnt1 gene replaced with the apr cassette This work 
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Scab 2255 Cosmid + full length Scabies lnt2 This work 
Scab 2255 lnt2::hyg Cosmid 2255 with the lnt2 gene replaced with the hyg cassette This work 
Scab 2255 lnt1::apr See above This work 
Primers   
   lgt KOfor gtcggccgggcccgacagggtagcgtcgaccctgccatgattccggggatccg 
tcgacc 
This work 
lgt KOrev tgggcaggcatcacatcgagcgaaccggctgtcgcgtcatgtaggctggagct 
gcttc 
This work 
lgt C-trunc rev tcacggctccaccacggcctc This work 
lgt TESTfor ggcggcagcggctcccgcaaggccg This work 
lgt TESTrev tgggcaggcatcacatcgagcgaac This work 
Scab lgt comp For acatctacgcggaccagtccatgac This work 
Scab lgt comp Rev tgggcaggcatcacatcgagcgaac This work 
lnt1 KOfor tgtcggcgccggggtgacgcgccgtacactccccgagtgattccggggatcc 
gtcgacc 
This work 
lnt1 KOrev ccccgccgttccggcacgcgcacgcgaggcgtacggctatgtaggctggag 
ctgcttc 
This work 
lnt1 TESTfor gatcagcgccgagctccccacggtg This work 
lnt1 TESTrev ccccgccgttccggcacgcgcacgc This work 
lnt2 KOfor actggagggacgcaccgggtggcagggaggcgctgtatgattccggggatc 
cgtcgacc 
This work 
lnt2 KOrev gggcagggtgctcagcgcccgggacgccctggccactcatgtaggctggag 
ctgcttc 
This work 
lnt2 TESTfor actggagggacgcaccgggt This work 
lnt2 TESTrev gggcagggtgctcagcgccc This work 
P1 attccggggatccgtcgacc This work 
P2 tgtaggctggagctgcttc This work 
Scab Nec1 test for atgagcgcgaacggaagcccc This work 
Scab Nec1 test rev ctactttctcgttatccatat This work 
agarase test for  gtggtcaaccgacgtgatctc This work 
agarase test rev ctacacggcctgatacgtcct This work 
 
 
was run on 1mm IPG well NuPAGE® 4-12% Bis-Tris ZOOMTM Gels (Invitrogen 
#NP0330BOX) at 200V for 40 minutes using MES SDS running buffer (Invitrogen 
#NP0002). The gels were stained by using a colloidal Coomassie blue stain and then scanned 
using a GS800 Calibrated Densitometer (BioRad). 
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Purification of lipoproteins from membrane fractions. Solid cultures were grown on top of 
cellophane discs, harvested and then re-suspended in 20mM NaH2PO4 pH7.4 500mM NaCl 
(0.5ml/8.5cm plate), supplemented with lysozyme (30 mg/ml) and CompleteTM EDTA-free 
protease inhibitors (Roche). Mycelium was lysed by sonication on ice, until visual assessment 
indicated lysis was complete. Supernatants were separated into soluble and membrane 
fractions by ultracentrifugation (40,000 rpm, Beckman Ti70 rotor, 90 minutes at 4ºC). The 
supernatant at this stage was routinely retained as the cytoplasmic fraction. The pellet was re-
suspended in 20mM NaH2PO4 pH7.4 500mM NaCl, 1% Triton-X-100, plus and CompleteTM 
EDTA-free protease inhibitors (Roche) (0.5ml/8.5cm plate) and incubated with gentle 
agitation at 4°C for 60 minutes.  The mixture was then ultracentrifuged again, as previously. 
The supernatant was applied to a 1ml Hi-Trap Ni column equilibrated in 20mM NaH2PO4 
pH7.4 500mM NaCl, 0.1% (v/v) Triton-X-100 using an ÄKTA FPLC system at 1ml/min. The 
column was washed in 20mM NaH2PO4 pH7.4, 500mM NaCl, 20mM Imidazole, 0.1% (v/v) 
Triton-X-100 and bound proteins were eluted using a gradient of 20-300mM Imidazole over 
30ml.  
 
Mass spectrometry. Purified lipoproteins were prepared using the method of Ujihara et al. 
(Ujihara et al., 2008) and analysed as described previously (Tschumi et al., 2009). 
 
Potato necrosis assay. A potato tuber of the cultivar Maris Piper was washed and peeled. The 
tuber was surface sterilised by immersion in 2% bleach for 5 minutes, with stirring. The 
potato was transferred using sterile forceps into a beaker containing 500 ml of sterile water in 
the laminar flow hood. The potato was rinsed for 2 minutes, and transferred to a second 
beaker of sterile water where it was washed as before. After washing was completed, the 
potato was lain on some sterile paper towels and cores were taken using a sturdy potato peeler 
(sterilised with ethanol). These cores were sliced into discs 0.5 cm thick using a sterile 
scalpel. The slices were placed onto sterile filter paper, prewetted with 2 ml of sterile water, in 
a petri dish. Four potato slices were placed in each dish. Plates of the S. scabies strains were 
prepared on IPM agar. Spores were plated in order to obtain confluent lawns of bacteria. The 
plates were incubated for 5 nights, and agar plugs (1 cm2) were cut using a sterile scalpel. A 
plug was placed on each potato piece, spore side down. Uninoculated IPM agar was used as a 
negative control. The plates were sealed and incubated at 30 °C in the dark for either 48 hours 
or 1 week. The agar plugs were then removed and the potato slices were viewed under a 
microscope to investigate signs of necrosis. 
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Radish seedling infection assay. Radish seeds of the cultivar Scarlet Globe were soaked in 
70% ethanol for 10 minutes, the ethanol removed, then soaked in 13% bleach for a further 10 
minutes. The bleach was removed, and the seeds were washed copiously in sterile H2O. The 
seeds were placed onto sterile filter paper in a Petri dish, pre-wetted with 2 ml sterile H2O. 
The seeds were incubated in the dark at room temperature for 24 hours. Cultures of various 
S. scabies strains were set up by growing 1 x 106 spores in 10 ml of 50% TSB/YEME media, 
with the relevant antibiotics at 30°C for 20 hours. After this time had elapsed the mycelium 
was collected by centrifugation and washed twice in TSB. After the final wash the mycelium 
was resuspended in 1 ml of TSB broth, with 500 µl being spread over half a square Petri dish 
containing plant MS medium (1% agar, added sucrose). The remaining 500 µl of mycelium 
were placed in a 12 well cell culture plate, into which seedlings at the same stage of 
germination were immersed prior to being placed in the Petri dish. These dishes were sealed 
and stored vertically in an incubation chamber at 21°C with a day length of 12 hours. 
 
 
RESULTS 
 
Bioinformatic identification and analysis of S. scabies lipoproteins.  
 
Putative Sec- and Tat-dependent lipoproteins were identified by bioinformatic analysis of the 
S. scabies proteome as described previously (Thompson et al., 2010) and are listed in Table 
S1. A total of 231 putative lipoproteins were identified, indicating that lipoproteins represent 
at least 2% of the S. scabies proteome. Approximately 10% of these putative lipoproteins are 
confidently predicted to be Tat substrates, indicating that ca. 18% of the total Tat substrates 
identified by Joshi et al. (Joshi et al., 2010) are likely lipoproteins, including five Tat 
lipoproteins validated in the agarase secretion assay (Table S1). As in S. coelicolor and other 
actinomycetes, putative lipoprotein functions (Table 2) include many substrate binding 
proteins (SBP) of ABC transport systems (Table S2), enzymes, lipoproteins involved in cell 
envelope sensing, redox and cell wall homeostasis remodelling processes, and a significant 
proportion (35%) of hypothetical proteins of unknown function (Table S3). With regard to 
cell wall processess, seven putative lipoproteins belong to the YkuD family of L,D 
transpeptidases involved in peptidoglycan remodelling. As these lipoproteins are also well 
represented in S. coelicolor (Thompson et al., 2010) it may be that these putative 
transpeptidases are significant in Streptomyces growth and development. Potential lipoprotein
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Table 2. Lipoprotein functions in Streptomyces scabies. 
 
Function Numbers % Examples References 
Solute binding proteins 102 44% SCAB81041 
spermidine/putrescine 
SBP 
(Joshi et al., 2010) 
Putative enzymes 21 9% SCAB20691 
polysaccharide 
deacetylase 
 
Redox processes 9 4% CtaC, Cytochrome c 
oxidase subunit 2 
(Thompson et al., 2010) 
Signal transduction (two 
component accessory 
lipoproteins) 
5 2% LpqB, CseA (Hoskisson & Hutchings, 
2006; Hutchings, 2007) 
Cell envelope processes 13 6% SCAB10101 putative 
transpeptidase 
(Thompson et al., 2010) 
Function unknown 81 35%   
 
virulence factors include several putative degradative enzymes such as peptidases/proteases, 
four polysaccharide deacetylases, an α-N-acetylglucosaminidase and an α-L-
arabinofuranosidase (Table S3). Also consistent with the acquisition of host derived nutrients 
are the identification of many SBP for sugars and amino acids/peptides (Table S2). As in 
S. coelicolor (Thompson et al., 2010) it is notable that a significant proportion of the putative 
sugar-binding SBP (notably all those of the COG1653 family, n=36) are located in incomplete 
ABC operons that lack genes encoding the cognate energising ATPases. These ABC systems 
are presumptively energised by the single MsiK orthologue (SCAB_50161), which is 
orthologous to the multifunctional ATPase MsiK of Streptomyces reticuli (Schlosser et al., 
1997) and the promiscuous Bacillus subtilis MsmX ATPase (Ferreira & Sa-Nogueira, 2010). 
Notably, the pathogenicity island of S. scabies encodes three lipoproteins, SCAB77271, 
SCAB77361 and SCAB77471, all of which are putative COG1653 family SBP (Table S2) 
(Huguet-Tapia et al., 2011). In addition, the putative lipoprotein SBP and confirmed Tat 
substrate SCAB81041 has been implicated in S. scabies virulence by a previous study which 
demonstrated that a ∆scab81041 mutant has a moderate virulence phenotype (Joshi et al., 
2010).  
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Disrupting lipoprotein biogenesis in S. scabies.  
 
The lipoprotein biogenesis enzymes were identified by BLAST searching the S. scabies 
genome with the Lgt and Lsp sequences from S. coelicolor (Thompson et al., 2010) and the 
Lnt sequences from Escherichia coli, Mycobacterium tuberculosis and Mycobacterium 
smegmatis (Fig. S1). In contrast to S. coelicolor and Streptomyces clavuligerus, but in 
common with most other bacteria, S. scabies encodes a single Lgt enzyme (SCAB68531) 
along with a single Lsp enzyme (SCAB68121). The two putative S. scabies Lnt enzymes, 
which we have named Lnt1 (SCAB83111) and Lnt2 (SCAB76621), share a low amino acid 
sequence identity to each other (23%) and low levels of identity to E. coli Lnt (20% and 22%, 
respectively) and to M. tuberculosis Ppm1 (44% and 26%, respectively), which has been 
shown to have an N-terminal Lnt domain (Tschumi et al., 2009). However, both Lnt1 and 
Lnt2 contain the three conserved residues (E267, K355, C387) that form the catalytic triad in 
E. coli Lnt and the mycobacterial Lnt enzymes (Fig. S1) (Buddelmeijer & Young, 2010; 
Vidal-Ingigliardi et al., 2007). This led us to hypothesise that both Lnt homologues might 
catalyse the N-acylation of lipoproteins in Streptomyces because, to our knowledge, all 
genome-sequenced Streptomyces species encode both Lnt1 and Lnt2 homologues. An ordered 
cosmid library was used to replace each gene with an apramycin or hygromycin resistance 
cassette and these disrupted cosmids were conjugated into wild-type S. scabies strain 87-22. 
Single lgt, lsp and lnt mutants and a double lnt mutant were selected on the basis of 
apramycin and hygromycin resistance (see Experimental Procedures). Deleting lsp and lgt had 
a severe effect on the colony morphology of S. scabies, with both mutants exhibiting flatter, 
pock marked colonies with less obvious sporulation and the lsp null mutant in particular 
forming smaller colonies about half the size of the wild-type colonies. Deletion of the putative 
lnt genes individually or in combination had no visible effect on growth or development (Fig. 
1A). The macroscopic phenotype of the S. scabies lsp mutant is less severe than that of an 
S. coelicolor lsp mutant but is consistent in that both form smaller, flatter colonies than their 
respective wild type strains. The S. scabies lgt and lsp mutants are also affected in 
development, they formed fewer coiled spore chains than the wild type and there is clearly 
less septation occurring in both the lgt and lsp mutants (Fig. 1B). These data are consistent 
with the phenotype of an S. coelicolor lsp mutant (Thompson et al., 2010). These data 
suggests that disrupting lipoprotein biogenesis in Streptomyces at either the lipidation or 
signal cleavage stages has a serious effect on growth and development. The wild-type colony 
morphology was only partially restored in the lgt and lsp mutants by complementation in 
CHAPTER 4 
127 
 
trans with the S. scabies lgt or lsp genes (Fig. 1A) which suggests that secondary mutations 
may have arisen in the chromosomes of these strains. Previous results for S. coelicolor also 
suggested that disrupting lsp results in secondary mutations elsewhere in the chromosome 
(Thompson et al., 2010). Heterologous expression of the S. coelicolor lsp gene also partially 
restored the wild-type colony morphology in the S. scabies lsp mutant as did both 
S. coelicolor lgt1 and lgt2 genes in the S. scabies lgt mutant. Significantly, this last result 
provides evidence that both S. coelicolor lgt genes encode functional Lgt homologues (Fig. 
1A). 
 
 
 
Fig. 1. A. Light microscope images (x 40 magnification) of single colonies of S. scabies wild-type 87-22, 
∆lgt, ∆lsp and ∆lnt strains as indicated, after 5 days growth on IPM agar. The ∆lgt and ∆lsp mutants form 
small and flatter colonies compared with the characteristic colonies of wild-type 87-22 that are raised in the 
centre. Complementation of the ∆lgt and ∆lsp mutants in single copy in trans only partially restores the wild-
type phenotype. B. Scanning Electron Microscope images of single colonies of S. scabies wild-type 87-22, ∆lgt 
and ∆lsp. After five nights growth the mutant strains have fewer spore chains than the wild-type, suggesting a 
developmental delay. 
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Analysing the lipoproteome of S. scabies.  
 
Our previous study in S. coelicolor analysed the effects of an lsp mutation on the 
lipoproteome of Streptomyces in some detail and demonstrated that lipoproteins were either 
lost from the membrane or retained with their signal peptides intact (Thompson et al., 2010). 
In this work we focussed our efforts on identifying lipoproteins in the wild-type and ∆lgt 
strains of S. scabies. Whole cell lysates of agar plate grown cultures were extracted with 
Triton X-114 and proteins in the lipophilic (detergent) fraction were precipitated with 
chloroform and methanol and resolved by two-dimensional (2D) gel electrophoresis, as 
described previously (Thompson et al., 2010; Widdick et al., 2006). MALDI TOF analysis of 
protein spots present in the wild-type samples revealed that 17 (~7.5%) of the putative 
lipoproteins identified by the bioinformatic analysis were present in the lipophilic fraction of 
the wild type strain, suggesting they are indeed lipoproteins (Table 3); Fig. 2A). No 
lipoproteins were detected in the lipophilic fraction of the ∆lgt strain consistent with the idea 
that removing Lgt prevents lipidation of lipoproteins in S. scabies (Fig. 2B). Notably, the four
proteins detected to be more abundant in this fraction are non-lipoproteins. A previous study 
on the role of Lgt in the Firmicute bacterium Listeria revealed that large numbers of 
lipoproteins are released into the growth medium in a ∆lgt strain (Baumgärtner et al., 2006). 
In S. scabies only 5 of the 17 lipoproteins identified in the wild-type lipophilic fraction were 
present in the extracellular fraction of the ∆lgt strain along with another lipoprotein, 
SCAB19841, that was not detected in the wild-type lipophilic or cell wall wash fractions (Fig. 
S2, Tables 2 and S4). The remainder of the lipoproteins detected in the wild-type lipophilic 
fraction were not detected in either the lipophilic or cell wall wash fractions of the lgt strain, 
suggesting they are either not expressed (loss of SBPs would affect uptake of compounds and 
might affect regulation of cognate pathways) or that they are degraded by intramembrane or 
extracellular proteases. Loss of an unlipidated precursor of the CseA lipoprotein of 
S. coelicolor due to apparent proteolysis has been observed previously. The N-terminal 
peptides of the putative lipoproteins in the lgt cell wall wash fraction were not detected by 
MALDI TOF so conclusions cannot be drawn about the processing of lipoproteins shed into 
the extracellular environment in these strains. 
For more rapid phenotypic comparison of the lipophilic fractions of the wild-type, lgt, lsp and 
lnt mutants and complemented mutant strains, samples were applied to 7 cm isoelectric 
focussing strips and separated in the second dimension on precast mini gels (see Experimental 
Procedures). These gels were run with biological duplicate samples and are for comparison 
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Table 3. Lipoproteins identified in wild-type Streptomyces scabies 87-22 and the isogenic 
lgt mutant by 2D PAGE. 
 
Spot ID Gene number Function Identified 
1 SCAB05351 Putative enzyme (polyketide cyclase)  WT lipophilic fraction 
2 SCAB08741 Putative SBP for peptides WT lipophilic fraction 
3 SCAB19051 Putative SBP for sugars WT lipophilic fraction 
4 SCAB21021, XylF Putative SBP for pentose sugars WT lipophilic fraction 
5 SCAB24891 Putative SBP for amino acids  WT lipophilic fraction 
6 SCAB27411 Putative SBP for oligopeptides WT lipophilic fraction 
7 SCAB29881 Putative SBP for amino acids  WT lipophilic fraction 
8 SCAB29961 Putative SBP for sugars  WT lipophilic fraction 
9 SCAB31531, BldKB Putative SBP for peptides WT lipophilic fraction 
10 SCAB34981 Putative SBP for ribonucleosides  WT lipophilic fraction 
11 SCAB49311, PstS Putative SBP for phosphate. WT lipophilic fraction 
12 SCAB57751 Putative SBP for sugars WT lipophilic fraction 
13 SCAB68931 Putative SBP for branched chain amino acids WT lipophilic fraction 
14 SCAB73351 Putative SBP for dipeptides WT lipophilic fraction 
15 SCAB75441 Putative SBP for Fe3+  WT lipophilic fraction 
16 SCAB76561 Putative SBP WT lipophilic fraction 
17 SCAB85451 Putative SBP for Fe3+ hydroxamate  WT lipophilic fraction 
18 SCAB19841 Putative SBP for nitrate-sulfonate-bicarbonate ∆lgt lipophilic fraction 
 
only, no protein spots were analysed. In agreement with the 2D gel analysis reported above 
(Fig. 2) and previously (Thompson et al., 2010) the protein patterns are markedly different 
between wild-type, lgt and lsp strains suggesting a loss or movement of lipoproteins from the 
lipophilic fraction in both the lgt and lsp mutants (representative gels are shown in Fig. 3). In 
contrast, the lnt single and double mutants were indistinguishable from the wild-type 
suggesting deletion of the lnt genes individually or in combination does not lead to the loss of 
lipoproteins from the lipophilic fraction (Fig. 3). These data are consistent with the 
observation that diacylated lipoproteins (generated by the action of Lgt and Lsp) are stably 
anchored to the membranes of monoderm bacteria. In the lsp mutant complemented with 
S. coelicolor or S. scabies lsp and in the lgt mutant complemented with either S. scabies lgt or 
with S. coelicolor lgt1 or lgt2 the pattern of protein spots in the lipophilic fraction was 
indistinguishable from the wild-type thus confirming that the loss or movement of protein 
spots in this fraction is due to loss of Lgt or Lsp activity (Figs. S3A and B). This also proves 
that both S. coelicolor Lgt1 (SCO2034) and Lgt2 (SCO7822) can lipidate lipoprotein 
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precursors and that S. coelicolor Lsp is functional in the heterologous host S. scabies. The 
Lgt1 and Lgt2 enzymes are 79% and 60% identical, respectively, to S. scabies Lgt while the 
S. scabies and S. coelicolor Lsp enzymes share 82% identity.  
 
 
 
Fig. 2. Two dimensional polyacrylamide gels analysis of proteins extracted from the lipophilic fractions of 
the S. scabies wild-type (A) and ∆lgt strains (B). Protein spots are highlighted with arrows and numbered with 
the corresponding proteins listed next to each gel. Functions of the putative lipoproteins are listed in Table 3. 
The four proteins identified as more abundant in the lipophilic fractions of the ∆lgt strain are: the putative 
membrane protein SCAB30501 (T1); the putative enolase SCAB54441 (T2); the ATP synthase beta subunit 
SCAB28761 (T3); and the ATP synthase alpha subunit SCAB28781 (T4). 
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Lnt catalyses the N-acylation of lipoproteins in Streptomyces.  
 
The results presented above suggest that neither Lnt homologue is required for correct 
lipoprotein localisation in the cytoplasmic membrane. However, this does not rule out a role 
for these putative Lnt enzymes in the N-acylation of lipoproteins in Streptomyces since 
diacylation by Lgt may be sufficient for membrane localisation. To determine whether Lnt1 
or Lnt2 have lipoprotein N-acyl transferase activity we heterologously produced a His-tagged 
S. coelicolor lipoprotein, SCO3484, in the S. scabies wild-type and lnt mutant strains and 
used nickel affinity chromatography to purify SCO3484-His from membrane fractions 
isolated from each strain (see Experimental Procedures). The N-terminal modifications of 
SCO3484-His were examined using MALDI-TOF as described previously (Tschumi et al., 
2009). The predicted and experimentally determined m/z of the N-terminal peptides of 
SCO3484 with diacyl- or triacylation with C15, C16 and C17 fatty acids are shown in Table 3  
 
 
 
Fig. 3. Mini two-dimensional gel analysis of Triton X-114 extracted proteins from S. scabies wild-type 87-
22, ∆lgt, ∆lsp and ∆lnt strains after two days growth on YEME agar.  
 
and indicate that the N-terminal peptide of SCO3484 is triacylated in wild-type S. scabies 87-
22 (Table 3 and Fig. 4). The N-terminal fragment of SCO3484-His purified from the lnt1 and 
lnt1 lnt2 mutants is diacylated thus demonstrating that lnt1 is required for N-acylation and that 
Lnt2 alone cannot compensate for the lnt1 deletion in the lnt1 single deletion. Conversely, the 
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SCO3484-His lipoprotein purified from the single lnt2 mutant gives a mixture of diacylated 
and triacylated peptides (Table 3 and Fig. 4) indicating that although Lnt1 is sufficient for 
N-terminal acylation this step does not function as efficiently as in the wild type background. 
These data suggest either a subsidiary but inessential activity for Lnt2 or that Lnt2 does not
 
Table 3. Calculated m/z values and predicted chain lengths for diacylated and 
triacylated N-terminal tryptic peptides of the SCO3484-His lipoprotein purified from 
wild-type S. scabies 87-22, the isogenic lgt mutant complemented with S. coelicolor lgt1 
or lgt2 and isogenic lnt1, lnt2 and lnt1 lnt2 mutants as noted. 
 
Calculated 
m/z 
Predicted chain 
lengths 
 
Observed m/z values of N-terminal Peptides 
 
  S. scabies 
wild-type 
∆lgt + 
Sclgt1 
∆lgt + 
Sclgt2 
∆lnt1 ∆lnt2 ∆lnt1, 2 
2016.17 C15/C15/C15 2016.11 - - - - - 
2030.19 C15/C15/C16 2030.14 2030.18 2030.18 - 2030.18 - 
2044.17 C15/C15/C17 
C15/C16/C16 
2044.15 2044.20 2044.20 - 2044.20 - 
2058.22 C15/C15/C18 
C15/C16/C17 
C16/C16/C16 
2058.16 2058.22 2058.22 - 2058.22 - 
2072.24 C15/C15/C19 
C15/C16/C18 
C15/C17/C17 
C16/C16/C17 
2072.17 
  
2072.22 - - - - 
1791.17 C15/C15 - - - - - 1791.92 
1805.99 C15/C16 - - - 1805.97 1805.97 1805.94 
1820.01 C16/C16 - - - 1820.00 1820.02 1819.95 
1834.02 C15/C18 
C16/C17 
- - - 1833.96 - 1833.98 
 
function directly in lipoprotein N-acylation. In this respect it was previously observed that an 
E. coli lnt depletion strain could not be complemented with one of the S. coelicolor lnt 
homologues, sco1336 (Vidal-Ingigliardi et al., 2007). These data demonstrate that S. scabies
Lnt1 is indeed a functional lipoprotein N-acyl transferase but also suggest that some 
Streptomyces Lnt homologues may not be functional in lipoprotein acylation. An alternative 
explanation may be a possible ‘dominant negative’ phenotype of lnt1 deletion, that is, where 
deletion of lnt1 affects Lnt2 function, although we cannot at present suggest a mechanism for 
this.  
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Fig 4. MALDI-TOF analysis with monoisotopic m/z values of SCO3484-His lipoprotein derived from the 
S. scabies ∆lgt strain complemented with S. coelicolor lgt1 or lgt2 respectively, the ∆lnt1, ∆lnt2 and ∆lnt1 
lnt2 strains and the wild-type (wt) strain. Only m/z range from 1750-2100 is depicted. Filled circles: 
triacylated N-terminal peptides. Open stars: diacylated N-terminal peptides. 
 
 
Lipoprotein biogenesis in Streptomyces is ordered.  
 
The results presented above show that an S. scabies lgt mutant can be complemented by 
heterologously expressing either lgt1 or lgt2 from S. coelicolor and provides evidence that 
both enzymes encode functional Lgt enzymes (Figs 1A and 3). To analyse the N-terminal 
modifications catalysed by the two S. coelicolor Lgt enzymes, we purified SCO3484-His 
from the S. scabies lgt mutant complemented with either S. coelicolor lgt1 or lgt2. In both 
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complemented strains we detected triacylated SCO3484-His suggesting that both enzymes 
diacylate this lipoprotein in an S. scabies lgt mutant and allow signal cleavage and 
N-acylation to occur (Table 3 and Fig. 4). We also purified SCO3484-His from the secreted 
fraction of the S. scabies lgt mutant and analysed the N-terminus by Edman sequencing.  
 
 
 
Fig 5. MALDI-TOF analysis with monoisotopic m/z values of SCO3484-His lipoprotein derived from the 
S. scabies ∆lsp strain. Complete m/z range (A) and blown-up m/z range from 2700-3700 (B). Filled triangles 
show diacylated N-terminal peptides. 
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Although protein yield was low, sequencing of the N-terminus revealed a ragged N-terminus 
with the sequences starting with an alanine either from the -2 or -1 position, AAXSGGGNSS 
and AXSGGGNSSQ, respectively (data not shown), suggesting the signal sequence has most 
likely been cleaved by a Type I signal peptidase. This is consistent with the loss of Lgt 
function because Lsp rarely cleaves unlipidated substrates. Finally we analysed SCO3484-His 
purified from the membrane fraction of an S. scabies lsp mutant. In Gram-negative bacteria 
lipoprotein biogenesis occurs in strict order from Lgt to Lsp to Lnt, with Lsp only recognizing 
diacylated substrates. However, this is not true in all Gram-positive bacteria tested, since Lsp 
can cleave the signal peptide from unlipidated substrates in Listeria (Baumgärtner et al., 
2006). By definition, N-acylation can only occur after cleavage of the signal peptide because 
 
Table 4. Calculated and predicted m/z values for the N-terminal tryptic peptide 
RGFLGGSLGVAGAVLLAACSGGGNSSQGSGGSK of the SCO3484-His lipoprotein 
purified from the isogenic lsp mutant 
 
Calculated m/z Predicted chain lengths Observed m/z values 
2879.44 - n.f. 
3415.93 C15/C16 3415.91 
3429.95 C16/C16 3429.94 
 
 
this event allows access to the amino terminus of the +1 cysteine. Analysis of the S. scabies 
lsp mutant identified an N-terminal fragment with the sequence 
RGFLGGSLGVAGAVLLAACSGGGNSSQGSGGSK whose m/z of 3414.88, 3415.91 and 
3429.39 is consistent with the addition of C15/C16 or C16/C16 diacyl chains (Table 4 and 
Fig. 5). This fragment includes part of the uncleaved signal peptide of SCO3484 with a lipid 
group attached to the cysteine residue in the LAAC lipobox motif. These results show that 
lipidation occurs before signal peptide cleavage and that lipoprotein biogenesis in 
Streptomyces likely occurs in the order Lgt to Lsp to Lnt. 
 
Disrupting lipoprotein biosynthesis has only a moderate effect on virulence.  
 
To determine whether disrupting lipoprotein biogenesis has an effect on the virulence of 
S. scabies, the wild-type and mutant strains of S. scabies were first tested in a potato necrosis 
assay, whereby agar plugs containing each strain of S. scabies are placed face down onto 
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sterile potato slices, such that the bacteria are in direct contact with the potato, and an 
uninoculated agar plug is used as a negative control (Joshi et al., 2007). This experiment was 
repeated at least ten times with each strain and taken together the data suggests that the lgt, lsp 
and lnt mutants cause the same levels of potato necrosis as the wild-type strain (representative 
images are shown in Fig. 6). To investigate the virulence of the wild-type and mutant strains 
on whole plants we used the previously established S. scabies radish seedling infection assay 
(Bignell et al., 2010b). Sterilised seeds were germinated and then immersed in either 
uninoculated broth or broth inoculated with S. coelicolor (negative controls), S. scabies wild-
type, lgt, lsp and lnt mutants (see Experimental Procedures). The seeds were plated onto plant 
MS medium with sucrose and grown for seven days. The negative control plant, overlaid with 
sterile growth medium, shows healthy growth, with a long primary root, and multiple 
secondary roots (Fig 7A). After 7 days the primary roots were typically between 11-12 cm in 
length. The leaves are healthy and new leaf growth can be seen at the apical meristem. The 
 
 
 
Fig 6. Sterile potato disks were exposed to uninoculated agar (control), or agar inoculated with wild-type 
S. scabies and the S. scabies ∆lgt, ∆lsp, ∆lnt1, ∆lnt2 and ∆lnt1 lnt2 strains as shown and necrosis was 
examined after 2 days (top) and 5 days (bottom) growth. These are representative images from ten replicate 
experiments carried out for each strain. 
 
stem of the plant was typically between 1.3 and 1.6 cm. This growth pattern is also seen in 
control plants treated with the non-pathogenic S. coelicolor (Fig. 7A). However, plants 
infected with wild-type S. scabies are stunted, with a primary root of between 4-6 cm and 
there is very little secondary root growth evident. The secondary roots that are present are 
much smaller than in the negative control (Fig. 7A). Very small leaves were also observed in 
the S. scabies wild-type infected plants, there was no evidence of further leaf growth and the 
stem was shorter than in the negative control plants, rarely exceeding 1.5 cm in length. This 
phenotype was relatively consistent for the wild-type and each of the S. scabies mutants tested 
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in ten separate experiments, although the main root was slightly longer in plants infected with 
the lgt or lsp mutants compared to wild-type and lnt mutants and contained more side 
branches, suggesting that disrupting lipoprotein biosynthesis might have a moderate effect on 
the virulence of S. scabies (Fig. 7A). 
To further examine these effects the infected plant roots were examined using light 
microscopy (x 40 magnification). A complex network of root hairs can be seen in the plants 
 
 
Fig 7. A. Radish seedlings were mock infected with growth medium (TSB) or wild-type S. coelicolor and 
with wild-type S. scabies and the isogenic ∆lgt, ∆lsp, ∆lnt1, ∆lnt2 and ∆lnt1 lnt2 strains as shown, then 
grown for seven nights. All of the S. scabies infected plants were stunted in growth compared to the control 
plants although the lgt and lsp infected plants were consistently slightly larger than those infected with wild-type 
S. scabies suggesting a moderate effect on virulence. Assays were performed a minimum of ten times. B. Light 
microscope (x 40 magnification) examination of the roots of radish seedlings either mock infected with growth 
medium (TSB) or wild-type S. coelicolor and with wild-type S. scabies and the ∆lgt, ∆lsp, ∆lnt1, ∆lnt2 and ∆lnt1 
lnt2 strains as shown, after seven days growth.  
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treated with sterile growth medium or with growth medium inoculated with the non-
pathogenic S. coelicolor (Fig. 7B). The entire root system grew into the agar making the 
plants difficult to remove without also removing a large amount of agar. In contrast, the root 
systems in plants infected with the S. scabies strains were much less complex. In the plants 
infected with wild-type S. scabies only the stunted primary root was present, with multiple 
brown nodules that represent failed secondary roots (Fig. 7B). These infected roots grow on 
the surface and cannot penetrate the growth medium. Only the fragile attachments of the root 
hairs allowed the plant to remain attached to the agar. This was also observed for the 
S. scabies lgt, lsp and lnt mutants. However, while infection with the lgt, lsp and lnt double 
mutants resulted in the stunted primary root seen in the wild-type infected plants, the overall 
phenotype is not as severe, and multiple secondary roots were consistently observed (Fig. 
7B). Cumulatively, these data suggest a minor contribution of lipoproteins to the virulence of 
S. scabies, although since the lgt and lsp strains have growth and developmental phenotypes 
(Fig. 1) this reduced virulence may be indirect because these strains are less robust than the 
wild-type. 
 
 
DISCUSSION 
 
The results presented here have extended our previous work on Streptomyces lipoprotein 
biogenesis by investigating the function of Streptomyces Lgt and Lsp in the plant pathogen 
S. scabies. Deleting the lsp gene in S. scabies resulted in a very similar phenotype to the 
S. coelicolor lsp mutant, with a small colony phenotype and delayed sporulation that could 
not be fully complemented by reintroducing the S. scabies lsp gene. This supports the more in 
depth analysis of lsp in S. coelicolor which suggested that deletion of lsp results in secondary 
mutations that suppress the otherwise lethal effects of losing Lsp from the cell (Thompson et 
al., 2010). Preliminary analysis of the genome sequences of the S. coelicolor lsp mutant and 
its parent strain suggest that a major transposition event has occurred in the lsp mutant 
(Widdick, Chandra and Hutchings, unpublished). S. coelicolor encodes two homologues of 
Lgt and the genes encoding these homologues could be deleted individually but not together 
in the same strain, which also suggested that lipoprotein biogenesis could be essential in this 
organism. In the current work the single lgt gene in S. scabies was successfully deleted and 
resulted in a growth and developmental phenotype similar to, but less severe than, that seen 
for the S. coelicolor and S. scabies lsp mutants. It is not clear why the lsp mutation has a more 
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severe effect than the lgt mutation in S. scabies but it is possibly due to the presence of 
lipoproteins with uncleaved signal sequences in the membrane which could accumulate and 
lead to membrane destabilisation and cell death. The S. scabies lgt mutation was only partially 
complemented by reintroduction of the S. scabies lgt gene, again supporting our suppressor 
mutation hypothesis. Two dimensional gel electrophoresis revealed a large scale loss of 
lipoproteins from the lipophilic fractions of the lgt mutant and a loss and major rearrangement 
of proteins in the lsp mutant suggesting the severe macro- and microscopic phenotypes 
observed in these strains result, at least partially, from loss of some or all of the lipoproteins 
from their membranes. Many of the lipoproteins missing from the lgt mutant membrane were 
detected in the extracellular fraction suggesting that, in the absence of lipidation, they are 
secreted out of the cell (Fig. 2 and Fig. S2). Lipoproteins were restored to the lipophilic 
fraction by in trans complementation with the corresponding genes from S. coelicolor or 
S. scabies. Crucially these results also confirm that S. coelicolor has two functional Lgt 
homologues, the first such demonstration for any bacterium.  
Deletion of lgt or lsp had only a moderate effect on virulence in the radish seedling assay 
when compared with wild-type S. scabies and the uninfected controls (Fig. 7). The moderate 
effects on virulence may be due, at least in part, to the aberrant localisation or loss of the 
lipoprotein SCAB81041, removal of which has previously been demonstrated to moderately 
attenuate virulence of S. scabies (Joshi et al., 2010). We also cannot discount the possibility 
that other lipoproteins may be involved in virulence. These could include the PAI lipoproteins 
SCAB77271, SCAB77361 and SCAB77471, although their functions and potential roles in 
the virulence of S. scabies remain to be investigated. None of these lipoproteins were detected 
in this work although it should be noted that the 2D gel analysis only identified ~10% of the 
predicted lipoproteome, consistent with similar experiments in S. coelicolor (Thompson et al., 
2010). However, it is also possible that the slower growing lgt and lsp mutant strains are less 
able to colonise the plant roots. 
We have previously noted that actinomycete bacteria encode homologues of the Lnt enzymes 
which N-acylate lipoproteins in Gram-negative bacteria and direct them to the outer 
membrane via the Lol pathway (Hutchings et al., 2009). It was subsequently shown that the 
M. smegmatis and M. tuberculosis Lnt homologues are true lipoprotein N-acyl transferase 
enzymes and are required for triacylation of lipoproteins in mycobacteria (Brülle et al., 2010; 
Tschumi et al., 2009). This finding is tantalising since mycobacteria have long been 
postulated to have an outer membrane made up of mycolic acids and this outer membrane 
bilayer hypothesis was recently proven experimentally (Hoffmann et al., 2008; Zuber et al., 
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2008). It is tempting therefore to hypothesise that lipoproteins may be transported from the 
cytoplasmic membrane to the outer membrane by an as yet undiscovered pathway. Such 
pathways must exist to transport proteins such as porins to the mycobacterial outer membrane 
and there is evidence that some lipoproteins in mycobacteria are surface exposed 
(Mawuenyega et al., 2005; Niederweis et al., 2010; Wu et al., 1998). In this work we report 
that lipoproteins are triacylated in Streptomyces bacteria that apparently do not possess an 
outer membrane. This suggests that N-acylation of lipoproteins has an additional function in 
bacteria, or an alternative function in Gram-positive bacteria, and has not simply evolved to 
target lipoproteins to the Lol apparatus of Gram-negative bacteria. Intriguingly, N-acylation 
has also been reported in the low GC branch of Gram-positive bacteria Firmicutes despite a 
lack of Lnt homologues in the genomes of these bacteria (Kurokawa et al., 2009; Navarre et 
al., 1996). This again suggests there is a function for triacylation of lipoproteins in Gram-
positive bacteria and in Gram-negative bacteria when they are retained in the cytoplasmic 
membrane by a sorting signal (Robichon et al., 2005). No function for triacylation could be 
elucidated from this study because deletion of either lnt1 or lnt2 singly or in combination had 
no obvious effect on lipoprotein stability in the cytoplasmic membrane. An lnt double mutant 
was moderately affected in virulence, with infected roots looking similar to those infected by 
the lgt and lsp mutants (Fig. 7B). These data are difficult to interpret at present since an lnt1 
mutation has the same effect as an lnt double mutation in terms of lipidation of SCO3484 but 
the lnt1 mutant was not affected in virulence (Fig. 7B). 
Importantly this is the first study of a bacterium with more than one Lnt enzyme and our 
results indicate that Lnt1 is indeed a lipoprotein N-acyl transferase. Although Lnt2 was not 
demonstrated to compensate for loss of Lnt1, the data suggest that both Lnt enzymes are 
required for efficient N-acylation of the heterologously expressed S. coelicolor lipoprotein 
SCO3484 as removal of Lnt2 resulted in a mixture of diacylated and triacylated SCO3484 
whereas only triacylated SCO3484 was detected in the wild type background. This implies 
Lnt2 does play a role in N-acylation of lipoproteins, perhaps through the formation of 
heterodimers with Lnt1. Despite sharing only 22% amino acid sequence identity both Lnt1 
and Lnt2 contain the conserved catalytic residues identified in E. coli Lnt and so we do not 
exclude the possibility that Lnt2 alone can catalyse N-acylation of other lipoproteins in 
S. scabies. It will be necessary to analyse the N-terminal modifications of multiple native 
S. scabies lipoproteins in the wild-type and lnt strains to fully elucidate the functions of these 
enzymes but given the technical challenge of purifying lipoproteins expressed at native levels 
this will not be trivial. We conclude that while Streptomyces are the first monoderm bacteria 
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to contain experimentally verified Lnt enzymes, alternative enzymes unrelated to Lnt at the 
sequence level likely exist to catalyse N-acylation in the low GC Firmicute bacteria. The 
function of N-acylation in monoderm bacteria remains to be discovered. 
In summary, this work has shown that lipoprotein biogenesis is likely a highly significant 
pathway in S. scabies as it is in S. coelicolor: although we were able to generate both lgt and 
lsp mutants these exhibited severe defects in growth and development, consistent with the 
bioinformatic analysis that lipoproteins are an abundant and functionally diverse category of 
protein in S. scabies. In addition to, or perhaps because of, their growth phenotypes, the lgt or 
lsp strains were also less virulent than wild-type S. scabies. This is also consistent with the 
identification of several candidate lipoproteins that could be involved in virulence and 
individual knockout mutations in these candidate lipoprotein genes will be necessary to 
elucidate their roles in plant infection. Crucially, this work has also extended the previous 
study by discovering a third N-acylation step in the Streptomyces lipoprotein biogenesis 
pathway. We have confirmed that Streptomyces encode functional Lnt enzymes that triacylate 
their lipoproteins. Future work will be aimed at elucidating the functions of Lnt1 and Lnt2 
and mapping the secondary mutations that arise when lipoprotein biogenesis is disrupted in 
Streptomyces species.  
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My contribution as a co-author to this manuscript was as follows: 
• MALDI-TOF data analysis 
• MALDI-TOF/TOF data analysis 
• Proof-reading of the manuscript 
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Lipidation of proteins is required for their anchoring into membranes and their sorting to the 
cell surface in all bacteria. Recent studies aimed at elucidating the role of lipoproteins and 
their synthesizing enzymes in the biology of mycobacteria. Lipoproteins are crucial for the 
synthesis of the mycobacterial cell wall, uptake of nutrients, signalling, sensing of 
environmental stress or host-pathogen interactions.  
In the present study the membrane anchor of lipoproteins from M. smegmatis, M. bovis and 
S. scabies were characterized at the molecular level. Lipoproteins of these species are 
triacylated as they carry a diacylglyceryl residue and an additional N-acyl. Triacylation of 
lipoproteins therefore seems to be a conserved mechanism in both Gram-negative and G+C-
rich Gram-positive bacteria.  
In Gram-negative bacteria, N-acylation by Lnt is a prerequisite for the transport of 
lipoproteins to the outer membrane by the Lol system. Likewise, N-acylation of mycobacterial 
lipoproteins may be required for the transport to the mycobacterial outer membrane, which 
resembles the outer membrane of Gram-negative bacteria. But, there are no Lol homologues 
present in the genomes of mycobacteria and their transport system still remains under 
investigation. Possible approaches to identify the transport system could be the expression of 
a lipoprotein construct with a reporter suitable for screening transposon libraries of 
mycobacteria, or in vivo photocrosslinking, by which a putative transporter is bound to a 
reporter lipoprotein and afterwards purified and analysed by fingerprint. 
By MALDI-TOF/TOF analyses, palmitic, oleic and tuberculostearic acid were identified as 
ester-linked fatty acids of the diacylglyceryl residue, while palmitic and tuberculostearic acid 
were found as N-acyl in mycobacteria. In S. scabies, C15 to C18 fatty acids were found to be 
ester-linked fatty acids of the diacylglyceryl residue, while C15 up to C19 fatty acids were 
found as N-acyl. Thus, the mycobacterial lipoprotein-synthezising enzymes differ in substrate 
specificity from that in E. coli. The recognition of lipoproteins by the innate host-immune 
system is mediated through the perception of the di- or triacylation by TLR-2 and its co-
receptors TLR-1 and TLR-6, respectively. The effect of the acyl-chain length and the 
composition of the fatty acids on TLR signalling have not been investigated in detail. If the 
selection and arrangement of fatty acids of the membrane anchor is crucial for the function of 
the lipoprotein, its recognition by transporters or for its correct localization in bacteria is 
another interesting point for further investigation.  
Beside the modifications with fatty acids, lipoproteins LprF and LppX in this study were also 
found with hexose glycosylations. O-glycosylations are known to occur at Ser and Thr 
residues, but the exact glycosylation site within the peptide is still unknown. Although an
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influence of glycosylation on the correct subcellular lipoprotein localization and its protection 
from proteolytic degradation is proposed, the information about its function isscarce. 
Generation of deletion mutants lacking the polyprenol-monophosphomannose synthase (Ppm) 
gene in M. smegmatis would be one option to investigate the effects of glycosylation on 
lipoprotein function, localization or degradation. Of note, Ppm is essential in M. tuberculosis. 
A tool for the identification of glycosylation sites could be lipoprotein analyses with mass 
spectrometry in combination with site directed mutagenesis. 
Within this study, BCG_2070c was confirmed as functional Lnt in M. bovis BCG. But, a 
second open reading frame, BCG_2279c homologous to E. coli Lnt was found. Streptomyces 
ssp. also encode two Lnt homologues, which both seem to be required for efficient lipoprotein 
N-acylation. Although BCG_2279c was not able to compensate Lnt function in the 
BCG_2070c deletion mutant in this study, a role of BCG_2279c as Lnt under special 
conditions could be supposed. Therefore, analyses of lipoproteins from BCG_2070c deletion 
mutants grown under specific growth conditions like stress or nutrient starvation would be an 
approach to investigate the role of the second Lnt homologue.  
The antituberculosis drug pipeline is still not sufficiently filled and the vaccines used at 
present do not provide effective protection against tuberculosis in adults. Due to their 
contribution to virulence, lipoproteins and their synthesizing enzymes are promising 
candidates as drug targets. Moreover, some lipoproteins confer a protective immune response 
and may therefore be used as subunit vaccines. But, despite progress in lipoprotein research 
much remains to be learned with respect to the synthesis, function and localization of 
mycobacterial lipoproteins and their role in host-pathogen interactions. The results of this 
study may contribute to provide the knowledge which is required on the way to combat 
tuberculosis.  
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